Non-pathogenic strains of HIV-1 containing mutations in the NEF gene or the U3 region of the long terminal repeat

The present invention relates to non-pathogenic strains of HIV-1 and to components, parts, fragments and derivatives thereof and to genetic sequences derived therefrom and their use in the development of diagnostic and therapeutic compositions for the treatment and prophylaxis of AIDS and AIDS-related disorders. The present invention also relates to a method for attenuating pathogenic stains of HIV-1 by mutagenizing particular regions of the HIV-1 genome.
Bibliographic details of the publications referred to in this specification are collected at the end of the description. Sequence Identity Numbers (SEQ ID NOs.) for the nucleotide and amino acid sequences referred to in the specification are defined following the bibliography.
Throughout this specification, unless the context requires other wise, the word "comprise", or variations such as "comprises" or "comprising", will be understood to imply the inclusion of a stated element or integer or group of elements or integers but not the exclusion of any other element or integer or group of elements or integers.
Genomic nucleotide sequences of HIV-1 strains referred to herein are represented by their corresponding DNA sequence.
Exemplary viral isolates referred to herein as "C18" and "C98" were deposited at the PHLS Centre for Applied Microbiology and Research, European Collection of Animal Cell Cultures (ECACC), Division of Biologies, Porton Down, Salisibury, Wiltshire SP4 OJG. C18 was deposited on Oct. 17, 1994 under Provisional Accession Number V94101706 and C98 was deposited on Oct. 31, 1994 under Provisional Accession Number V941031169. Viral isolate "C54" was deposited at ECACC on Mar. 10, 1995 under Provisional Accession Number V95031022.
A summary of particular deletion mutants of HIV-1 of the present invention referred to herein is given in FIG. 11.
Acquired Immune Deficiency Syndrome (AIDS) and AIDS related disorders are the clinical result of infection by Human Immunodeficiency Virus type I (HIV-1) (Barre-Sinoussi et al, 1983). Infection by HIV-1 is generally characterised by progressive immune system damage (Teeuwsen et al, 1990; Clerici et al, 1989) leading to opportunistic infections, malignancies or wasting syndrome that constitute clinically-defined AIDS (Busch et al, 1991 ; Klaslow et al, 1990).
The high mortality rate of individuals Infected with HIV-1 together with the social and economic consequences of the continuing HIV-1 epidemic has created an urgent need for a safe and effective treatment and/or prophylaxis against the devastating effects of AIDS. However, despite over a decade of high level scientific research into the pathogenesis of HIV-1 and the clinical manifestations of the disease, together with a detailed molecular analysis of the virus, there has been little success in the development of an effective vaccine. To date, the most effective therapy is treatment with zidovudine (AZT) which delays the onset of full blown AIDS and alleviates to some extent the symptoms of HIV-1 infection. However, AZT is not an innocuous compound and AZT, metabolic products thereof or impurities therein can cause a number of side effects which limit long term treatment with the drug. Furthermore, AZT resistant isolates have been reported during treatment. Clearly, therefore, a need exists to develop alternative strategies in preventing and treating HIV-1 infection.
The initial phases of HIV-1 infection are summarised by Levy (1993) as involving attachment, fission and nucleocapsid entry. These phases have been the traditional foci in research into development of antiviral strategies. The molecular events at the virus genomic level have also been the subject of intense scientific research with an aim being the development of a live attenuated vaccine as a possible approach for the treatment or prophylaxis of HIV-1 infection.
There is a high variable rate of progression from initial HIV-1 infection to AIDS which reflects a rapidly changing pathogen and variable immune response of the host to infection (Sheppard et al, 1993). With regards to the latter, HIV-1 can be considered as a heterogenous group of viruses differing at the genetic level with concomitant variable pathogenicity. For example, HIV-1 strains can differ in their capacity to kill cells. Furthermore, it appears that HIV-1 strains evolve in a host after infection and that the evolution varies depending on the tissues infected by the virus. The major sites in the genome apparently responsible for biological and pathological variation are the highly variable envelope region (Cheng-Mayer et al, 1991; Shioda et al, 1992; Hwang, et al 1991; Sullivan et al, 1993; Groenink et al, 1993) and the viral regulatory regions such as tat (Leguern et al, 1993). The genetic complexity of the HIV-1 group of viruses together with their variable pathogenicity, are major difficulties in the development of live vaccines, genetic vaccines or component vaccines.
Notwithstanding the highly pathogenic nature of HIV-1, there are some reports of long term survival of subjects infected with the virus (Learmont et al, 1992; Levy, 1993; Sheppard et al, 1993; Lifson et al 1991). It is not always clear, however, whether a benign course following HIV-1 infection is due to host factors, viral factors or other unknown factors. There are reports that most infected people have at least laboratory evidence of progressive immune system damage in the form of CD4+cell loss (Lang et al, 1989) and defective immune responses (Clerici et al, 1989).
Although simian monkeys have been used as an in vivo model for HIV and Simian Immunodeficiency Virus (SIV) infection, a major handicap in AIDS research has been the absence of suitable in vivo models to study the pathogencsis of the disease and, in particular, to study the viruses involved in benign infection. The need for a suitable in vivo model is heightened by the fact that results obtained in vitro cannot necessarily be extrapolated to what occurs in vivo. This was clearly observed by Mosier et al (1993) where conflicting results were obtained in animals compared to cell cultures.
Despite the absence of suitable in vivo models, considerable scientific research has been directed to attenuating HIV-1 strains by mutagenesis of the virus genome. Deletions in the nef gene have been implicated in attenuated strains of SIV and their use in providing protective effects in monkeys (Daniel et al, 1992). However, there are conflicting reports on the possible negative influence the nef gene product has on the rate or extent of virus replication (Terwilliger et al, 1986,Luciw et al, 1987; Niederman et al, 1989; Kim et al, 1989; Hammes et al, 1989). In fact, Kim et al (1989) found that nef did not affect HIV-1 replication or HIV-1 long terminal repeat (LTR)-driven CAT expression. Kestler III et al (1991) found that nef gene is required for fill pathogenic potential in SIV. However, such is the complexity of the HIV-1 group of viruses and the variability of immune responses between individuals let alone different species, that it is far from clear whether nef deleted strains of HIV-1 would behave similarly to nef deleted strains of SIV-1. There is a need, therefore, in order to investigate the possibility of nef deleted HIV-1 strain as a vaccine candidate, to identify individuals infected with such modified viruses.
Learmont et al (1992) reported that a cohort of five persons infected with blood products from a single HIV-1 infected donor have remained asymptomatic from up to about 10-14 years after infection. Subsequently, a sixth person has been identified as being part of the cohort. Both the donor and recipients were HIV-1 seropositive but with no indications of clinical symptoms of HIV-1 related disease and CD4+cell number and .beta..sub.2 -microglobulin levels have remained in the normal range. The identification of this cohort of benignly infected individuals provides a unique In vivo model in which the pathogenesis of HIV-1 infection can be studied at the clinical and molecular biological levels.
However, it has not always possible using conventional isolation procedures to routinely and reproducibly isolate viral strains from the above mentioned donor or recipients which has frustrated efforts to investigate the cause of the asymptomatic individuals. In accordance with the present invention, methods have now been established to isolate viruses from the above individuals. It has been determined, in accordance with the present invention, that the six individuals of the cohort are infected by non-pathogenic strains of HIV-1. Furthermore, the non-pathogenic strains of HIV-1 carry one or more nucleotide mutations. The non-pathogenic strains of the present invention enable the generation of a range of therapeutic, diagnostic and targeting agents against HIV-1 infection. The present invention also enables the attenuation of previously pathogenic strains of HIV-1.
Accordingly, one aspect of the present invention contemplates a non-pathog enic isolate of HIV-1 or a component, part, fragment or derivative thereof.
In a related embodiment, there is provided a novel isolate of HIV-1 or a component, part, fragment or derivative thereof wherein said HIV-1 isolate is capable of stimulating in a human or primate subject an immune response such as a humoral immune response to at least one HIV-1 glycoprotein such as but not limited to gp41-45, gp120 and/or gp160 while not substantially reducing in said human or primate subject proliferative responses and cytokine production to a mitogen, alloantigen and/or recall antigen compared to a healthy, non-infected human or primate subject. Preferably, the cytokine is IL-2. Preferably, the mitogen is ConA or PHA and the recall antigen is influenza or tetanus toxoid. Preferably, the HIV-1 isolate is non-pathogenic.
More particularly, the present invention relates to an isolated HIV-1 strain which:
(i) is substantially non-pathogenic in human subjects; and
(ii) carries one or more mutations in its genome resulting in the inability to direct synthesis of at least one pathogenic HIV-1 derived polypeptide or protein.
Even more particularly, the present invention provides an isolated HIV-1 strain which:
(i) is substantially non-pathogenic in human subjects; and
(ii) carries a mutation in the nef gene and/or a long terminal repeat (LTR) region or in a functionally equivalent location in the HIV-1 genome.
Still even more particularly, the present invention is directed to an isolated virus which:
(i) has a genome which is capable of hybridising under medium stringency conditions to complementary nucleic acid from a pathogenic strain of HIV-1;
(ii) is substantially non-pathogenic in human subjects;
(iii) carries one or more deletion mutations in a region of its genome corresponding to a nef gene in said pathogenic strain of HIV-1 ; and
(iv) optionally carries a mutation in one or both LTR regions.
In a related embodiment, there is provided an isolated virus which:
(i) has a genome which is capable of hybridising under medium stringency conditions to complementary nucleic acid from a pathogenic strain of HIV-1;
(ii) is substantially non-pathogenic in human subjects;
(iii) carries one or more deletion mutations in an LTR region of its genome; and
(iv) optionally carries a mutation in a region corresponding to a nef gene in said pathogenic strain of HIV-1.
In a further related embodiment, there is provided an isolated virus which:
(i) has a genome which is capable of hybridising under medium stringency conditions to complementary nucleic acid from a pathogenic strain of HIV-1;
(ii) is substantially non-pathogenic in human subjects; and
(iii) carries one or more deletion mutations in a region of its genome corresponding to a region which contains nef coding sequences and LTR nucleotide sequences.
In a particularly preferred embodiment, the present invention provides non-pathogenic HIV-1 isolate C18 deposited at the ECACC on Oct. 17, 1994 under Provisional Accession Number V94101706.
In a related embodiment, the present invention provides non-pathogenic HIV-1 isolate C98 deposited at the ECACC on Oct. 31, 1994 under Provisional Accession Number V941031169.
In another embodiment, the present invention provides non-pathogenic HIV-1 isolate C54 deposited at ECACC on Mar. 10, 1995 under Provisional Accession No. V95031022
Although pathogenicity is a relative term, it is used herein in relation to the capacity of a strain of HIV-1 to induce AIDS or AIDS-related disorders in an individual over time. Accordingly, a "non-pathogenic" strain of HIV-1 is a strain which, at the clinical level, does not lead to the development of AIDS, at least within the median time of 6-10 years following infection with HIV1. At the laboratory level, a non-pathogenic strain of HIV-1 is considered not to alter CD4+ cell counts or .beta..sub.2 -microglobulin concentrations. In addition, a non-pathogenic strain of HIV-1 may not alter CD8+and CD3+cell counts and would not alter lymphocyte counts. CD4+: CD8+ratios also remain unchanged relative to normal non-infected individuals. Furthermore, generally, a non-pathogenic strain of HIV-1 does not induce p24 antigenaemia A non-pathogenic HIV-1 of the present invention is generally still infectious but individuals infected with the virus remain free of symptoms for at least 6-10 years after infection.
A laboratory classified non-pathogenic strain of HIV-1 may be determined at any time after infection, The term "non-pathogenic" is not to be considered as a strain that is never pathogenic under any conditions as this might depend on the host individual, the level of immune responsiveness in that individual and the extent or otherwise of other, for example, immune comprising disorders. Accordingly, a "non-pathogenic"HIV-1 isolate of the present invention may also be considered a "low virulent" strain of the virus. A non-pathogenic strain of HIV-1 as contemplated herein may be isolated from an asymptomatic individual or may be derived from a pathogenic strain by mutation. Although the present invention is not to be limited to any particular pathogenic strain of HIV-1, for reference purposes, an example of a pathogenic strain is HIV-1 NL4-3 strain as described by Myers et al (1992).
The non-pathogenic nature of the HIV-1 of the present invention is conveniently evidenced by the cohort of seven individuals comprising one donor and six recipients which have remained free of symptoms or signs of HIV-1 Infection for greater than the median time of 6-10 years. However, the individuals of the cohort are seropositive for HIV-1 following infection with the virus as determined by Western blot analysis and genetic analysis (e.g. using PCR techniques). A seropositive individual is one showing reactivity to at least one HIV-1 glycoprotein (such as but not limited to gp 41-45, gp120, gp 160) and at least three other virus-specific bands.
In accordance with the present invention, a non-pathogenic HIV-1 isolate is also a strain of HIV-1 which:
(i) induces an immune response in a human or primate subject; and
(ii) does not substantially reduce proliferative responses or cytokine production to a mitogen, alloantigen and/or recall antigen relative to a healthy, non-infected subject.
Preferably, the immune response such as to a glycoprotein, for example gp41-45, gp120 and/or gp1160. Preferably, the cytokine monitored is an interleukin, such as IL-2. Preferably, the recall antigen is influenza or tetanus toxoid. A non-pathogenic HIV-1 isolate is also one which:
(iii) does not substantially alter proliferative responses or cytokine production to allorgeneic mononuclear cells.
The genomes or complementary DNA therefrom of the non-pathogenic HIV-1 isolates of the present invention are capable of hybridising under medium stringency conditions to the corresponding genome or complementary DNA of a pathogenic strain of HIV-1 (e.g. HIV-1 strain NL4-3). The ability to hybridise to a pathogenic rain of HIV-1 only applies to a comparison of the entire genome/complementary DNA of a non-pathogenic strain or a fragment which includes genetic material corresponding to a region in the genome 3' of the nef gene in a pathogenic strain of HIV-1.
For the purposes of reference only, a suitable genomic nucleotide sequence from a pathogenic HIV-1 strain is set forth in SEQ ID NO: 1 from HIV-1 strain NL4-3 (Myers et al, 1992):
1 TGGAAGGGCTAATTTGGTCCCAAAAAAGACAAGAGATCCTTGATCTGTGG 51 ATCTACCACACACAAGGCTACTTCCCTGATTGGCAGAACTACACACCAGG 101 GCCAGGGATCAGATATCCACTGACCTTTGGATGGTGCTTCAAGTTAGTAC 151 CAGTTGAACCAGAGCAAGTAGAAGAGGCCAAATAAGGAGAGAAGAACAGC 201 TTGTTACACCCTATGAGCCAGCATGGGATGGAGGACCCGGAGGGAGAAGT 251 ATTAGTGTGGAAGTTTGACAGCCTCCTAGCATTTCGTCACATGGCCCGAG 301 AGCTGCATCCGGAGTACTACAAAGACTGCTGACATCGAGCTTTCTACAAG 351 GGACTTTCCGCTGGGGACTTTCCAGGGAGGTGTGGCCTGGGCGGGACTGG 401 GGAGTGGCGAGCCCTCAGATGCTACATATAAGCAGCTGCTTTTTGCCTGT 451 ACTGGGTCTCTCTGGTTAGACCAGATCTGAGCCTGGGAGCTCTCTGGCTA 501 ACTAGGGAACCCACTGCTTAAGCCTCAATAAAGCTTGCCTTGAGTGCTCA 551 AAGTAGTGTGTGCCCGTCTGTTGTGTGACTCTGGTAACTAGAGATCCCTC 601 AGACCCTTTTAGTCAGTGTGGAAAATCTCTAGCAGTGGCGCCCGAACAGG 651 GACTTGAAAGCGAAAGTAAAGCCAGAGGAGATCTCTCGACGCAGGACTCG 701 GCTTGCTGAAGCGCGCACGGCAAGAGGCGAGGGGCGGCGACTGGTGAGTA 751 CGCCAAAAATTTTGACTAGCGGAGGCTAGAAGGAGAGAGATGGGTGCGAG 801 AGCGTCGGTATTAAGCGGGGGAGAATTAGATAAATGGGAAAAAATTCGGT 851 TAAGGCCAGGGGGAAAGAAACAATATAAACTAAAACATATAGTATGGGCA 901 AGCAGGGAGCTAGAACGATTCGCAGTTAATCCTGGCCTTTTAGAGACATC 951 AGAAGGCTGTAGACAAATACTGGGACAGCTACAACCATCCCTTCAGACAG1001 GATCAGAAGAACTTAGATCATTATATAATACAATAGCAGTCCTCTATTGT1051 GTGCATCAAAGGATAGATGTAAAAGACACCAAGGAAGCCTTAGATAAGAT1101 AGAGGAAGAGCAAAACAAAAGTAAGAAAAAGGCACAGCAAGCAGCAGCTG1151 ACACAGGAAACAACAGCCAGGTCAGCCAAAATTACCCTATAGTGCAGAAC1201 CTCCAGGGGCAAATGGTACATCAGGCCATATCACCTAGAACTTTAAATGC1251 ATGGGTAAAAGTAGTAGAAGAGAAGGCTTTCAGCCCAGAAGTAATACCCA1301 TGTTTTCAGCATTATCAGAAGGAGCCACCCCACAAGATTTAAATACCATG1351 CTAAACACAGTGGGGGGACATCAAGCAGCCATGCAAATGTTAAAAGAGAC1401 CATCAATGAGGAAGCTGCAGAATGGGATAGATTGCATCCAGTGCATGCAG1451 GGCCTATTGCACCAGGCCAGATGAGAGAACCAAGGGGAAGTGACATAGCA1501 GGAACTACTAGTACCCTTCAGGAACAAATAGGATGGATGACACATAATCC1551 ACCTATCCCAGTAGGAGAAATCTATAAAAGATGGATAATCCTGGGATTAA1601 ATAAAATAGTAAGAATGTATAGCCCTACCAGCATTCTGGACATAAGACAA1651 GGACCAAAGGAACCCTTTAGAGACTATGTAGACCGATTCTATAAAACTCT1701 AAGAGCCGAGCAAGCTTCACAAGAGGTAAAAAATTGGATGACAGAAACCT1751 TGTTGGTCCAAAATGCGAACCCAGATTGTAAGACTATTTTAAAAGCATTG1801 GGACCAGGAGCGACACTAGAAGAAATGATGACAGCATGTCAGGGAGTGGG1851 GGGACCCGGCCATAAAGCAAGAGTTTTGGCTGAAGCAATGAGCCAAGTAA1901 CAAATCCAGCTACCATAATGATACAGAAAGGCAATTTTAGGAACCAAAGA1951 AAGACTGTTAAGTGTTTCAATTGTGGCAAAGAAGGGCACATAGCCAAAAA2001 TTGCAGGGCCCCTAGGAAAAAGGGCTGTTGGAAATGTGGAAAGGAAGGAC2051 ACCAAATGAAAGATTGTACTGAGAGACAGGCTAATTTTTTAGGGAAGATC2101 TGGCCTTCCCACAAGGGAAGGCCAGGGAATTTTCTTCAGAGCAGACCAGA2151 GCCAACAGCCCCACCAGAAGAGAGCTTCAGGTTTGGGGAAGAGACAACAA2201 CTCCCTCTCAGAAGCAGGAGCCGATAGACAAGGAACTGTATCCTTTAGCT2251 TCCCTCAGATCACTCTTTGGCAGCGACCCCTCGTCACAATAAAGATAGGG2301 GGGCAATTAAAGGAAGCTCTATTAGATACAGGAGCAGATGATACAGTATT2351 AGAAGAAATGAATTTGCCAGGAAGATGGAAACCAAAAATGATAGGGGGAA2401 TTGGAGGTTTTATCAAAGTAGGACAGTATGATCAGATACTCATAGAAATC2451 TGCGGACATAAAGCTATAGGTACAGTATTAGTAGGACCTACACCTGTCAA2501 CATAATTGGAAGAAATCTGTTGACTCAGATTGGCTGCACTTTAAATTTTC2551 CCATTAGTCCTATTGAGACTGTACCAGTAAAATTAAAGCCAGGAATGGAT2601 GGCCCAAAAGTTAAACAATGGCCATTGACAGAAGAAAAAATAAAAGCATT2651 AGTAGAAATTTGTACAGAAATGGAAAAGGAAGGAAAAATTTCAAAAATTG2701 GGCCTGAAAATCCATACAATACTCCAGTATTTGCCATAAAGAAAAAAGAC2751 AGTACTAAATGGAGAAAATTAGTAGATTTCAGAGAACTTAATAAGAGAAC2801 TCAAGATTTCTGGGAAGTTCAATTAGGAATACCACATCCTGCAGGGTTAA2851 AACAGAAAAAATCAGTAACAGTACTGGATGTGGGCGATGCATATTTTTCA2901 GTTCCCTTAGATAAAGACTTCAGGAAGTATACTGCATTTACCATACCTAG2951 TATAAACAATGAGACACCAGGGATTAGATATCAGTACAATGTGCTTCCAC3001 AGGGATGGAAAGGATCACCAGCAATATTCCAGTGTAGCATGACAAAAATC3051 TTAGAGCCTTTTAGAAAACAAAATCCAGACATAGTCATCTATCAATACAT3101 GGATGATTTGTATGTAGGATCTGACTTAGAAATAGGGCAGCATAGAACAA3151 AAATAGAGGAACTGAGACAACATCTGTTGAGGTGGGGATTTACCACACCA3201 GACAAAAAACATCAGAAAGAACCTCCATTCCTTTGGATGGGTTATGAACT3251 CCATCCTGATAAATGGACAGTACAGCCTATAGTGCTGCCAGAAAAGGACA3301 GCTGGACTGTCAATGACATACAGAAATTAGTGGGAAAATTGAATTGGGCA3351 AGTCAGATTTATGCAGGGATTAAAGTAAGGCAATTATGTAAACTTCTTAG3401 GGGAACCAAAGCACTAACAGAAGTAGTACCACTAACAGAAGAAGCAGAGC3451 TAGAACTGGCAGAAAACAGGGAGATTCTAAAAGAACCGGTACATGGAGTG3501 TATTATGACCCATCAAAAGACTTAATAGCAGAAATACAGAAGCAGGGGCA3551 AGGCCAATGGACATATCAAATTTATCAAGAGCCATTTAAAAATCTGAAAA3601 CAGGAAAATATGCAAGAATGAAGGGTGCCCACACTAATGATGTGAAACAA3651 TTAACAGAGGCAGTACAAAAAATAGCCACAGAAAGCATAGTAATATGGGG3701 AAAGACTCCTAAATTTAAATTACCCATACAAAAGGAAACATGGGAAGCAT3751 GGTGGACAGAGTATTGGCAAGCCACCTGGATTCCTGAGTGGGAGTTTGTC3801 AATACCCCTCCCTTAGTGAAGTTATGGTACCAGTTAGAGAAAGAACCCAT3851 AATAGGAGCAGAAACTTTCTATGTAGATGGGGCAGCCAATAGGGAAACTA3901 AATTAGGAAAAGCAGGATATGTAACTGACAGAGGAAGACAAAAAGTTGTC3951 CCCCTAACGGACACAACAAATCAGAAGACTGAGTTACAAGCAATTCATCT4001 AGCTTTGCAGGATTCGGGATTAGAAGTAAACATAGTGACAGACTCACAAT4051 ATGCATTGGGAATCATTCAAGCACAACCAGATAAGAGTGAATCAGAGTTA4101 GTCAGTCAAATAATAGAGCAGTTAATAAAAAAGGAAAAAGTCTACCTGGC4151 ATGGGTACCAGCACACAAAGGAATTGGAGGAAATGAACAAGTAGATGGGT4201 TGGTCAGTGCTGGAATCAGGAAAGTACTATTTTTAGATGGAATAGATAAG4251 GCCCAAGAAGAACATGAGAAATATCACAGTAATTGGAGAGCAATGGCTAG4301 TGATTTTAACCTACCACCTGTAGTAGCAAAAGAAATAGTAGCCAGCTGTG4351 ATAAATGTCAGCTAAAAGGGGAAGCCATGCATGGACAAGTAGACTGTAGC4401 CCAGGAATATGGCAGCTAGATTGTACACATTTAGAAGGAAAAGTTATCTT4451 GGTAGCAGTTCATGTAGCCAGTGGATATATAGAAGCAGAAGTAATTCCAG4501 CAGAGACAGGGCAAGAAACAGCATACTTCCTCTTAAAATTAGCAGGAAGA4551 TGGCCAGTAAAAACAGTACATACAGACAATGGCAGCAATTTCACCAGTAC4601 TACAGTTAAGGCCGCCTGTTGGTGGGCGGGGATCAAGCAGGAATTTGGCA4651 TTCCCTACAATCCCCAAAGTCAAGGAGTAATAGAATCTATGAATAAAGAA4701 TTAAAGAAAATTATAGGACAGGTAAGAGATCAGGCTGAACATCTTAAGAC4751 AGCAGTACAAATGGCAGTATTCATCCACAATTTTAAAAGAAAAGGGGGGA4801 TTGGGGGGTACAGTGCAGGGGAAAGAATAGTAGACATAATAGCAACAGAC4851 ATACAAACTAAAGAATTACAAAAACAAATTACAAAAATTCAAAATTTTCG4901 GGTTTATTACAGGGACAGCAGAGATCCAGTTTGGAAAGGACCAGCAAAGC4951 TCCTCTGGAAAGGTGAAGGGGCAGTAGTAATACAAGATAATAGTGACATA5001 AAAGTAGTGCCAAGAAGAAAAGCAAAGATCATCAGGGATTATGGAAAACA5051 GATGGCAGGTGATGATTGTGTGGCAAGTAGACAGGATGAGGATTAACACA5101 TGGAAAAGATTAGTAAAACACCATATGTATATTTCAAGGAAAGCTAAGGA5151 CTGGTTTTATAGACATCACTATGAAAGTACTAATCCAAAAATAAGTTCAG5201 AAGTACACATCCCACTAGGGGATGCTAAATTAGTAATAACAACATATTGG5251 GGTCTGCATACAGGAGAAAGAGACTGGCATTTGGGTCAGGGAGTCTCCAT5301 AGAATGGAGGAAAAAGAGATATAGCACACAAGTAGACCCTGACCTAGCAG5351 ACCAACTAATTCATCTGCACTATTTTGATTGTTTTTCAGAATCTGCTATA5401 AGAAATACCATATTAGGACGTATAGTTAGTCCTAGGTGTGAATATCAAGC5451 AGGACATAACAAGGTAGGATCTCTACAGTACTTGGCACTAGCAGCATTAA5501 TAAAACCAAAACAGATAAAGCCACCTTTGCCTAGTGTTAGGAAACTGACA5551 GAGGACAGATGGAACAAGCCCCAGAAGACCAAGGGCCACAGAGGGAGCCA5601 TACAATGAATGGACACTAGAGCTTTTAGAGGAACTTAAGAGTGAAGCTGT5651 TAGACATTTTCCTAGGATATGGCTCCATAACTTAGGACAACATATCTATG5701 AAACTTACGGGGATACTTGGGCAGGAGTGGAAGCCATAATAAGAATTCTG5751 CAACAACTGCTGTTTATCCATTTCAGAATTGGGTGTCGACATAGCAGAAT5801 AGGCGTTACTCGACAGAGGAGAGCAAGAAATGGAGCCAGTAGATCCTAGA5851 CTAGAGCCCTGGAAGCATCCAGGAAGTCAGCCTAAAACTGCTTGTACCAA5901 TTGCTATTGTAAAAAGTGTTGCTTTCATTGCCAAGTTTGTTTCATGACAA5951 AAGCCTTAGGCATCTCCTATGGCAGGAAGAAGCGGAGACAGCGACGAAGA6001 GCTCATCAGAACAGTCAGACTCATCAAGCTTCTCTATCAAAGCAGTAAGT6051 AGTACATGTAATGCAACCTATAATAGTAGCAATAGTAGCATTAGTAGTAG6101 CAATAATAATAGCAATAGTTGTGTGGTCCATAGTAATCATAGAATATAGG6151 AAAATATTAAGACAAAGAAAAATAGACAGGTTAATTGATAGACTAATAGA6201 AAGAGCAGAAGACAGTGGCAATGAGAGTGAAGGAGAAGTATCAGCACTTG6251 TGGAGATGGGGGTGGAAATGGGGCACCATGCTCCTTGGGATATTGATGAT6301 CTGTAGTGCTACAGAAAAATTGTGGGTCACAGTCTATTATGGGGTACCTG6351 TGTGGAAGGAAGCAACCACCACTCTATTTTGTGCATCAGATGCTAAAGCA6401 TATGATACAGAGGTACATAATGTTTGGGCCACACATGCCTGTGTACCCAC6451 AGACCCCAACCCACAAGAAGTAGTATTGGTAAATGTGACAGAAAATTTTA6501 ACATGTGGAAAAATGACATGGTAGAACAGATGCATGAGGATATAATCAGT6551 TTATGGGATCAAAGCCTAAAGCCATGTGTAAAATTAACCCCACTCTGTGT6601 TAGTTTAAAGTGCACTGATTTGAAGAATGATACTAATACCAATAGTAGTA6651 GCGGGAGAATGATAATGGAGAAAGGAGAGATAAAAAACTGCTCTTTCAAT6701 ATCAGCACAAGCATAAGAGATAAGGTGCAGAAAGAATATGCATTCTTTTA6751 TAAACTTGATATAGTACCAATAGATAATACCAGCTATAGGTTGATAAGTT6801 GTAACACCTCAGTCATTACACAGGCCTGTCCAAAGGTATCCTTTGAGCCA6851 ATTCCCATACATTATTGTGCCCCGGCTGGTTTTGCGATTCTAAAATGTAA6901 TAATAAGACGTTCAATGGAACAGGACCATGTACAAATGTCAGCACAGTAC6951 AATGTACACATGGAATCAGGCCAGTAGTATCAACTCAACTGCTGTTAAAT7001 GGCAGTCTAGCAGAAGAAGATGTAGTAATTAGATCTGCCAATTTCACAGA7051 CAATGCTAAAACCATAATAGTACAGCTGAACACATCTGTAGAAATTAATT7101 GTACAAGACCCAACAACAATACAAGAAAAAGTATCCGTATCCAGAGGGGA7151 CCAGGGAGAGCATTTGTTACAATAGGAAAAATAGGAAATATGAGACAAGC7201 ACATTGTAACATTAGTAGAGCAAAATGGAATGCCACTTTAAAACAGATAG7251 CTAGCAAATTAAGAGAACAATTTGGAAATAATAAAACAATAATCTTTAAG7301 CAATCCTCAGGAGGGGACCCAGAAATTGTAACGCACAGTTTTAATTGTGG7351 AGGGGAATTTTTCTACTGTAATTCAACACAACTGTTTAATAGTACTTGGT7401 TTAATAGTACTTGGAGTACTGAAGGGTCAAATAACACTGAAGGAAGTGAC7451 ACAATCACACTCCCATGCAGAATAAAACAATTTATAAACATGTGGCAGGA7501 AGTAGGAAAAGCAATGTATGCCCCTCCCATCAGTGGACAAATTAGATGTT7551 CATCAAATATTACTGGGCTGCTATTAACAAGAGATGGTGGTAATAACAAC7601 AATGGGTCCGAGATCTTCAGACCTGGAGGAGGCGATATGAGGGACAATTG7651 GAGAAGTGAATTATATAAATATAAAGTAGTAAAAATTGAACCATTAGGAG7701 TAGCACCCACCAAGGCAAAGAGAAGAGTGGTGCAGAGAGAAAAAAGAGCA7751 GTGGGAATAGGAGCTTTGTTCCTTGGGTTCTTGGGAGCAGCAGGAAGCAC7801 TATGGGCTGCACGTCAATGACGCTGACGGTACAGGCCAGACAATTATTGT7851 CTGATATAGTGCAGCAGCAGAACAATTTGCTGAGGGCTATTGAGGCGCAA7901 CAGCATCTGTTGCAACTCACAGTCTGGGGCATCAAACAGCTCCAGGCAAG7951 AATCCTGGCTGTGGAAAGATACCTAAAGGATCAACAGCTCCTGGGGATTT8001 GGGGTTGCTCTGGAAAACTCATTTGCACCACTGCTGTGCCTTGGAATGCT8051 AGTTGGAGTAATAAATCTCTGGAACAGATTTGGAATAACATGACCTGGAT8101 GGAGTGGGACAGAGAAATTAACAATTACACAAGCTTAATACACTCCTTAA8151 TTGAAGAATCGCAAAACCAGCAAGAAAAGAATGAACAAGAATTATTGGAA8201 TTAGATAAATGGGCAAGTTTGTGGAATTGGTTTAACATAACAAATTGGCT8251 GTGGTATATAAAATTATTCATAATGATAGTAGGAGGCTTGGTAGGTTTAA8301 GAATAGTTTTTGCTGTACTTTCTATAGTGAATAGAGTTAGGCAGGGATAT8351 TCACCATTATCGTTTCAGACCCACCTCCCAATCCCGAGGGGACCCGACAG8401 GCCCGAAGGAATAGAAGAAGAAGGTGGAGAGAGAGACAGAGACAGATCCA8451 TTCGATTAGTGAACGGATCCTTAGCACTTATCTGGGACGATCTGCGGAGC8501 CTGTGCCTCTTCAGCTACCACCGCTTGAGAGACTTACTCTTGATTGTAAC8551 GAGGATTGTGGAACTTCTGGGACGCAGGGGGTGGGAAGCCCTCAAATATT8601 GGTGGAATCTCCTACAGTATTGGAGTCAGGAACTAAAGAATAGTGCTGTT8651 AACTTGCTCAATGCCACAGCCATAGCAGTAGCTGAGGGGACAGATAGGGT8701 TATAGAAGTATTACAAGCAGCTTATAGAGCTATTCGCCACATACCTAGAA8751 GAATAAGACAGGGCTTGGAAAGGATTTTGCTATAAGATGGGTGGCAAGTG8801 GTCAAAAAGTAGTGTGATTGGATGGCCTGCTGTAAGGGAAAGAATGAGAC8851 GAGCTGAGCCAGCAGCAGATGGGGTGGGAGCAGTATCTCGAGACCTAGAA8901 AAACATGGAGCAATCACAAGTAGCAATACAGCAGCTAACAATGCTGCTTG8951 TGCCTGGCTAGAAGCACAAGAGGAGGAAGAGGTGGGTTTTCCAGTCACAC9001 CTCAGGTACCTTTAAGACCAATGACTTACAAGGCAGCTGTAGATCTTAGC9051 CACTTTTTAAAAGAAAAGGGGGGACTGGAAGGGCTAATTCACTCCCAAAG9101 AAGACAAGATATCCTTGATCTGTGGATCTACCACACACAAGGCTACTTCC9151 CTGATTGGCAGAACTACACACCAGGGCCAGGGGTCAGATATCCACTGACC9201 TTTGGATGGTGCTACAAGCTAGTACCAGTTGAGCCAGATAAGGTAGAAGA9251 GGCCAATAAAGGAGAGAACACCAGCTTGTTACACCCTGTGAGCCTGCATG9301 GAATGGATGACCCTGAGAGAGAAGTGTTAGAGTGGAGGTTTGACAGCCGC9351 CTAGCATTTCATCACGTGGCCCGAGAGCTGCATCCGGAGTACTTCAAGAA9401 CTGCTGACATCGAGCTTGCTACAAGGGACTTTCCGCTGGGGACTTTCCAG9451 GGAGGCGTGGCCTGGGCGGGACTGGGGAGTGGCGAGCCCTCAGATGCTGC9501 ATATAAGCAGCTGCTTTTTGCCTGTACTGGGTCTCTCTGGTTAGACCAGA9551 TCTGAGCCTGGGAGCTCTCTGGCTAACTAGGGAACCCACTGCTTAAGCCT9601 CAATAAAGCTTGCCTTGAGTGCTTCAAGTAGTGTGTGCCCGTCTGTTGTG9651 TGACTCTGGTAACTAGAGATCCCTCAGACCCTTTTAGTCAGTGTGGAAAA9701 TCTCTAGCA
However, for the purposes of comparing the nucleotide sequences of non-pathogenic HIV-1 strains including the ability to hybridise to a reference strain, the present invention extends to a genomic nucleotide sequence from any pathogenic strain of HIV-1.
Accordingly, in a particularly preferred embodiment, there is provided a viral isolate which;
(i) caries a genome which is capable of hybridising under medium stringency conditions to SEQ ID NO: 1 or a complementary form thereof or an analogous sequence from another pathogenic strain of HIV-1; and
(ii) carries a deletion mutation in a region corresponding to the nef gene and/or in an LTR region. Generally, such an HIV-1 isolate is non-pathogenic as hereinbefore defined.
In a related embodiment, there is provided an isolated virus which:
(i) has a genome which is capable of hybridising under medium stringency conditions to complementary nucleic acid from a pathogenic strain of HIV-1;
and
(ii) carries one or more deletion mutations in a region of its genome corresponding to a region which contains nef coding sequences and LTR nucleotide sequences.
For the purposes of defining the level of stringency, reference can conveniently be made to Maniatis et al (1982) at pages 387-389 which is herein incorporated by reference where the washing steps disclosed are considered high stringency. A low stringency is defined herein as being in 1-3.times.SSC/0.1-0.5% w/v SDS at 37-50.degree. C. for 2-3 hours. Depending on the source and concentration of nucleic acid involved in the hybridisation, alternative conditions of stringency may be employed such as medium stringent conditions which are considered herein to be 0.1-1.times.SSC/0.25-0.5% w/v SDS at.gtoreq.45.degree. C. for 2-3 hours or high stringent conditions considered herein to be 0.1-1.times.SSC/0.1% w/v SDS at 60.degree. C. for 1-3 hours.
In a particularly preferred embodiment of the present invention, the non-pathogenic strain of HIV-1 carries a mutation in the nef gene and/or LTR region of the genome.
A "mutation" is considered herein to include a single or multiple nucleotide substitution, deletion and/or addition. Most preferred mutations are single or multiple deletions of at least one, most preferably at least ten and even more preferably at least twenty contiguous nucleotides from a region corresponding to the nef gene and/or the LTR region. When the non-pathogenic virus carries a mutation in the LTR region, this generally occurs 5' of the Sp1 sites.
According to a preferred aspect of the present invention, there is provided a viral isolate which:
(i) is reactive to antibodies to a glycoprotein from HIV-1 such as at least one of gp41-45, gp120 and/or gp160;
(ii) is substantially non-pathogenic in human subjects; and
(iii) carries a deletion mutation of at least ten nucleotides in a region corresponding to the nef gene and/or LTR region of a pathogenic strain of HIV-1.
In another embodiment, there is provided a viral isolate which:
(i) is capable of inducing an immune response to at least one of gag, pot and/or env;
(ii) is substantially non-pathogenic in human subjects; and
(iii) carries a deletion mutation of at least ten nucleotides in a region corresponding to the nef gene and/or LTR region of a pathogenic strain of HIV-1.
Preferably, in respect of the latter embodiment, the immune response is an antibody or a cell mediated response. In a most preferred embodiment, the immune response is a humoral immune response.
The nucleotide sequence of the nef gene in HIV-1 NL4-3 is defined in SEQ ID NO: 650:
ATGGGTGGCAAGTGGTCAAAAAGTAGTGTGATTGGATGGCCTGCTGTAAGGGAAAGAATGAGACGAGCTGAGCCAGCAGCAGATGGGGTGGGAGCAGTATCTCGAGACCTAGAAAAACATGGAGCAATCACAAGTAGCAATACAGCAGCTAACAATGCTGCTTGTGCCTGGCTAGAAGCACAAGAGGAGGAAGAGGTGGGTTTTCCAGTCACACCTCAGGTACCTTTAAGACCAATGACTTACAAGGCAGCTGTAGATCTTAGCCACTTTTTAAAAGAAAAGGGGGGACTGGAAGGGCTAATTCACTCCCAAAGAAGACAAGATATCCTTGATCTGTGGATCTACCACACACAAGGCTACTTCCCTGATTGGCAGAACTACACACCAGGGCCAGGGGTCAGATATCCACTGACCTTTGGATGGTGCTACAAGCTAGTACCAGTTGAGCCAGATAAGGTAGAAGAGGCCAATAAAGGAGAGAACACCAGCTTGTTACACCCTGTGAGCCTGCATGGAATGGATGACCCTGAGAGAGAAGTGTTAGAGTGGAGGTTTGACAGCCGCCTAGCATTTCATCACGTGGCCCGAGAGCTGCATCCGGAGTACTTCAAGAACTGCTGA
The present invention extends to any or all single or multiple nucleotide deletions to a contiguous series of at least ten nucleotides from the nef gene which render the strain avirulent. The deletions may encompass the entire gene or parts thereof and may represent a single deletion or two or more deletions. Put in alternative terms, the non-pathogenic HIV-1 isolates of the present invention comprise a nucleotide sequence at the corresponding nef gene region non-identifiable to SEQ ID NO: 650, said non-identity comprising at least 5%, more preferably at least 10% and even more preferably at least 20% variation thereon.
In a preferred embodiment, therefore, the present invention contemplates a viral isolate which:
(i) is reactive to antibodies to a glycoprotein from HIV-1 such as at least one of gp41-45, gp120 and/or gp160;
(ii) carries a genome or a part or fragment thereof capable of hybridising under medium stringency conditions to a nucleotide sequence as set forth in SEQ ID NO: 1 or a complementary form thereof or an analogous sequence from another pathogenic strain of HIV-1;
(iii) carries a deletion of at least ten nucleotides in a region corresponding to the nef gene in HIV-1 NL4-3; and
wherein said deletion encompasses one or more of the following decanucleotides from the nef gene of HIV-1 NL4-3 or corresponding sequences from another pathogenic strain of HIV-1:
ATGGGTGGCA (SEQ ID NO: 2); TGGGTGGCAA (SEQ ID NO: 3);GGGTGGCAAG (SEQ ID NO: 4); GGTGGCAAGT (SEQ ID NO: 5);GTGGCAAGTG (SEQ ID NO: 6); TGGCAAGTGG (SEQ ID NO: 7);GGCAAGTGGT (SEQ ID NO: 8); GCAAGTGGTC (SEQ ID NO: 9);CAAGTGGTCA (SEQ ID NO: 10); AAGTGGTCAA (SEQ ID NO: 11);AGTGGTCAAA (SEQ ID NO: 12); GTGGTCAAAA (SEQ ID NO: 13);TGGTCAAAAA (SEQ ID NO: 14); GGTCAAAAAG (SEQ ID NO: 15);GTCAAAAAGT (SEQ ID NO: 16); TCAAAAAGTA (SEQ ID NO: 17);CAAAAAGTAG (SEQ ID NO: 18); AAAAAGTAGT (SEQ ID NO: 19);AAAAGTAGTG (SEQ ID NO: 20); AAAGTAGTGT (SEQ ID NO: 21);AAGTAGTGTG (SEQ ID NO: 22); AGTAGTGTGA (SEQ ID NO: 23);GTAGTGTGAT (SEQ ID NO: 24); TAGTGTGATT (SEQ ID NO: 25);AGTGTGATTG (SEQ ID NO: 26); GTGTGATTGG (SEQ ID NO: 27);TGTGATTGGA (SEQ ID NO: 28); GTGATTGGAT (SEQ ID NO: 29);TGATTGGATG (SEQ ID NO: 30); GATTGGATGG (SEQ ID NO: 31);ATTGGATGGC (SEQ ID NO: 32); TTGGATGGCC (SEQ ID NO: 33);TGGATGGCCT (SEQ ID NO: 34); GGATGGCCTG (SEQ ID NO: 35);GATGGCCTGC (SEQ ID NO: 36); ATGGCCTGCT (SEQ ID NO: 37);TGGCCTGCTG (SEQ ID NO: 38); GGCCTGCTGT (SEQ ID NO: 39);GCCTGCTGTA (SEQ ID NO: 40); CCTGCTGTAA (SEQ ID NO: 41);CTGCTGTAAG (SEQ ID NO: 42); TGCTGTAAGG (SEQ ID NO: 43);GCTGTAAGGG (SEQ ID NO: 44); CTGTAAGGGA (SEQ ID NO: 45);TGTAAGGGAA (SEQ ID NO: 46); GTAAGGGAAA (SEQ ID NO: 47);TAAGGGAAAG (SEQ ID NO: 48); AAGGGAAAGA (SEQ ID NO: 49);AGGGAAAGAA (SEQ ID NO: 50); GGGAAAGAAT (SEQ ID NO: 51);GGAAAGAATG (SEQ ID NO: 52); GAAAGAATGA (SEQ ID NO: 53);AAAGAATGAG (SEQ ID NO: 54); AAGAATGAGA (SEQ ID NO: 55);AGAATGAGAC (SEQ ID NO: 56); GAATGAGACG (SEQ ID NO: 57);AATGAGACGA (SEQ ID NO: 58); ATGAGACGAG (SEQ ID NO: 59);TGAGACGAGC (SEQ ID NO: 60); GAGACGAGCT (SEQ ID NO: 61);AGACGAGCTG (SEQ ID NO: 62); GACGAGCTGA (SEQ ID NO: 63);ACGAGCTGAG (SEQ ID NO: 64); CGAGCTGAGC (SEQ ID NO: 65);GAGCTGAGCC (SEQ ID NO: 66); AGCTGAGCCA (SEQ ID NO: 67);GCTGAGCCAG (SEQ ID NO: 68); CTGAGCCAGC (SEQ ID NO: 69);TGAGCCAGCA (SEQ ID NO: 70); GAGCCAGCAG (SEQ ID NO: 71);AGCCAGCAGC (SEQ ID NO: 72); GCCAGCAGCA (SEQ ID NO: 73);CCAGCAGCAG (SEQ ID NO: 74); CAGCAGCAGA (SEQ ID NO: 75);AGCAGCAGAT (SEQ ID NO: 76); GCAGCAGATG (SEQ ID NO: 77);CAGCAGATGG (SEQ ID NO: 78); AGCAGATGGG (SEQ ID NO: 79);GCAGATGGGG (SEQ ID NO: 80); CAGATGGGGT (SEQ ID NO: 81);AGATGGGGTG (SEQ ID NO: 82); GATGGGGTGG (SEQ ID NO: 83);ATGGGGTGGG (SEQ ID NO: 84); TGGGGTGGGA (SEQ ID NO: 85);GGGGTGGGAG (SEQ ID NO: 86); GGGTGGGAGC (SEQ ID NO: 87);GGTGGGAGCA (SEQ ID NO: 88); GTGGGAGCAG (SEQ ID NO: 89);TGGGAGCAGT (SEQ ID NO: 90); GGGAGCAGTA (SEQ ID NO: 91);GGAGCAGTAT (SEQ ID NO: 92); GAGCAGTATC (SEQ ID NO: 93);AGCAGTATCT (SEQ ID NO: 94); GCAGTATCTC (SEQ ID NO: 95);CAGTATCTCG (SEQ ID NO: 96); AGTATCTCGA (SEQ ID NO: 97);GTATCTCGAG (SEQ ID NO: 98); TATCTCGAGA (SEQ ID NO: 99);ATCTCGAGAC (SEQ ID NO: 100); TCTCGAGACC (SEQ ID NO: 101);CTCGAGACCT (SEQ ID NO: 102); TCGAGACCTA (SEQ ID NO: 103);CGAGACCTAG (SEQ ID NO: 104); GAGACCTAGA (SEQ ID NO: 105);AGACCTAGAA (SEQ ID NO: 106); GACCTAGAAA (SEQ ID NO: 107);ACCTAGAAAA (SEQ ID NO: 108); CCTAGAAAAA (SEQ ID NO: 109);CTAGAAAAAC (SEQ ID NO: 110); TAGAAAAACA (SEQ ID NO: 111);AGAAAAACAT (SEQ ID NO: 112); GAAAAACATG (SEQ ID NO: 113);AAAAACATGG (SEQ ID NO: 114); AAAACATGGA (SEQ ID NO: 115);AAACATGGAG (SEQ ID NO: 116); AACATGGAGC (SEQ ID NO: 117);ACATGGAGCA (SEQ ID NO: 118); CATGGAGCAA (SEQ ID NO: 119);ATGGAGCAAT (SEQ ID NO: 120); TGGAGCAATC (SEQ ID NO: 121);GGAGCAATCA (SEQ ID NO: 122); GAGCAATCAC (SEQ ID NO: 123);AGCAATCACA (SEQ ID NO: 124); GCAATCACAA (SEQ ID NO: 125);CAATCACAAG (SEQ ID NO: 126); AATCACAAGT (SEQ ID NO: 127);ATCACAAGTA (SEQ ID NO: 128); TCACAAGTAG (SEQ ID NO: 129);CACAAGTAGC (SEQ ID NO: 130); ACAAGTAGCA (SEQ ID NO: 131);CAAGTAGCAA (SEQ ID NO: 132); AAGTAGCAAT (SEQ ID NO: 133);AGTAGCAATA (SEQ ID NO: 134); GTAGCAATAC (SEQ ID NO: 135);TAGCAATACA (SEQ ID NO: 136); AGCAATACAG (SEQ ID NO: 137);GCAATACAGC (SEQ ID NO: 138); CAATACAGCA (SEQ ID NO: 139);AATACAGCAG (SEQ ID NO: 140); ATACAGCAGC (SEQ ID NO: 141);TACAGCAGCT (SEQ ID NO: 142); ACAGCAGCTA (SEQ ID NO: 143);CAGCAGCTAA (SEQ ID NO: 144); AGCAGCTAAC (SEQ ID NO: 145);GCAGCTAACA (SEQ ID NO: 146); CAGCTAACAA (SEQ ID NO: 147);AGCTAACAAT (SEQ ID NO: 148); GCTAACAATG (SEQ ID NO: 149);CTAACAATGC (SEQ ID NO: 150); TAACAATGCT (SEQ ID NO: 151);AACAATGCTG (SEQ ID NO: 152); ACAATGCTGC (SEQ ID NO: 153);CAATGCTGCT (SEQ ID NO: 154); AATGCTGCTT (SEQ ID NO: 155);ATGCTGCTTG (SEQ ID NO: 156); TGCTGCTTGT (SEQ ID NO: 157);GCTGCTTGTG (SEQ ID NO: 158); CTGCTTGTGC (SEQ ID NO: 159);TGCTTGTGCC (SEQ ID NO: 160); GCTTGTGCCT (SEQ ID NO: 161);CTTGTGCCTG (SEQ ID NO: 162); TTGTGCCTGG (SEQ ID NO: 163);TGTGCCTGGC (SEQ ID NO: 164); GTGCCTGGCT (SEQ ID NO: 165);TGCCTGGCTA (SEQ ID NO: 166); GCCTGGCTAG (SEQ ID NO: 167);CCTGGCTAGA (SEQ ID NO: 168); CTGGCTAGAA (SEQ ID NO: 169);TGGCTAGAAG (SEQ ID NO: 170); GGCTAGAAGC (SEQ ID NO: 171);GCTAGAAGCA (SEQ ID NO: 172); CTAGAAGCAC (SEQ ID NO: 173);TAGAAGCACA (SEQ ID NO: 174); AGAAGCACAA (SEQ ID NO: 175);GAAGCACAAG (SEQ ID NO: 176); AAGCACAAGA (SEQ ID NO: 177);AGCACAAGAG (SEQ ID NO: 178); GCACAAGAGG (SEQ ID NO: 179);CACAAGAGGA (SEQ ID NO: 180); ACAAGAGGAG (SEQ ID NO: 181);CAAGAGGAGG (SEQ ID NO: 182); AAGAGGAGGA (SEQ ID NO: 183);AGAGGAGGAA (SEQ ID NO: 184); GAGGAGGAAG (SEQ ID NO: 185);AGGAGGAAGA (SEQ ID NO: 186); GGAGGAAGAG (SEQ ID NO: 187);GAGGAAGAGG (SEQ ID NO: 188); AGGAAGAGGT (SEQ ID NO: 189);GGAAGAGGTG (SEQ ID NO: 190); GAAGAGGTGG (SEQ ID NO: 191);AAGAGGTGGG (SEQ ID NO: 192); AGAGGTGGGT (SEQ ID NO: 193);GAGGTGGGTT (SEQ ID NO: 194); AGGTGGGTTT (SEQ ID NO: 195);GGTGGGTTTT (SEQ ID NO: 196); GTGGGTTTTC (SEQ ID NO: 197);TGGGTTTTCC (SEQ ID NO: 198); GGGTTTTCCA (SEQ ID NO: 199);GGTTTTCCAG (SEQ ID NO: 200); GTTTTCCAGT (SEQ ID NO: 201);TTTTCCAGTC (SEQ ID NO: 202); TTTCCAGTCA (SEQ ID NO: 203);TTCCAGTCAC (SEQ ID NO: 204); TCCAGTCACA (SEQ ID NO: 205);CCAGTCACAC (SEQ ID NO: 206); CAGTCACACC (SEQ ID NO: 207);AGTCACACCT (SEQ ID NO: 208); GTCACACCTC (SEQ ID NO: 209);TCACACCTCA (SEQ ID NO: 210); CACACCTCAG (SEQ ID NO: 211);ACACCTCAGG (SEQ ID NO: 212); CACCTCAGGT (SEQ ID NO: 213);ACCTCAGGTA (SEQ ID NO: 214); CCTCAGGTAC (SEQ ID NO: 215);CTCAGGTACC (SEQ ID NO: 216); TCAGGTACCT (SEQ ID NO: 217);CAGGTACCTT (SEQ ID NO: 218); AGGTACCTTT (SEQ ID NO: 219);GGTACCTTTA (SEQ ID NO: 220); GTACCTTTAA (SEQ ID NO: 221);TACCTTTAAG (SEQ ID NO: 222); ACCTTTAAGA (SEQ ID NO: 223);CCTTTAAGAC (SEQ ID NO: 224); CTTTAAGACC (SEQ ID NO: 225);TTTAAGACCA (SEQ ID NO: 226); TTAAGACCAA (SEQ ID NO: 227);TAAGACCAAT (SEQ ID NO: 228); AAGACCAATG (SEQ ID NO: 229);AGACCAATGA (SEQ ID NO: 230); GACCAATGAC (SEQ ID NO: 231);ACCAATGACT (SEQ ID NO: 232); CCAATGACTT (SEQ ID NO: 233);CAATGACTTA (SEQ ID NO: 234); AATGACTTAC (SEQ ID NO: 235);ATGACTTACA (SEQ ID NO: 236); TGACTTACAA (SEQ ID NO: 237);GACTTACAAG (SEQ ID NO: 238); ACTTACAAGG (SEQ ID NO: 239);CTTACAAGGC (SEQ ID NO: 240); TTACAAGGCA (SEQ ID NO: 241);TACAAGGCAG (SEQ ID NO: 242); ACAAGGCAGC (SEQ ID NO: 243);CAAGGCAGCT (SEQ ID NO: 244); AAGGCAGCTG (SEQ ID NO: 245);AGGCAGCTGT (SEQ ID NO: 246); GGCAGCTGTA (SEQ ID NO: 247);GCAGCTGTAG (SEQ ID NO: 248); CAGCTGTAGA (SEQ ID NO: 249);AGCTGTAGAT (SEQ ID NO: 250); GCTGTAGATC (SEQ ID NO: 251);CTGTAGATCT (SEQ ID NO: 252); TGTAGATCTT (SEQ ID NO: 253);GTAGATCTTA (SEQ ID NO: 254); TAGATCTTAG (SEQ ID NO: 255);AGATCTTAGC (SEQ ID NO: 256); GATCTTAGCC (SEQ ID NO: 257);ATCTTAGCCA (SEQ ID NO: 258); TCTTAGCCAC (SEQ ID NO: 259);CTTAGCCACT (SEQ ID NO: 260); TTAGCCACTT (SEQ ID NO: 261);TAGCCACTTT (SEQ ID NO: 262); AGCCACTTTT (SEQ ID NO: 263);GCCACTTTTT (SEQ ID NO: 264); CCACTTTTTA (SEQ ID NO: 265);CACTTTTTAA (SEQ ID NO: 266); ACTTTTTAAA (SEQ ID NO: 267);CTTTTTAAAA (SEQ ID NO: 268); TTTTTAAAAG (SEQ ID NO: 269);TTTTAAAAGA (SEQ ID NO: 270); TTTAAAAGAA (SEQ ID NO: 271);TTAAAAGAAA (SEQ ID NO: 272); TAAAAGAAAA (SEQ ID NO: 273);AAAAGAAAAG (SEQ ID NO: 274); AAAGAAAAGG (SEQ ID NO: 275);AAGAAAAGGG (SEQ ID NO: 276); AGAAAAGGGG (SEQ ID NO: 277);GAAAAGGGGG (SEQ ID NO: 278); AAAAGGGGGG (SEQ ID NO: 279);AAAGGGGGGA (SEQ ID NO: 280); AAGGGGGGAC (SEQ ID NO: 281);AGGGGGGACT (SEQ ID NO: 282); GGGGGGACTG (SEQ ID NO: 283);GGGGGACTGG (SEQ ID NO: 284); GGGGACTGGA (SEQ ID NO: 285);GGGACTGGAA (SEQ ID NO: 286); GGACTGGAAG (SEQ ID NO: 287);GACTGGAAGG (SEQ ID NO: 288); ACTGGAAGGG (SEQ ID NO: 289);CTGGAAGGGC (SEQ ID NO: 290); TGGAAGGGCT (SEQ ID NO: 291);GGAAGGGCTA (SEQ ID NO: 292); GAAGGGCTAA (SEQ ID NO: 293);AAGGGCTAAT (SEQ ID NO: 294); AGGGCTAATT (SEQ ID NO: 295);GGGCTAATTC (SEQ ID NO: 296); GGCTAATTCA (SEQ ID NO: 297);GCTAATTCAC (SEQ ID NO: 298); CTAATTCACT (SEQ ID NO: 299);TAATTCACTC (SEQ ID NO: 300); AATTCACTCC (SEQ ID NO: 301);ATTCACTCCC (SEQ ID NO: 302); TTCACTCCCA (SEQ ID NO: 303);TCACTCCCAA (SEQ ID NO: 304); CACTCCCAAA (SEQ ID NO: 305);ACTCCCAAAG (SEQ ID NO: 306); CTCCCAAAGA (SEQ ID NO: 307);TCCCAAAGAA (SEQ ID NO: 308); CCCAAAGAAG (SEQ ID NO: 309);CCAAAGAAGA (SEQ ID NO: 310); CAAAGAAGAC (SEQ ID NO: 311);AAAGAAGACA (SEQ ID NO: 312); AAGAAGACAA (SEQ ID NO: 313);AGAAGACAAG (SEQ ID NO: 314); GAAGACAAGA (SEQ ID NO: 315);AAGACAAGAT (SEQ ID NO: 316); AGACAAGATA (SEQ ID NO: 317);GACAAGATAT (SEQ ID NO: 318); ACAAGATATC (SEQ ID NO: 319);CAAGATATCC (SEQ ID NO: 320); AAGATATCCT (SEQ ID NO: 321);AGATATCCTT (SEQ ID NO: 322); GATATCCTTG (SEQ ID NO: 323);ATATCCTTGA (SEQ ID NO: 324); TATCCTTGAT (SEQ ID NO: 325);ATCCTTGATC (SEQ ID NO: 326); TCCTTGATCT (SEQ ID NO: 327);CCTTGATCTG (SEQ ID NO: 328); CTTGATCTGT (SEQ ID NO: 329);TTGATCTGTG (SEQ ID NO: 330); TGATCTGTGG (SEQ ID NO: 331);GATCTGTGGA (SEQ ID NO: 332); ATCTGTGGAT (SEQ ID NO: 333);TCTGTGGATC (SEQ ID NO: 334); CTGTGGATCT (SEQ ID NO: 335);TGTGGATCTA (SEQ ID NO: 336); GTGGATCTAC (SEQ ID NO: 337);TGGATCTACC (SEQ ID NO: 338); GGATCTACCA (SEQ ID NO: 339);GATCTACCAC (SEQ ID NO: 340); ATCTACCACA (SEQ ID NO: 341);TCTACCACAC (SEQ ID NO: 342); CTACCACACA (SEQ ID NO: 343);TACCACACAC (SEQ ID NO: 344); ACCACACACA (SEQ ID NO: 345);CCACACACAA (SEQ ID NO: 346); CACACACAAG (SEQ ID NO: 347);ACACACAAGG (SEQ ID NO: 348); CACACAAGGC (SEQ ID NO: 349);ACACAAGGCT (SEQ ID NO: 350); CACAAGGCTA (SEQ ID NO: 351);ACAAGGCTAC (SEQ ID NO: 352); CAAGGCTACT (SEQ ID NO: 353);AAGGCTACTT (SEQ ID NO: 354); AGGCTACTTC (SEQ ID NO: 355);GGCTACTTCC (SEQ ID NO: 356); GCTACTTCCC (SEQ ID NO: 357);CTACTTCCCT (SEQ ID NO: 358); TACTTCCCTG (SEQ ID NO: 359);ACTTCCCTGA (SEQ ID NO: 360); CTTCCCTGAT (SEQ ID NO: 361);TTCCCTGATT (SEQ ID NO: 362); TCCCTGATTG (SEQ ID NO: 363);CCCTGATTGG (SEQ ID NO: 364); CCTGATTGGC (SEQ ID NO: 365);CTGATTGGCA (SEQ ID NO: 366); TGATTGGCAG (SEQ ID NO: 367);GATTGGCAGA (SEQ ID NO: 368); ATTGGCAGAA (SEQ ID NO: 369);TTGGCAGAAC (SEQ ID NO: 370); TGGCAGAACT (SEQ ID NO: 371);GGCAGAACTA (SEQ ID NO: 372); GCAGAACTAC (SEQ ID NO: 373);CAGAACTACA (SEQ ID NO: 374); AGAACTACAC (SEQ ID NO: 375);GAACTACACA (SEQ ID NO: 376); AACTACACAC (SEQ ID NO: 377);ACTACACACC (SEQ ID NO: 378); CTACACACCA (SEQ ID NO: 379);TACACACCAG (SEQ ID NO: 380); ACACACCAGG (SEQ ID NO: 381);CACACCAGGG (SEQ ID NO: 382); ACACCAGGGC (SEQ ID NO: 383);CACCAGGGCC (SEQ ID NO: 384); ACCAGGGCCA (SEQ ID NO: 385);CCAGGGCCAG (SEQ ID NO: 386); CAGGGCCAGG (SEQ ID NO: 387);AGGGCCAGGG (SEQ ID NO: 388); GGGCCAGGGG (SEQ ID NO: 389);GGCCAGGGGT (SEQ ID NO: 390); GCCAGGGGTC (SEQ ID NO: 391);CCAGGGGTCA (SEQ ID NO: 392); CAGGGGTCAG (SEQ ID NO: 393);AGGGGTCAGA (SEQ ID NO: 394); GGGGTCAGAT (SEQ ID NO: 395);GGGTCAGATA (SEQ ID NO: 396); GGTCAGATAT (SEQ ID NO: 397);GTCAGATATC (SEQ ID NO: 398); TCAGATATCC (SEQ ID NO: 399);CAGATATCCA (SEQ ID NO: 400); AGATATCCAC (SEQ ID NO: 401);GATATCCACT (SEQ ID NO: 402); ATATCCACTG (SEQ ID NO: 403);TATCCACTGA (SEQ ID NO: 404); ATCCACTGAC (SEQ ID NO: 405);TCCACTGACC (SEQ ID NO: 406); CCACTGACCT (SEQ ID NO: 407);CACTGACCTT (SEQ ID NO: 408); ACTGACCTTT (SEQ ID NO: 409);CTGACCTTTG (SEQ ID NO: 410); TGACCTTTGG (SEQ ID NO: 411);GACCTTTGGA (SEQ ID NO: 412); ACCTTTGGAT (SEQ ID NO: 413);CCTTTGGATG (SEQ ID NO: 414); CTTTGGATGG (SEQ ID NO: 415);TTTGGATGGT (SEQ ID NO: 416); TTGGATGGTG (SEQ ID NO: 417);TGGATGGTGC (SEQ ID NO: 418); GGATGGTGCT (SEQ ID NO: 419);GATGGTGCTA (SEQ ID NO: 420); ATGGTGCTAC (SEQ ID NO: 421);TGGTGCTACA (SEQ ID NO: 422); GGTGCTACAA (SEQ ID NO: 423);GTGCTACAAG (SEQ ID NO: 424); TGCTACAAGC (SEQ ID NO: 425);GCTACAAGCT (SEQ ID NO: 426); CTACAAGCTA (SEQ ID NO: 427);TACAAGCTAG (SEQ ID NO: 428); ACAAGCTAGT (SEQ ID NO: 429);CAAGCTAGTA (SEQ ID NO: 430); AAGCTAGTAC (SEQ ID NO: 431);AGCTAGTACC (SEQ ID NO: 432); GCTAGTACCA (SEQ ID NO: 433);CTAGTACCAG (SEQ ID NO: 434); TAGTACCAGT (SEQ ID NO: 435);AGTACCAGTT (SEQ ID NO: 436); GTACCAGTTG (SEQ ID NO: 437);TACCAGTTGA (SEQ ID NO: 438); ACCAGTTGAG (SEQ ID NO; 439);CCAGTTGAGC (SEQ ID NO: 440); CAGTTGAGCC (SEQ ID NO: 441);AGTTGAGCCA (SEQ ID NO: 442); GTTGAGCCAG (SEQ ID NO: 443);TTGAGCCAGA (SEQ ID NO: 444); TGAGCCAGAT (SEQ ID NO: 445);GAGCCAGATA (SEQ ID NO: 446); AGCCAGATAA (SEQ ID NO: 447);GCCAGATAAG (SEQ ID NO: 448); CCAGATAAGG (SEQ ID NO: 449);CAGATAAGGT (SEQ ID NO: 450); AGATAAGGTA (SEQ ID NO: 451);GATAAGGTAG (SEQ ID NO: 452); ATAAGGTAGA (SEQ ID NO: 453);TAAGGTAGAA (SEQ ID NO: 454); AAGGTAGAAG (SEQ ID NO: 455);AGGTAGAAGA (SEQ ID NO: 456); GGTAGAAGAG (SEQ ID NO: 457);GTAGAAGAGG (SEQ ID NO: 458); TAGAAGAGGC (SEQ ID NO: 459);AGAAGAGGCC (SEQ ID NO: 460); GAAGAGGCCA (SEQ ID NO: 461);AAGAGGCCAA (SEQ ID NO: 462); AGAGGCCAAT (SEQ ID NO: 463);GAGGCCAATA (SEQ ID NO: 464); AGGCCAATAA (SEQ ID NO: 465);GGCCAATAAA (SEQ ID NO: 466); GCCAATAAAG (SEQ ID NO: 467);CCAATAAAGG (SEQ ID NO: 468); CAATAAAGGA (SEQ ID NO: 469);AATAAAGGAG (SEQ ID NO: 470); ATAAAGGAGA (SEQ ID NO: 471);TAAAGGAGAG (SEQ ID NO: 472); AAAGGAGAGA (SEQ ID NO: 473);AAGGAGAGAA (SEQ ID NO: 474); AGGAGAGAAC (SEQ ID NO: 475);GGAGAGAACA (SEQ ID NO: 476); GAGAGAACAC (SEQ ID NO: 477);AGAGAACACC (SEQ ID NO: 478); GAGAACACCA (SEQ ID NO: 479);AGAACACCAG (SEQ ID NO: 480); GAACACCAGC (SEQ ID NO: 481);AACACCAGCT (SEQ ID NO: 482); ACACCAGCTT (SEQ ID NO: 483);CACCAGCTTG (SEQ ID NO: 484); ACCAGCTTGT (SEQ ID NO: 485);CCAGCTTGTT (SEQ ID NO: 486); CAGCTTGTTA (SEQ ID NO: 487);AGCTTGTTAC (SEQ ID NO: 488); GCTTGTTACA (SEQ ID NO: 489);CTTGTTACAC (SEQ ID NO: 490); TTGTTACACC (SEQ ID NO: 491);TGTTACACCC (SEQ ID NO: 492); GTTACACCCT (SEQ ID NO: 493);TTACACCCTG (SEQ ID NO: 494); TACACCCTGT (SEQ ID NO: 495);ACACCCTGTG (SEQ ID NO: 496); CACCCTGTGA (SEQ ID NO: 497);ACCCTGTGAG (SEQ ID NO: 498); CCCTGTGAGC (SEQ ID NO: 499);CCTGTGAGCC (SEQ ID NO: 500); CTGTGAGCCT (SEQ ID NO: 501);TGTGAGCCTG (SEQ ID NO: 502); GTGAGCCTGC (SEQ ID NO: 503);TGAGCCTGCA (SEQ ID NO: 504); GAGCCTGCAT (SEQ ID NO: 505);AGCCTGCATG (SEQ ID NO: 506); GCCTGCATGG (SEQ ID NO: 507);CCTGCATGGA (SEQ ID NO: 508); CTGCATGGAA (SEQ ID NO: 509);TGCATGGAAT (SEQ ID NO: 510); GCATGGAATG (SEQ ID NO: 511);CATGGAATGG (SEQ ID NO: 512); ATGGAATGGA (SEQ ID NO: 513);TGGAATGGAT (SEQ ID NO: 514); GGAATGGATG (SEQ ID NO: 515);GAATGGATGA (SEQ ID NO: 516); AATGGATGAC (SEQ ID NO: 517);ATGGATGACC (SEQ ID NO: 518); TGGATGACCC (SEQ ID NO: 519);GGATGACCCT (SEQ ID NO: 520); GATGACCCTG (SEQ ID NO: 521);ATGACCCTGA (SEQ ID NO: 522); TGACCCTGAG (SEQ ID NO: 523);GACCCTGAGA (SEQ ID NO: 524); ACCCTGAGAG (SEQ ID NO: 525);CCCTGAGAGA (SEQ ID NO: 526); CCTGAGAGAG (SEQ ID NO: 527);CTGAGAGAGA (SEQ ID NO: 528); TGAGAGAGAA (SEQ ID NO: 529);GAGAGAGAAG (SEQ ID NO: 530); AGAGAGAAGT (SEQ ID NO: 531);GAGAGAAGTG (SEQ ID NO: 532); AGAGAAGTGT (SEQ ID NO: 533);GAGAAGTGTT (SEQ ID NO: 534); AGAAGTGTTA (SEQ ID NO: 535);GAAGTGTTAG (SEQ ID NO: 536); AAGTGTTAGA (SEQ ID NO: 537);AGTGTTAGAG (SEQ ID NO: 538); GTGTTAGAGT (SEQ ID NO: 539);TGTTAGAGTG (SEQ ID NO: 540); GTTAGAGTGG (SEQ ID NO: 541);TTAGAGTGGA (SEQ ID NO: 542); TAGAGTGGAG (SEQ ID NO: 543);AGAGTGGAGG (SEQ ID NO: 544); GAGTGGAGGT (SEQ ID NO: 545);AGTGGAGGTT (SEQ ID NO: 546); GTGGAGGTTT (SEQ ID NO: 547);TGGAGGTTTG (SEQ ID NO: 548); GGAGGTTTGA (SEQ ID NO: 549);GAGGTTTGAC (SEQ ID NO: 550); AGGTTTGACA (SEQ ID NO: 551);GGTTTGACAG (SEQ ID NO: 552); GTTTGACAGC (SEQ ID NO: 553);TTTGACAGCC (SEQ ID NO: 554); TTGACAGCCG (SEQ ID NO: 555);TGACAGCCGC (SEQ ID NO: 556); GACAGCCGCC (SEQ ID NO: 557);ACAGCCGCCT (SEQ ID NO: 558); CAGCCGCCTA (SEQ ID NO: 559);AGCCGCCTAG (SEQ ID NO: 560); GCCGCCTAGC (SEQ ID NO: 561);CCGCCTAGCA (SEQ ID NO: 562); CGCCTAGCAT (SEQ ID NO: 563);GCCTAGCATT (SEQ ID NO: 564); CCTAGCATTT (SEQ ID NO: 565);CTAGCATTTC (SEQ ID NO: 566); TAGCATTTCA (SEQ ID NO: 567);AGCATTTCAT (SEQ ID NO: 568); GCATTTCATC (SEQ ID NO: 569);CATTTCATCA (SEQ ID NO: 570); ATTTCATCAC (SEQ ID NO: 571);TTTCATCACG (SEQ ID NO: 572); TTCATCACGT (SEQ ID NO: 573);TCATCACGTG (SEQ ID NO: 574); CATCACGTGG (SEQ ID NO: 575);ATCACGTGGC (SEQ ID NO: 576); TCACGTGGCC (SEQ ID NO: 577);CACGTGGCCC (SEQ ID NO: 578); ACGTGGCCCG (SEQ ID NO: 579);CGTGGCCCGA (SEQ ID NO: 580); GTGGCCCGAG (SEQ ID NO: 581);TGGCCCGAGA (SEQ ID NO: 582); GGCCCGAGAG (SEQ ID NO: 583);GCCCGAGAGC (SEQ ID NO: 584); CCCGAGAGCT (SEQ ID NO: 585);CCGAGAGCTG (SEQ ID NO: 586); CGAGAGCTGC (SEQ ID NO: 587);GAGAGCTGCA (SEQ ID NO: 588); AGAGCTGCAT (SEQ ID NO: 589);GAGCTGCATC (SEQ ID NO: 590); AGCTGCATCC (SEQ ID NO: 591);GCTGCATCCG (SEQ ID NO: 592); CTGCATCCGG (SEQ ID NO: 593);TGCATCCGGA (SEQ ID NO: 594); GCATCCGGAG (SEQ ID NO: 595);CATCCGGAGT (SEQ ID NO: 596); ATCCGGAGTA (SEQ ID NO: 597);TCCGGAGTAC (SEQ ID NO: 598); CCGGAGTACT (SEQ ID NO: 599);CGGAGTACTT (SEQ ID NO: 600); GGAGTACTTC (SEQ ID NO: 601);GAGTACTTCA (SEQ ID NO: 602); AGTACTTCAA (SEQ ID NO: 603);GTACTTCAAG (SEQ ID NO: 604); TACTTCAAGA (SEQ ID NO: 605);ACTTCAAGAA (SEQ ID NO: 606); CTTCAAGAAC (SEQ ID NO: 607);TTCAAGAACT (SEQ ID NO: 608); TCAAGAACTG (SEQ ID NO: 609);CAAGAACTGC (SEQ ID NO: 610); AAGAACTGCT (SEQ ID NO: 611);AGAACTGCTG (SEQ ID NO: 612); GAACTGCTGA (SEQ ID NO: 613).
Generally, the subject HIV-1 isolate is non-pathogenic as hereinbefore defined. Additionally, reference herein to "a deletion" includes reference to a contiguous or non-contiguous series of two or more deletions.
The non-pathogenic isolate may carry a single decanucleotide deletion or may carry more than one decanucleotide deletion. Where it carries multiple deletions these may all correspond to a contiguous sequence or be from different parts of the nef gene. Furthermore, the terminal end portions of a deletion may lie within a decanucleotide as defined above. It is emphasised that the present invention extends to analogous sequences from other pathogenic strains of HIV-1 which might carry nef genes with a slightly altered sequence relative to HIV-1 strain NL4-3.
In a most preferred embodiment of the present invention, there is provided a non-pathogenic strain of HIV-1 carrying a nucleotide sequence in its genome as set forth in SEQ ID No. 614:
GAAGAGATTTGGGAGAACATGACCTGGATGCAGTGGGAAAAAGAAATTCACAATCACACAAAATACATATACTCCTTACTTGAAAAATCGCAGAACCAACAAGAAAAGAATGAACAAGAACTATTGGAATTGGATCAATGGGCAAGTTTGTGGAATTGGTTTGACATAACAAAATGGCTGTGGTATATAAAAATATTCATAATGGTAGTAGGAGGCTTGATAGGTTTAAGAATAGTTTTTGCTGTACTTTCTATAGTGAATAGAGTTAGGCAGGGATACTCACCATTGTCGTTTCAGACCCTCCTCCCAACCCCGAGGGGACCCGACAGGCCCGAAGGAATCGAAGAAGAAGGTGGAGAGAGAGACAGAGACAGATCCACTCGATTAGTACACGGATTCTTAGCACTTTTCTGGGACGACCTGAGGAGCCTGTGCCTCTTCCTCTACCACCACTTGAGAGACTTACTCTTGATTGTAACAAGGATTGTGGAACTTCTGGGACGCAGGGGATGGGAAGCCCTCAAATATTGGTGGAACCTCCTAAAGTATTGGAGCCAGGAACTGCAGAAGAGTGCTGTTATCTTGCTCAATGCCACCGCCATAGCAGTAGCTGAGGGGACAGATAGAGTTTTAGAAGTATTACAAAGAGCTTATAGAGCTATCCTCCACATACCTAGAAGAATAAGACAGGGCCTCGAAATGGCTTTGCTATAAAATGGGTGGCAAGTGAGCAAAAAGTAGTGTAGTCAGATAGCATGCATCATAAGGGGTGGGGGCCAACAACTAACAATGCTGATCGTGCCTGGCTAGAAGCACAAGAGAAGGAAGAAGCGGGTTTTCCAGTCAAACCTCAGGTAGCTGTAGATCTTAGCCACTTTTTAAAAGAAAAGGGGGGACTGGAAGGGCTAATTCACTCCCAAAGAAGACAAGATACACAGTGCTGCAAACTATTACCAGTGGAGTCAGCGAAGATAGAAGAGGCCAATGGAGGAGAAAACCACAGATTGTTCTGTTGGGGACTTTCCATCCGTTGGGGACTTTCCAAGGCGGCGTGGCCTGGGTGACTAGTTCCGGTGGGGACTTTCCAAGAAGGCGCGGCCTGGGCGGGACTGGGGAGTGGCGAGCCCTCAGATGCTGCATATAAGCAGCTGCTTTCTGCTGTTACTGGGTCTCTCGGGTTAGACCAGATCTGAGCCTGGGAGCTCTCTGGCTAACTAGGGAACCCACTGCTTAAGCCTCAATAAAGCTTGCCTTGAGTGCTTCAAGTAGTGTGTGCCCGTCTGTTGTGTGACTCTGGTATCTAG;
and/or SEQ ID NO: 615:
GAAACAATTTGGGATAACATGACCTGGATGCAGTGGGAAAGAGAAATTGACAATTACACAAACATAATATACACCTTAATTGAAGAATCGCAGAACCAACAAGAAAAAAATGAACTAGAATTATTGGAATTGGATAAATGGGCAAATTTGTGGAATTGGTTTAGTATATCAAACTGGCTATGGTATATAAAATTATTCATAATGGTAGTAGGAGGCTTGGTAGGTTTAAGAATAGTTTTTACTGTACTTTCTATAGTGAATAGAGTTAGGCAGGGATACTCACCATTGTCGTTTCAGACCCACCTCCCAACCCCGAAGGGACCCGACAGGCCAGAAGGAATCGAAGAAGAAGGTGGAGAGAGAGACAGAGGCAGCTCCACTCGATTAGTGCACGGATTCTTAGCACTTTTCTGGGACGACCTGAGGAGTCTGTGCCTCTTCAGCTACCACCACTTGAGAGACTTACTCTTGATTGTAACGAGGATTGTGGAACTTCTGGGACGCAGGGGATGGGAAGCCCTCAAATACTGGTGGAATCTCCTGCAGTATTGGAGGCAGGAACTACAGAAGAGTGCTGTTAGCTTGTTCAATGGCACGGCCATAGCAGTAGCTGAGGGGACAGATAGAGTTATAGAAGCTTTACGAAGGGCTTATAGAGCTATTCTCCACATACCTAGAAGAATAAGACAGGGCTTAGAAAGGGCTTTGCTATAAAATGGGTGGCAAGTGGTCAGAAAGTAGTGTGGTTAGAAGGCATGTACCTTTAAGACAAGGCAGCTATAGATCTTAGCCGCTTTTTAAAAGAAAAGGGGGGACTGGAAGGGCTAATTCACTCACAGAGAAGATCAGTTGAACCAGAAGAAGATAGAAGAGGCCATGAAGAAGAAAACAACAGATTGTTCCGTTTGTTCCGTTGGGGACTTTCCAGGAGACGTGGCCTGAGTGATAAGCCGCTGGGGACTTTCCGAAGAGGCGTGACGGGACTTTCCAAGGCGACGTGGCCTGGGCGGGACTGGGGAGTGGCGAGCCCTCAGATGCTGCATATAAGCAGCTGCTTTCTGCCTGTACTGGGTCTCTCTGGTTAGACCAGATCTGAGCCTGGGAGCTCTCTGGCTAACTAGGGAACCCACTGCTTAAGCCTCAATAAAGCTTGCCTTGAGTGCTTCAAGTAGTGTGTGCCCGTCTGTTGTGTGACTCTGGTATCTAGA.
The present invention, however, extends to HIV-1 isolates which are non-pathogenic; carry genomes capable of hybridising under low stringency conditions to SEQ ID NO: 614 or SEQ ID NO: 615; and which do not direct the synthesis of a full length nef gene product.
In a further embodiment the present invention contemplates a viral isolate which:
(i) is reactive to antibodies to a glycoprotein from HIV-1 such as at least one of gp41-45, gp120 and/or gp160;
(ii) carries a genome or a part or fragment thereof capable of hybridising under medium stringency conditions to a nucleotide sequence as set forth in SEQ ID NO: 1 or a complementary form thereof or an analogous sequence from another pathogenic strain of HIV-1;
(iii) carries a deletion of at least ten nucleotides in a region corresponding to the LTR region in HIV-1 NL4-3; and
wherein said deletion encompasses one or more of the following decanucleotides from the LTR region of HIV-1 NL4-3 or corresponding sequences from another pathogenic strain of HIV-1:
GCTTTTTGCC (SEQ ID NO: 652); CTTTTTGCCT (SEQ ID NO: 653);TTTTTGCCTG (SEQ ID NO: 654); TTTTGCCTGT (SEQ ID NO: 655);TTTGCCTGTA (SEQ ID NO: 656); TTGCCTGTAC (SEQ ID NO: 657);TGCCTGTACT (SEQ ID NO: 658); GCCTGTACTG (SEQ ID NO: 659);CCTGTACTGG (SEQ ID NO: 660); CTGTACTGGG (SEQ ID NO: 661);TGTACTGGGT (SEQ ID NO: 662); GTACTGGGTC (SEQ ID NO: 663);TACTGGGTCT (SEQ ID NO: 664); ACTGGGTCTC (SEQ ID NO: 665);CTGGGTCTCT (SEQ ID NO: 666); TGGGTCTCTC (SEQ ID NO: 667);GGGTCTCTCT (SEQ ID NO: 668); GGTCTCTCTG (SEQ ID NO: 669);GTCTCTCTGG (SEQ ID NO: 670); TCTCTCTGGT (SEQ ID NO: 671);CTCTCTGGTT (SEQ ID NO: 672); TCTCTGGTTA (SEQ ID NO: 673);CTCTGGTTAG (SEQ ID NO: 674); TCTCTGGTTA (SEQ ID NO: 675);CTGGTTAGAC (SEQ ID NO: 676); TGGTTAGACC (SEQ ID NO: 677);GGTTAGACCA (SEQ ID NO: 678); GTTAGACCAG (SEQ ID NO: 679);TTAGACCAGA (SEQ ID NO: 680); TAGACCAGAT (SEQ ID NO: 681);AGACCAGATC (SEQ ID NO: 682); GACCAGATCT (SEQ ID NO: 683);ACCAGATCTG (SEQ ID NO: 684); CCAGATCTGA (SEQ ID NO: 685);CAGATCTGAG (SEQ ID NO: 686); AGATCTGAGC (SEQ ID NO: 687);GATCTGAGCC (SEQ ID NO: 688); ATCTGAGCCT (SEQ ID NO: 689);TCTGAGCCTG (SEQ ID NO: 690); CTGAGCCTGG (SEQ ID NO: 691);TGAGCCTGGG (SEQ ID NO: 692); GAGCCTGGGA (SEQ ID NO: 693);AGCCTGGGAG (SEQ ID NO: 694); GCCTGGGAGC (SEQ ID NO: 695);CCTGGGAGCT (SEQ ID NO: 696); CTGGGAGCTC (SEQ ID NO: 697);TGGGAGCTCT (SEQ ID NO: 698); GGGAGCTCTC (SEQ ID NO: 699);GGAGCTCTCT (SEQ ID NO: 700); GAGCTCTCTG (SEQ ID NO: 701);AGCTCTCTGG (SEQ ID NO: 702); GCTCTCTGGC (SEQ ID NO: 703);CTCTCTGGCT (SEQ ID NO: 704); TCTCTGGCTA (SEQ ID NO: 705);CTCTGGCTAA (SEQ ID NO: 706); TCTGGCTAAC (SEQ ID NO: 707);CTGGCTAACT (SEQ ID NO: 708); TGGCTAACTA (SEQ ID NO: 709);GGCTAACTAG (SEQ ID NO: 710); GCTAACTAGG (SEQ ID NO: 711);CTAACTAGGG (SEQ ID NO: 712); TAACTAGGGA (SEQ ID NO: 713);AACTAGGGAA (SEQ ID NO: 714); ACTAGGGAAC (SEQ ID NO: 715);CTAGGGAACC (SEQ ID NO: 716); TAGGGAACCC (SEQ ID NO: 717);AGGGAACCCA (SEQ ID NO: 718); GGGAACCCAC (SEQ ID NO: 719);GGAACCCACT (SEQ ID NO: 720); GAACCCACTG (SEQ ID NO: 721);AACCCACTGC (SEQ ID NO: 722); ACCCACTGCT (SEQ ID NO: 723);CCCACTGCTT (SEQ ID NO: 724); CCACTGCTTA (SEQ ID NO: 725);CACTGCTTAA (SEQ ID NO: 726); ACTGCTTAAG (SEQ ID NO: 727);CTGCTTAAGC (SEQ ID NO: 728); TGCTTAAGCC (SEQ ID NO: 729);GCTTAAGCCT (SEQ ID NO: 730); CTTAAGCCTC (SEQ ID NO: 731);TTAAGCCTCA (SEQ ID NO: 732); TAAGCCTCAA (SEQ ID NO: 733);AAGCCTCAAT (SEQ ID NO: 734); AGCCTCAATA (SEQ ID NO: 735);GCCTCAATAA (SEQ ID NO: 736); CCTCAATAAA (SEQ ID NO: 737);CTCAATAAAG (SEQ ID NO: 738); TCAATAAAGC (SEQ ID NO: 739);CAATAAAGCT (SEQ ID NO: 740); AATAAAGCTT (SEQ ID NO: 741);ATAAAGCTTG (SEQ ID NO: 742); TAAAGCTTGC (SEQ ID NO: 743);AAAGCTTGCC (SEQ ID NO: 744); AAGCTTGCCT (SEQ ID NO: 745);AGCTTGCCTT (SEQ ID NO: 746); GCTTGCCTTG (SEQ ID NO: 747);CTTGCCTTGA (SEQ ID NO: 748); TTGCCTTGAG (SEQ ID NO: 749);TGCCTTGAGT (SEQ ID NO: 750); GCCTTGAGTG (SEQ ID NO: 751);CCTTGAGTGC (SEQ ID NO: 752); CTTGAGTGCT (SEQ ID NO: 753);TTGAGTGCTT (SEQ ID NO: 754); TGAGTGCTTC (SEQ ID NO: 755);GAGTGCTTCA (SEQ ID NO: 756); AGTGCTTCAA (SEQ ID NO: 757);GTGCTTCAAG (SEQ ID NO: 758); TGCTTCAAGT (SEQ ID NO: 759);GCTTCAAGTA (SEQ ID NO: 760); CTTCAAGTAG (SEQ ID NO: 761);TTCAAGTAGT (SEQ ID NO: 762); TCAAGTAGTG (SEQ ID NO: 763);CAAGTAGTGT (SEQ ID NO: 764); AAGTAGTGTG (SEQ ID NO: 765);AGTAGTGTGT (SEQ ID NO: 766); GTAGTGTGTG (SEQ ID NO: 767);TAGTGTGTGC (SEQ ID NO: 768); AGTGTGTGCC (SEQ ID NO: 769);GTGTGTGCCC (SEQ ID NO: 770); TGTGTGCCCG (SEQ ID NO: 771);GTGTGCCCGT (SEQ ID NO: 772); TGTGCCCGTC (SEQ ID NO: 773);GTGCCCGTCT (SEQ ID NO: 774); TGCCCGTCTG (SEQ ID NO: 775);GCCCGTCTGT (SEQ ID NO: 776); CCCGTCTGTT (SEQ ID NO: 777);CCGTCTGTTG (SEQ ID NO: 778); CGTCTGTTGT (SEQ ID NO: 779);GTCTGTTGTG (SEQ ID NO: 780); TCTGTTGTGT (SEQ ID NO: 781);CTGTTGTGTG (SEQ ID NO: 782); TGTTGTGTGA (SEQ ID NO: 783);GTTGTGTGAC (SEQ ID NO: 784); TTGTGTGACT (SEQ ID NO: 785);TGTGTGACTC (SEQ ID NO: 786); GTGTGACTCT (SEQ ID NO: 787);TGTGTGACTC (SEQ ID NO: 788); GTGTGACTCT (SEQ ID NO: 789);TGTGACTCTG (SEQ ID NO: 790); GTGACTCTGG (SEQ ID NO: 791);TGACTCTGGT (SEQ ID NO: 792); GACTCTGGTA (SEQ ID NO: 793);ACTCTGGTAA (SEQ ID NO: 794); CTCTGGTAAC (SEQ ID NO: 795);TCTGGTAACT (SEQ ID NO: 796); CTGGTAACTA (SEQ ID NO: 797);TGGTAACTAG (SEQ ID NO: 798); GGTAACTAGA (SEQ ID NO: 799).
The non-pathogenic isolate may carry a single decanucleotide deletion in the LTR region or may carry multiple deletions in the same region or in the LTR region and another region such as the nef gene. In particular, the mutation may be in the LTR /nef overlap region. Where it carries multiple deletions, these may correspond to a contiguous sequence or be from different parts of the LTR region and/or nef gene. Furthermore, the terminal end portions of a deletion may lie within a decanucleotide as defined above.
Yet another aspect of the present invention provides an infectious molecular clone comprising genetic sequences derived from the non-pathogenic HIV-1 isolates as hereinbefore described and includes genetic sequences encoding major structural proteins such as gag, env and pol. Infectious molecular clones are particularly useful as genetic compositions capable of "infecting" host cells without need of viral coat. The infectious molecular clones of the present invention may also be derived from pathogenic HIV-1 strains rendered non-pathogenic as hereindescribed.
According to this latter embodiment, there is contemplated a method of attenuating a pathogenic strain of HIV-1, said method comprising inducing a mutation in the nef gene and/or an LTR region to generate a non-pathogenic HIV-1 strain as hereinbefore described. Preferred mutations are deletions of at least ten nucleotides such as one or more of the decanucleotides as hereinbefore described. The mutations may also constitute substitutions and/or insertions of heterologous nucleic acid molecules in the nef and/or LTR regions such as the incorporation of a sense (i.e. co-suppression) antisense or ribozyme molecule (see below).
In still yet another embodiment of the present invention, there is provided an isolated, non-pathogenic strain of HIV-1 comprising a deletion in its genome of at least 10 nucleotide within the region of nucleotide 8787 and 9709 and more particularly within the region 8800 and 9700 and even more preferably within the region 8800 and 9410, using the nucleotide numbering of HIV-1 NL4-3.
In one embodiment, the deletion of at least 10 nucleotides is from within a region selected from the list consisting of (using the nucleotide numbers of HIV-1 NL4-3):
______________________________________nucleotide (i) 8830-8862; (ii) 9009-9035; (iii) 9019-9029; and (iv) 9033-9049.______________________________________
In another embodiment, the deletion of at least 10 nucleotides is from within a region selected from the list consisting of (using the nucleotide numbers of HIV-1 NL4-3):
______________________________________nucleotide (v) 9281-9371; (vi) 9281-9362; (vii) 9105-9224; and (viii) 9271-9370.______________________________________
In yet another embodiment, the deletion of at least 10 nucleotides is from within a region selected from the list consisting of (using the nucleotide numbers of HIV-1 NL4-3):
______________________________________nucleotide (ix) 8882-8928; (x) 8850-9006; (xi) 8792-9041; and (xii) 9112-9204.______________________________________
In still yet another embodiment, the deletion of at least 10 nucleotides is from within a region selected from the list consisting of (using the nucleotide numbers of HIV-1 NL4-3):
______________________________________nucleotide (xiii) 9105-9224; (xiv) 9389-9395; and (xv) 9281-9366.______________________________________
The above embodiments including any combinations thereof or functional equivalents thereof. Most preferred variants of HIV-1 are defined in Table 3.
Reference herein to the non-pathogenic HIV-1 strains of the present invention includes reference to components, parts, fragments and derivatives thereof including both genetic and non-genetic material. Furthermore, the non-pathogenic HIV-1 strains may be in isolated form or resident in peripheral blood mononuclear cells (PBMCs) or other like cells where the genome of the HIV-1 strains is integrated as DNA from said HIV-1 strains such as proviral DNA. In addition, the present invention extends to recombinant virus such as from (or resident in) prokaryotes or eukaryotes as well as in the form of infectious molecular clones.
Accordingly, the present invention provides for the non-pathogenic HIV-1 isolate, genomic material therefrom, complementary proviral DNA, molecular infectious clones, recombinant viral particles or genetic sequences therefrom or cells expressing same or blood cells carrying proviral DNA or to any mutants, derivatives, components, fragments, parts, homologues or analogues of the foregoing.
The non-pathogenic HIV-1 strains of the present invention are particularly useful in the development of therapeutic compositions, therapeutic molecules and/or diagnostic reagents. With regards to the former, the non-pathogenic HIV-1 strain may be considered as a live attenuated vaccine where individuals carrying DNA derived from said non-pathogenic HIV-1 strain such as proviral DNA in target cells are protected from infection by a corresponding pathogenic strain. The term "vaccine" is used in its broadest sense as a therapeutic composition or molecule which prevents or reduces HIV-1 infection or risk of infection or which ameliorates the symptoms of infection. It may involve the stimulation of an immune response or may involve blocking HIV-1 cells receptors and/or the use of genetic compositions, for example, to introduce riboymes or antisense molecules to HIV-1 directed genetic sequences or to prepare infectious molecular clones. For convenience, all such compositions are referred hereinafter to "therapeutic compositions".
Accordingly, the present invention contemplates a method for inhibiting or reducing the risk of infection by a pathogenic strain of HIV-1, said method comprising administering to a subject a non-pathogenic HIV-1 as hereinbefore defined in an amount effective to infect target cells and to generate target cells carrying proviral DNA from said non-pathogenic HIV-1. More particularly, the present invention contemplates a method for inhibiting or reducing productive infection of an individual by a pathogenic strain of HIV-1, said method comprising administering to a subject a non-pathogenic isolate of HIV-1 in an amount effective to infect target cells and to generate target cells carrying proviral DNA from said non-pathogenic HIV-1. By "productive infection" as used in the specification and claims herein is meant the infection of a cell or cells by a pathogenic strain of HIV-1 which leads ultimately to the symptomology of AIDS or AIDS related diseases. A cell infected productively produces pathogenic virions. By definition, infection of an individual by a non-pathogenic strain of HIV-1 would not lead to productive in infection. Non pathogenic HIV-1 strains generally replicate to a sufficient extent to protect cells against challenge by virulent or pathogenic strains. The methods of the present invention are applicable prophylactically (i.e. to prevent de novo infection) or therapeutically (i.e. to reduce or slow disease progression).
The present invention further provides a method for vaccinating an individual against the development of AIDS or AIDS related diseases, said method comprising administering to said individual a non-pathogenic isolate of HIV-1 in an amount effective to infect target cells and to generate target cells carrying proviral DNA from said non-pathogenic HIV-1. The term "vaccinating" should not be taken as limiting the invention to t he prevention of HIV-1 infection by solely immunological means. The term "vaccinating" includes any means of preventing productive infection of an individual by pathogenic HIV-1.
As an alternative to the above methods, a therapeutic composition as hereinbefore defined is administered. The non-pathogenic isolate may be administered inter alia as an isolated viral preparation or via infected blood cells. Another aspect of the invention provides a therapeutic composition for inhibiting or reducing the risk of infection by a pathogenic strain of HIV-1 said therapeutic composition comprising a non-pathogenic strain of HIV-1 or genetic sequences derived therefrom as hereinbefore described and optionally one or more pharmaceutically acceptable carriers and/or diluents. The therapeutic composition of the present invention is generally suitable for intravenous, intraperitoneal, intramuscular, intramucosal (e.g. nasal spray, respiratory spray) or other forms of parenteral administration. The therapeutic composition might also be administered via an implant or rectally or orally. In addition to the mutations contemplated above, the non-pathogenic HIV-1 strain may also contain one or more other mutations to further reduce the risk of reversion to virulence and/or to insert a genetic sequence capable of providing directly or indirectly an identifiable signal, having further anti-HIV-1 properties and /or immunostimulatory or cell regulatory properties,
For example, the non-pathogenic HIV-1 isolate in the therapeutic composition may comprise additional genetic material capable of directing expression of antisense nucleotide sequences to inhibit expression of one or more proteins encoded by a pathogenic strain of HIV-1. Alternatively, sense co-suppression may be employed. Preferred sense or antisense molecules would reduce expression of the nef gene or affect normal functioning of the LTR region.
According to this embodiment, the non-pathogenic HIV-1 strain may be considered as a targeting agent to introduce genetic constructs capable of reducing expression of one or more HIV-1 proteins or polypeptides. In this embodiment there is provided a viral isolate which:
(i) is genetically or immunologically related to a pathogenic strain of HIV-1;
(ii) is substantially non-pathogenic in human subjects;
(iii) comprises a first nucleotide sequence constituting its genome which is capable of hybridising under medium stringency conditions to SEQ ID NO: 1 or a complementary form thereof; and
(iv) comprises a second nucleotide sequence within said first nucleotide sequence and which second nucleotide sequence directs expression of a mRNA molecule capable of inhibiting, reducing or otherwise down-regulating translation of a protein or polypeptide encoded by a pathogenic strain of HIV-1 or inhibit, reduce or otherwise down regulate operation of a non-protein encoding a region of a pathogenic strain of HIV-1.
Preferred proteins or polypeptides targeted for reduced expression are those encoded by one or more of the following: gag, pol, env, tat, rev, vpu, vpr, vif and/or nef genes. The most preferred protein or polypeptide targeted for reduced expression is the product of the nef gene. Alternatively, the target nucleotide sequence does not encode a polypeptide or protein but is required for other functions such as integration or excision from the human genome or expression of genes on the viral genome. An example of such a nucleotide sequence is the LTR region. Accordingly, the present invention extends to disruption to the function of such regions.
The above aspect relates to use of antisense technology. The present invention extends, however, to use of ribozymes and/or co-suppression to achieve the same results. In an alternative embodiment, or in addition to, the second (or optionally a third) nucleotide sequence encodes an antiviral agent (e.g. interferon) and/or an immune enhancing agent.
The identification of deletions Inter alia in the nef gene and/or LTR region in asymptomatic subjects provides a unique opportunity to study the in vivo effects of attenuated HIV-1 strains carrying one or more mutations in selected genetic regions. In particular, the present invention provides a means for designing therapeutic compositions directed to inhibiting expression of a nef gene and/or LTR region in a pathogenic HIV-1 strain (such as contemplated above) as well as developing a therapeutic regimem aimed at inhibiting the activity of the nef gene product for the function of the LTR region. According to this latter embodiment, the present invention provides a therapeutic composition comprising a molecule capable of inhibiting the intracellular activity of the nef gene product and/or LTR region, said composition further comprising one or more pharmaceutically acceptable carriers and/or diluents.
The molecule contemplated by the above aspect of the subject invention may be a protein, polypeptide, peptide, chemical compound, sugar moiety or derivative of the nef gene product. The molecule will need to be capable of entering an infected cell. Where the molecule is a protein, polypeptide or peptide, it may be encoded by the second nucleotide sequence on the targeting vector as contemplated above. Alternatively, the molecule may be a nucleic acid molecule capable of targeting the nef gene or LTR region.
The deletion mutants of the present invention may result in a modified nef gene product either having no readily discernable activity or having activity different to the naturally occurring nef protein. In any event, if a mutant nef gene product is produced, it will generally have a lower molecular weight than the naturally occurring nef protein and will have a different overall amino acid sequence. This provides, therefore, for a means for diagnosing individuals with benign HIV-1 infection by, for example, assaying for a modified nef protein or screening for a modified nef gene sequence. Alternatively, benign HIV-1 infection may be detected by assaying for a modified LTR region such as an altered nucleotide sequence.
According to one embodiment, there is provided a method for determining the pathogenicity of an HIV-1 strain after said HIV-1 strain infects cells of an individual, said method comprising contacting a biological sample from said individual with an effective amount of an antibody specific to a nef protein from a non-pathogenic strain of HIV-1 (as hereinbefore defined) for a time and under conditions sufficient to form an antibody-modified nef protein complex and then detecting said complex. The presence of said complex is indicative of a modified nef gene product and of the non-pathogenicity of the strain of HIV-1. The biological sample is a sample likely to contain the modified nef gene product such as tissue extract or cell extract of an infected cell. However, where the modified nef gene product is capable of permeation or transport out of the cell, suitable biological fluid would include serum, whole blood, lymph and mucosal secretion amongst other fluids. Many variations in the subject assay are possible and are contemplated herein. For example, an assay could be based on the inability for a nef specific antibody to bind to a modified nef protein. For the purposes of the present invention the term "contacting" including "mixing".
The presence of a modified nef molecule in biological fluid can be detected using a wide range of immunoassay techniques such as those described in U.S. Pat. Nos. 4,016,043, 4,424,279 and 4,018,653. These include both single-site and two-site, or "sandwich", assays of the non-competitive types, as well as in the traditional competitive binding assays and include ELISA and RIA techniques. Sandwich assays are among the most useful and commonly used assays and are favoured for use in the present invention. A number of variations of the sandwich assay technique exist, and all are intended to be encompassed by the present invention. Briefly, and by way of example only, in a typical forward assay, a modified nef product-specific antibody is immobilised onto a solid substrate to form a first complex and the sample to be tested for modified nef product brought into contact with the bound molecule. After a suitable period of incubation, for a period of time sufficient to allow formation of an antibody-modified nef product secondary complex, a second modified nef protein antibody, labelled with a reporter molecule capable of producing a detectable signal, is then added and incubated, allowing time sufficient for the formation of a tertiary complex of antibody-modified nef product-antibody. Any unreacteded material is washed away, and the presence of the tertiary complex is determined by observation of a signal produced by the reporter molecule. The results may either be qualitative, by simple observation of the visible signal or may be quantitated by comparison with a control sample containing known amounts of hapten. Variations of the forward assay include a simultaneous assay, in which both sample and labelled antibody are added simultaneously to the bound antibody, or a reverse assay in which the labelled antibody and sample to be tested are first combined, incubated and then added simultaneously to the bound antibody. These techniques are well known to those skilled in the art, and the possibility of minor variations will be readily apparent. The antibodies used above may be monoclonal or polyclonal.
The solid substrate is typically glass or a polymer, the most commonly used polymers being cellulose, polyacrylamide, nylon, polystyrene, polyvinyl chloride or polypropylene. The solid supports may be in the form of tubes, beads, discs or microplates, or any other surface suitable for conducting an immunoassay. The binding processes are well-known in the art and generally consist of cross-linking covalently binding or physically adsorbing the molecule to the insoluble carrier.
By "reporter molecule", as used in the present specification, is meant a molecule which, by its chemical nature, produces an analytically identifiable signal which allows the detection of antigen-bound antibody. Detection may be either qualitative or quantitative. The most commonly used reporter molecule in this type of assay re either enzymes, fluorophores or radionuclide containing molecules (i.e. radioisotopes). In the case of an enzyme immunoassay, an enzyme is conjugated to the second antibody, generally by means of glutaraldehyde or periodate. As will be readily recognised, however, a wide variety of different conjugation techniques exist which are readily available to one skilled in the art. Commonly used enzymes include horseradish peroxidase, glucose oxidase, .beta.-galactosidase and alkaline phosphatase, amongst others. The substrates to be used with the specific enzymes are generally chosen for the production,upon hydrolysis by the corresponding enzyme, of a detectable colour change. It is also possible to employ fluorogenic substrates, which yield a fluorescent product.
Alternatively, fluorescent compounds, such as fluorescein and rhodamine, may be chemically coupled to antibodies without altering their binding capacity. When activated by illumination with light of a particular wavelength, the fluorochrome-labelled antibody adsorbs the light energy, inducing a state of excitability in the molecule, followed by emission of the light at a characteristic colour visually detectable with a light microscope. As in the EIA, the fluorescent labelled antibody is allowed to bind to the first antibody-hapten complex. After washing off the unbound reagent, the remaining complex is then exposed to the light of the appropriate wavelength, the fluorescence observed indicates the presence of the hapten of interest. Immunofluorescence and EIA techniques arc both very well established in the art and are particularly preferred for the present method. However, other reporter molecules, such as radioisotope, chemiluminescent or bioluminescent molecules, may also be employed. It will be readily apparent to the skilled technician how to vary the procedure to suit the required purpose. It will also be apparent that the foregoing can be used to label a modified nef product and to use same directly in the detection of, for example, circulatory antibodies specific to said modified nef product.
Alternatively, genetic assays may be conducted to screen for abberations in the nef gene and/or LTR region. Such a genetic assay may be by Southern or Northern blot analysis, PCR analysis or the like using oligonucleotides specific to a deleted region of a nef gene and/or LTR region.
According to this embodiment there is provided a method for determining the pathogenicity of an HIV-1 strain after said HIV-1 strain infects cells of an individual, said method comprising determining directly or indirectly the presence of a deletion mutation in the genome of said HIV-1 wherein the presence of a such a mutation is indicative of the presence of a non-pathogenic strain of HIV-1. The deletion mutation may result in the genome being unable to synthesise a polypeptide or protein from a pathogenic strain of HIV-1 or may direct the synthesis of a truncated form of said polypeptide or protein. The mutation may also lead to altered expression of a polypeptide detectable by, for example, decreased synthesis of a particular protein, such as the nef gene product. Alternatively, the deletion mutation affects the LTR region or a regulatory region of the HIV-1 genome. In either case, affected viruses may also be detected by, for example, observing low viral copy numbers such as low viral loads.
Preferably, said non-pathogenic HIV-1 carries a deletion in its genome of at least 10 nucleotides within the region from nucleotide 8787 to nucleotide 9709 using the nucleotide numbering of HIV-1 strain NL4-3.
Preferably, said non-pathogenic HIV-1 carries a deletion in its genome of at least 10 nucleotides from within a region selected from the list consisting of:
______________________________________nucleotide (i) 8830-8862; (ii) 9009-9035; (iii) 9019-9029; and (iv) 9033-9049.______________________________________
Preferably, said non-pathogenic HIV-1 carries a deletion in its genome of at least 10 nucleotides from within a region selected from the list consisting of:
______________________________________nucleotide (v) 9281-9371; (vi) 9281-9362; (vii) 9105-9224; and (viii) 9271-9370.______________________________________
Preferably, said non-pathogenic HIV-1 carries a deletion in its genome of at least 10 nucleotides from within a region selected from the list consisting of:
______________________________________nucleotide (ix) 8882-8928; (x) 8850-9006; (xi) 8792-9041; and (xii) 9112-9204.______________________________________
Preferably, said non-pathogenic HIV-1 carries a deletion in its genome of at least 10 nucleotides from within a region selected from the list consisting of:
______________________________________nucleotide (xiii) 9105-9224; (xiv) 9389-9395; and (xv) 9281-9366.______________________________________
The above nucleotide numbers are based on the nucleotide numbering in the NL4-3 genome.
Particularly preferred oligonucleotides are based on the deleted regions of the nef gene and/or LTR region such as but not limited to one or more oligonucleotides based on SEQ ID NO: 2 to SEQ ID NO: 613 and/or SEQ ID NO: 652 to SEQ ID NO: 799.
The present invention further extends to kits for the diagnosis of infection by pathogenic strains of HIV-1 or for determining the pathogenicity of infecting virus. The kits would be in compartmental form each comprising one or more suitable reagents for conducting the assay.
The present invention is further described by the following non-limiting Figures and Examples.

IN THE FIGURES:
FIG. 1 is a representation showing the alignment of the nucleotide sequences from donor D36 peripheral blood mononuclear cell (PBMC) [D36P] and non-pathogenic HIV-1 from recipient C18 HIV.sub.StV [C18S], C18 HIV.sub.MBC [C18M] and C98 HIV [C98H] and C54 PBMC [C54P] with the equivalent region of HIV-1 NL4-3. Sequences labelled PBMC are from patient PBMC, those labelled HIV are from virus isolated from patient PBMC and grown in culture. Numbering for HIV-1 NL4-3 is as per Myer et al (1992) where nucleotide 1 is the first nucleotide of the complete proviral DNA sequence. D36P, C18S, C18M, C98H and C54P are numbered from the start of the region sequenced. Identity with NL4-3 sequence is shown by (*). Deleted nucleotides are shown by (-). Spaces introduced to maximise alignment are shown by (,). Features in NL4-3 are marked by overlining the sequence, features in D36 and C18 are marked by underlining the sequence.
FIG. 2 shows the alignment of encoded amino acid sequences of (a) tat exon 3 and (b) rev exon 3 from HIV-1 NL4-3, D36 PBMC, C18 HIV.sub.StV and C98 HIV. In-phase termination codons (*) and NL4-3 encoded amino acid numbers are shown.
FIG. 3 is a representation showing the alignment of C-terminal envelope glycoprotein gp41 amino acid sequences encoded by D36 PMBC, C18 HIV.sub.StV, C18 HIV.sub.MBC and C98 HIV. Numbering is that of the amino acid sequence of the mature envelope glycoprotein of HIV NL4-3. Termination in shown by (#).
FIG. 4 is a representation showing alignment of amino acid sequences encoded by the nef genes of HIV-1 NL4-3, D36 PBMC, C18 HIV.sub.StV, C18 HIV.sub.MBC and C98 HIV. In phase termination codons are shown by (#). Identical amino acids are shown by (*). Residues underlined are those immediately before a deletion.
FIG. 5 shows a duplication of NFKB and Sp1 sequences in D36 PBMC, C18 HIV.sub.StV, C18 HIV.sub.MBC and C98 HIV demonstrated by alignment of their low homology region sequences with the NFKB-Sp1 region of HIV-1 NL4-3. Nucleotide numbering according to FIG. 1. Identity with NL4-3 sequence shown by (*) and NFKB and Sp1 sites in NL4-3 ovetlined. Position of nef/LTR region sequence deletion shown by (.DELTA.).
FIG. 6 is a graphical representation showing replication of C18 and C98 viral isolates and D36 PBMCs from asymptomatic patients in PHA-stimulated PBMCs. ##STR1##
FIG. 7 is a graphical representation showing replication of viral isolates from asymptomatic patients in non-PHA stimulated PBMCs. ##STR2##
228200 is an Australian isolate of HIV-1 described by Kiernan, R. et al (1990). Its characteristics include being, T cell trophic, with fast kinetics, high producer of HIV-1 and /or SI phenotype.
FIG. 8 is a graphical representation of cell surface receptor expression for syncytia-inducing inducing (SI)/ non-syncytia-inducing (NSI)/asymptomatic patient isolates. ##STR3##
228200 is defined in the legend to FIG. 7. 243925 is a viral isolate of HIV-1 which is monocyte/macrophage trophic and exhibits NSI phenotype (Dr Karen Coats-Fryer, PhD thesis entitled "Viral determinants of HIV-1 syncytium formation", the University of Melbourne, Parkville, Victoria, Australia.
FIG. 9 is a representation of the nucleotide sequence of C18 HIV-1.sub.MBC (SEQ ID NO: 800).
FIG. 10(a)-(g) are graphical representations showing clinical immunology of cohort; (a) CD3; (b)(i) CD4 (ii) CD4%; (c)(i) CD8; (ii) CD8%; (d) lymphocyte count; (e) CD4/CD8 ratio; (f) .beta.2-microglobulin; and (g) Kaplan-Meier estimates of time to disease progression (Cox & Oakes, 1989).
FIG. 11 is a schematic representation of the deletion mutants of the present invention.

A summary of the SEQ ID Nos. used in the subject specification is shown below:
______________________________________SEQ ID NO: DESCRIPTION______________________________________ 1 Nucleotide sequence of HIV-1 strain NL4-3 genome 2-613 Decanucleotides of nef gene from HIV-1 strain NL4-3614 Partial nucleotide sequence of D36 HIV-1 isolate615 Partial nucleotide sequence of C18 HIV-1.sub.MBC isolate616-625 PCR primers shown in Table 1626-633 Sequence primers shown in Table 2634 Amino acid residues 15-27 of HIV-1 NL4-3 nef protein635 HIV-1 NL4-3 tat exons (FIG. 2)636 HIV-1 D36 tat exons (FIG. 2)637 HIV-1 C18 tat exons (FIG. 2)638 HIV-1 NL4-3 rev exons (FIG. 2)639 HIV-1 D36 rev exons (FIG. 2)640 HIV-1 C18 rev exons (FIG. 2)641 HIV-1 NL4-3 C-terminal of gp41 (FIG. 3)642 HIV-1 D36 C-terminal of gp41 (FIG. 3)643 HIV-1 C18 C-terminal of gp41 (FIG. 3)644 HIV-1 NL4-3 nef gene (FIG. 4)645 HIV-1 D36 nef gene (FIG. 4)646 HIV-1 C18 nef gene (FIG. 4)647 HIV-1 NL4-3 NFKB/SP1 sequence (FIG. 5)648 HIV-1 D36 NFKB/SP1 sequence (FIG. 5)649 HIV-1 C18 NFKB/SP1 sequence (FIG. 5)650 Nucleotide sequence of nef gene from HIV-1 strain NL4-3651 Nucleotide sequence of env and nef regions of NL4-3652-799 Decanucleotides of LTR region from HIV-1 strain NL4-3800 Nucleotide sequence of C18 HIV-1.sub.MBC______________________________________
EXAMPLE 1
Source Material
For the purposes of the following examples, a non-pathogenic HIV-1 strain was isolated from a recipient of HIV-1 infected blood. The recipient is designated "C18". Other recipients are defied as "C54" and "C98". The donor is identified herein as "D36". Viral isolate D36 was deposited on Aug. 23, 1996 as Accession No. V96082324. The place of isolation may be indicated after the abbreviation of "HIV". For example, St Vincents Hospital, Sydney (HIV.sub.StV) or Macfarlane Burnet Centre of Medical Research, Melbourne (HIV.sub.MBC).
Exemplary viral isolates referred to herein as "C18" and "C98" were deposited at the PHLS Centre for Applied Microbiology and Research, European Collection of Animal Cell Cultures (ECACC), Division of Biologies, Porton Down, Salisbury, Wiltshire SP4 OJG. C18 was deposited on Oct. 17, 1994 under Provisional Accession Number V94101706 and C98 was deposited on Oct. 31, 1994 under Provisional Accession Number V941031169.
FIG. 11 is a summary of the deletion mutants of the present invention.
Viruses were isolated by the following procedures:
1. Infected peripheral blood mononuclear cells (PBMCs) were co cultured with HIV-1 seronegative donor PBMCs. A convenient source of seronegaitve donor PBMCs is a blood bank. The supernatants and cells are harvested every 7 days and fresh medium added with CD8 depleted PBMCs. CD8 depletion promotes the ability to isolate HIV-1. The culture and procedure is continued for up to approximately 5 weeks;
2. The infected PBMCs are purified from whole blood and these cells are cultured alone for up to 5 weeks, PMBCs alone are used because the virus is more likely to be monocytotropic. Fresh medium is added weekly and supernatant fluid is harvested at this time;
3. Supernatant fluids are harvested every approximately 7 days, fresh medium and fresh HIV-1 seronegative CD8 depleted PBMCs are added at this time;
4. HIV-1 seronegative PBMCs are pretreated with with M-CSF for approximately 72 hours prior to the addition of infected PBMCs. M-CSF has been shown to enhance HIV-1 replication in monocytes (Gendelman et al, 1988); or
5. The supernatant fluid is harvested from the cultures of step 4 every approximately 7 days, fresh medium added together with HIV-1 s seronegative stimulated CD8 depleted PBMCs. The virus is isolated from the infected PBMCs.
EXAMPLE 2
DNA Preparation and PCR Amplification
Non-pathogenic HIV-1 (e.g. strain C18) infected peripheral blood mononuclear cells (PBMC) were harvested 4 days after infection of phytohaemagglutinin (PHA) stimulated HIV-1 negative donor PBMC cultured by the method of Neate et al (1987) and washed in phosphate buffered saline (PBS). PBMC from Donor D36 and Recipients C18, C54 and C98 were prepared by Ficoll isopaque centrifugation of buffy coat cells and washed with PBS.
Approximately 10.sup.7 cells were lysed in 1 ml lysis solution (0.45% v/v NP40, 0.45% v/v Tween 20, 10 mM Tris-HCl pH 8.3, 40 mM KCl 2.5 mM MgCl.sub.2) and digested with 60 .mu.g/ml proteinase K (Boehringer Mannheim) at 55.degree. C. for 1 hour followed by 100.degree. C. for 10 minutes. Lysates were stored at -20.degree. C.
All polymerase chain reaction (PCR) primers (Table 1) and sequencing primers (Table 2) were synthesised using an Applied Biosystems model 391 DNA synthesiser using phosphoramidite chemistry.
Strict physical separation was maintained for sample, PCR reagent mix and PCR reaction preparations as well as amplification and analysis. Final reaction mixes (50 .mu.l) contained 2 .mu.l neat or diluted cell lysate, 0.2 .mu.M each primer, 200 mM dNTPs and 1.25,units Taq polynerase (Boehringer Mannheim) in PCR buffer, (10 mM Tris-HCl pH.3, 50 mM KCl, 100 .mu.g/ml gelatine) adjusted to the optimum MgCl.sub.2 concentration for the primer pair (1.5-3.0 mM). Aliquoted reagent mix was overlaid with 50 .mu.l mineral oil prior to addition of DNA template lysate. After template denaturation at 94.degree. C. for 3 min amplification was achieved with 30 cycles of 94.degree. C., 1 min; 55.degree. C., 1 min; 72.degree. C., 2 mins. A final elongation reaction was conducted at 72.degree. C. for 7 minutes. For double PCR amplification 2 .mu.l of first round product was added to the second reagent mix and amplified as before.
PCR amplified DNA was checked for quality, quantity and fragment size by agarose gel electrophoresis in Tris-Acetate-EDTA buffer (Sambrook et al, 1989) stained in ethidium bromide and viewed by UV transillumination.
EXAMPLE 3
DNA Sequence Analysis
The DNA sequence of PCR amplified HIV-1 regions was determined by the dideoxynucleotide method (Sanger et al, 1997) using Sequenase T7 polymerase (United States Biochemicals).
PCR amplified DNA was purified by PCR Magic prep resin chromatography (Promega). Approximately 2 to 7 .mu.g purified DNA plus long specific primer (Table 2) were denatured by boiling for 3 mins and snap frozen to -20.degree. C. The initial labelling reaction was for 3 minutes at 22.degree. C. (room temperature) with .sup.35 SdNTP (500 Ci/mmol; Dupont) followed by dideoxynucleotide termination reactions at 37.degree. C. for 5 minutes. NP40, to 0.45% a v/v, was included in denaturation and reaction mixes (Bachman et al, 1990). Sequencing reaction products were denatured in formamide and resolved on a 6% w/v polyacrylamide gel containing 8M urea, fixed in 10% v/v acetic acid, 10% v/v methanol and dried. Following autoradiography on XKI film (Kodak) the gel sequences were read assembled, translated to protein and aligned using the PC/GENE suite of programs (IntelliGenetics, USA).
TABLE 1______________________________________PCR PRIMERSPRIMER SEQUENCE.sup.1,3 POSITION.sup.2______________________________________Cl-1 TGGAAGGGCTAATTTGGT 1-18 (616)Cl-2 ATCTTCCCTAAAAAATTAGCCTGTC 2099-2075 (617)LTR-3' AGGCTCAGATCTGGTCTAAC 9559-9540 (618)SK68 AGCAGCAGGAAGCACTATGG 7786-7805 (619)Cl-6 TGCTAGAGATTTTCCACAC 9709-9691 (620)KS-2 AGTGAATAGAGTTAGGCAGG 8326-8345 (621)RT5'-v3 GTAAGACAGTATGATCAGATA 2418-2438 (622)RT3'-v2 TTGTAGGGAATTCCAAATTCC 4660-4640 (623)RT5'-v2 CAGGATCCTACACCTGTCAACATAAT 2487-2506 (624)RT3'-v1 GGGAATTCCTTATTCCTGCTTG 4655-4634 (625)______________________________________ .sup.1. Sequence is presented from 5' to 3' of the primer. .sup.2. Position is according to the numbering of HIV NL43 in Myers et al (1992). .sup.3. SEQ ID NOs are given in parentheses.
TABLE 2______________________________________SEQUENCING PRIMERSPRIMER SEQUENCE.sup.1,3 POSITION.sup.2______________________________________KS3 CCAGAAGTTCCACAATCC (626) 8570-8553KS4 TTCTTCTAGGTATGTGGAG (627) 8753-8735KS5 AGTGAATTAGCCCTTCCAG (628) 9093-9075KS6 TGCTAGAGATTTTCCACAC (629) 9709-9691SP2 TGCTCTGGAAAACTCAT (630) 8006-8022SP3 CTTTCTATAGTGAATAGAG (631) 8318-8336SP4 TATTGGAGTCAGGAACT (632) 8618-8634SPR GGTCTAACCAGAGAGAC (633) 9547-9531______________________________________ .sup.1. Sequence is presented from 5' to 3' of the primer. .sup.2. Position is according to the numbering of HIV NL43 in Myers et al (1992). .sup.3. SEQ ID NOs are given in parentheses.
EXAMPLE 4
Cells and Cell Culture
Peripheral blood was obtained from HIV-1 sero-negative volunteers and mononuclear cells prepared by centrifiugation on a Ficoll/Hypaque density gradient (Peper et al, 1968). PBMC were activated with phytohemagglutinin (PHA; 10 .mu.l/10.sup.6 cells) for 48 h at 37.degree. C. washed and then cultured in RPMI 1640 medium containing 10% v/v heat inactivated foetal calf serum, 15 mM HEPES, 0.1% v/v sodium bicarbonate, 25 .mu.g/ml polybrene (Sigma), 10% v/v interleukin 2 (Bochringer Mannheim) and 1:1000 anti-interferon (Miles) (IL-2 medium). Non-PHA stimulated cells were prepared in a similar manner except they were cultured in medium lacking PHA and IL-2.
EXAMPLE 5
Antipeptide-antisera
Antibodies specific for HIV-1 Nef were raised against a peptide corresponding to the predicted amino acid residues 15-27 (AVRERMRRAEPAA SEQ ID NO: 634) of Nef encoded by the HIV-1 clone pNL4.3 (Kemp et al, 1988). The peptide was conjugated to keyhole limpet hemocyanin (KLH; Calbiochem, Behring Diagnostics, CA) via glutaraldehyde and this complex used to immunise sheep (0.5 mg peptide conjugate/sheep). Antibodies to the peptide were purified by affinity chromatography. Reactivity of the antibodies with recombinant HIV-1 Nef 25 and 27 was demonstrated by immunoblotting.
EXAMPLE 6
Reactivity of anti-Nef (.sub.15-27) with HIV C18-infected Cells in Immunoblotting
Seven days post-infection HIV-1 C18-infected PBMCs and mock--infected cells were washed in PBS then lysed (0.5% w/v NP-40, 0.5% w/v sodium deoxycholate, 50 mM NaCl, 25 mM Tris-HCl, 10 mM EDTA, 0.01% w/v sodium azide and 10 mM phenylmethylsulphonylfluoride). After nuclei were spun out lysates were electrophoresed in a 13% w/v SDS-polyacrylamide gel (SDS-PAGE) and subsequently transferred to Hybond-C nitrocellulose (Amersham, Buckinghamshire, England) for 1 h at 100 V using a Bio-Rad protein transfer cell (Bio-Rad, Richmond, Calif.). Membranes were pre-incubated with 1% w/v BSA/PBS for 2 h at room temperature and then reacted with affinity purified sheep anti-Nef(.sub.15-27), diluted 1:100, overnight at room temperature. After three washes in 1% w/v BSA/PBS, the blots were incubated with donkey anti-sheep Ig conjugated to biotin (Amersham, diluted 1:500) for 1 h at room temperature. After extensive washing as described above the membranes were incubated with streptavidin-conjugated horse radish peroxidase (Amersham; diluted 1;500 for 1 h at room temperature. All dilutions were made with 1% w/v BSA in PBS. After further washing the membrane was developed with phenylenediamine substrate (Dako, Dapopatts, Denmark). The antibody preparation used in the immunoblotting experiments was free of detectable antibodies to the immunogenic carrier protein and coupling reagent.
EXAMPLE 7
Analysis by Polymerase Chain Reaction Amplification
A 5' fragment defined by primers Cl-1 and Cl-2 containing the 5' LTR and part of the gag gene was amplified. DNA from HIV-1 C18 infected PBMC gave an amplified fragment (amplimer) of about 1.9 kb compared with 2.1 kb for pHXB2 control template, implying a deletion of about 200 bp from HIV C18. Further amplification of this fragment with primers defining the U3 region of the LTR (Cl-1 and LTR-3') gave amplimers of about 300 bp for HIV-1 C18 infected PBMC DNA compared with 340 bp for C18 and D36 PBMC DNA and 484 bp for pHXB2 control. This implies the loss of approximately 140 to 180 bp from the U3 region of these proviral DNAs.
To analyse the nef-gene-3'LTR region, the nested primer pairs SK68-Cl-6 and KS-2-LTR-3' were used in a double PCR. Amplimers of approximately 830bp were obtained for HIV-1 C18 infected PBMC DNA as well as for PBMC DNA from Donor D36 and Recipients C18, C54 and C98 compared with approximately 1230 bp for pHXB2 DNA. These results suggest that about 400 bp of DNA have been deleted from the Donor and Recipient proviral DNAs.
In comparison, amplification of the polymerase gene region by double PCR with the nested primer pairs RT5'-v3-RT3'-v2 and RT5'-v2-RT3'-v1 gave a fragment (approximately 2.1 kb) the same size as the molecular clone pHXB2 fragment for HIV-1 C18 infected PBMC DNA, suggesting that deletions from this region were unlikely.
EXAMPLE 8
Nucleotide Sequence of the nef-3 ' LTR Region
PCR amplification experiments indicated an approximately 200 bp nucleotide deletion from both the nef gene and LTR regions of Donor D36 PBMC and Recipient C18 HIV-1 proviral DNA. To further analyse these regions, the DNA sequence was determined for the PCR amplified nef-3 '-LTR region of D36 PBMC, C18 isolates HIV.sub.MBC and HIV.sub.StV as well as isolate C98 HIV infected PBMC proviral DNA. The 3' region was amplified with outer primers (SK68-C16) and inner primers (SK68-LTR 3' or KS2-C16) and sequenced directly using a number of internal sequencing primers based on the HIV-1 NL4-3 nucleotide sequence (Table 2).
Alignment of the nucleotide sequences of the amplified 3' region of donor D36 PBMC and recipient C18 isolates HIV.sub.MBC and HIV.sub.StV and C98 HIV (FIG. 1) showed a number of nucleotide sequences changes, including deletions, relative to the nucleotide sequence of wild-type infectious HIV-1 (HIV-1 NL4-3). In the region of alignment, D36 PBMC lacked 291 nucleotides, C18 HIV.sub.StV differed in size by 388 nucleotides (comprising deletions of 397 nucleotides and an insertion of 9 nucleotides), C18 HIV.sub.MBC differed by 456 nucleotides and C98 HIV lacked 158 nucleotides compared with HIV-1 NL4-3. The overall identity with HIV-1 NL4-3 nucleotide sequence of D36 PBMC, C18 HIV.sub.StV, HIV.sub.MBC and C98 HIV nucleotide sequences, including deletions, was 73% (1157/1596), 67% (1459/1592), 62% (982/1592) and 79% (1105/1399), respectively.
The D36 PBMC sequence differed from HIV-1 NL4-3 in a number of features. A change in the wild type tat termination codon from TAG to TCG (Ser) extended the third tat exon (which starts at splice acceptor 10) by a further 15 amino acids to terminate at a conserved TAG (FIG. 1). The resulting C-terminal peptide is rich in charged amino acids (8/15) (FIG. 2a). The wild type rev termination codon has also changed (TAG to GAG, Glu) and the third rev exon is extended for 14 codons to terminate at a conserved TAG (FIG. 2b). The encoded extra amino acids are mainly polar (11/14) and charged in nature (FIG. 2b). The sequence also encodes the C-terminal 237 amino acids of Env gp41 (FIG. 3) terminating at the normal termination codon. The D36 PBMC Env amino acid sequence has 85% identity with the HIV NL4-3 sequence, increasing to 89% if similarities are included.
There are significant differences from HIV-1 NL4-3 downstream of the env (gp41) gene. A change in the fifth nef codon, from TGG (Trp) to TGA (FIG. 1), introduces an early termination in the D36 PBMC nef gene. The encoded Nef protein is identical to the N-terminal 4 amino acids of NL4-3 Nef (FIG. 4). Following the early termination there are deletions of 33, 47, 93 and 91 nucleotides and a region of low sequence homology, compared with HIV NL4-3, prior to the wild type nef termination codon site (HIV NL4-3nts 9405-9407) As well as removing a significant part of the nef gene, these deletions also bring into phase a further 6 termination codons. While the polypurine tract (plus strand primer binding site) and the first 38 nucleotides of the LTR U3 region are perfectly conserved, downstream U3 region sequences are disrupted by the 93 and 91 nucleotide deletions and the low homology region. The resulting U3 region lacks recognition sequences for the transcription factors c-myb, USF and TCF1.alpha. as well as one of the suggested NF-AT sites (Gaynor et al, 1992). Downstream from the 91 nucleotide deletion, a 59 nucleotide region of low homology contains two extra NFKB enhancer sites 19 nucleotides upstream of the usual site of a pair of NFKB sites, the upstream one of which is altered in its 5'-half in D36. Sequences further downstream are highly conserved with respect to HIV-1 NL4-3, including the position and number of Sp1 basal promoter sites, TATA box, TAR and polyadenylation signal sequences.
Similar to D36 PBMC, the C18 HIV.sub.StV and HIV.sub.MBC sequences show the tat third exon to be extended by 15 codons. All but two codons (altered by point mutations) are identical to those of D36 PBMC (FIG. 2a). The rev third exon of both C18 isolates is also extended (FIG. 2b) but by only three codons, identical to the first three codons of the D36 PBMC rev extension. The same 237 amino acid coding region of Env gp41 is found in both the C18 HIV DNA sequences (FIG. 3) and shows 85% identify, increasing to 88% if similarities are included, with the same region of the NL4-3 Env gp41is
It is in the nef gene and LTR regions that the major differences from wild-type HIV-1 arise, just as in D36 PBMC. The nef gene of C18 HIV.sub.StV encodes 24 amino acids with 9 of the 10 N-terminal being identical to the NL4-3 Nef protein (FIG. 4). Thereafter, deletions of 177 and 11 nucleotides cause a frameshift and termination at the 25th codon (FIG. 1). Downstream deletions of 120, 82 and 7 nucleotides cause further loss of wild type nef gene sequence and bring into phase a further three termination codons.
The nef gene of C18 HIV.sub.MBC encodes only 7 amino acids with only the initiator methionine identical to the NL4-3 Nef protein. This loss of identity and early termination is brought about by a 250 nucleotide deletion after the fifth nucleotide of the nef gene. Downstream deletions of 120 and 86 nucleotides cause further loss of wild-type nef gene sequences. In both C18 isolates there is perfect conservation of the polypurine tract and 29/31 nucleotides at the 5' end of the U3 region immediately before the 120 nucleotide deletion (FIG. 1). This deletion together with the downstream 82 and 7 nucleotide deletions in HIV.sub.StV and 86 nucleotide deletion in HIV.sub.MBC and the low homology region cause the loss of the 5' half of the NRT-1 site (Yamamoto et al 1992) and the downstream NFAT site. A third NFKB site is present 31 (HIV.sub.StV) and 33 (HIV.sub.MBC) nucleotides upstream of the expected pair of NFKB sites which are themselves separated by 13 nucleotides instead of the 4 nucleotides in HIV-1 NL4-3. The 5'-most Sp1 site sequence is slightly altered but sequences downstream including the other 2 Sp1 sites, the TATA box, TAR and polyadenylation signal sequences are identical to HIV-1 NL4-3 sequence.
The three sequences, D36 PBMC, C18 HIV.sub.StV and C18 HIV.sub.MBC show a number of similarities consistent with the transmission of virus from person D36 to person C18 as well as a number of differences indicating post-transmission divergence of sequence. All three have tat open reading frames (ORFs) extended by 15 codons. All three have extended rev ORFs. The new rev termination codon in both C18 HIV-1 isolates, three codons downstream of the NL4-3 rev termination codon, has a point mutation in D36 PBMC to make a Glu codon so that it continues for a further 11 codons (FIG. 2b) to terminate at a conserved TGA. The partial Env gp41 amino acid sequences are more closely related to each other (86% identity or 90% including similarities) than to HIV NL4-3 (85% and 89%, respectively).
The nucleotide sequence of the nef and LTR region of the HIV-1 isolate from recipient C98 (C98 HIV) is 90.3% identical (1264/1399) to the HIV NL4-3 sequence, ignoring deletions. Similar to the D36 PBMC and C18 HIV.sub.StV and HIV.sub.MBC isolates the C98 HIV sequence shows the third exon of tat to be extended by 15 codons with all but one being identical to the D36 PBMC tat extension. Also, the rev gene is extended by 3 codons, 2 of which are identical to the first 2 codons of the D36 PBMC rev extension. The sequence also encodes the C-terminal 223 amino acids of Env gp41 terminating at the normal termination codon. The C98 HIV Env amino acid sequence has 89% identity with HIV NL4-3 Env sequence, increasing to 92% of similarities are included.
As with the D36 PBMC and the C98 HIV isolate sequences it is the nef gene and LTR regions that major differences from the HIV NL4-3 sequence arise. The nef gene open reading frame of C98 HIV is much longer than in D36 PBMC, C18 HIV.sub.StV and HIV.sub.MBC, encoding 85 amino acids compared with 206 amino acids for NL4-3. Sixty eight of those 85 amino acids are identical to the N-terminal sequence of NL4-3 Nef. The single, small deletion (16 nucleotides) in the C98 HIV nef-alone regions (Table 3 ) occurs after nef codon 82 causing a frameshift and termination after a further 3 condons at the start of the highly conserved polypurine tract sequence immediately before the 3'-LTR. The nef/LTR region has two deletions totalling 142 nucleotides. The 5'-most deletion of 42 nucleotides includes the splice acceptor 12 sequence. The NRT-1, dyad symmetry and myb response element sequences are all intact. However, the downstream 100 nucleotide deletion includes sequences from the 3' end of the 5'-NF-AT and all of the 3' NF-AT sequences as well as the USF transcription factor recognition sequence. The downstream low homology region of 77 nucleotides lacks the TCP-1.alpha. sequence but has two additional NFKB sites 13 nucleotides apart and 26 nucleotides upstream of the 3'-half-remmant of the normal 5'-NFKB site. Sequence downstream, including the 3'-NFKB site, the 3 Sp1 sites, TATA box TAR and polyadenylation signal sequences are all highly conserved.
The main feature of the sequences is the series of deletions, with respect to HIV NL4-3, in the nef gene-3'-LTR region. These can be grouped into two regions namely the nef-alone region, that part of the nef gene upstream of the LTR, and the nef/LTR region, where the nef gene and LTR U3 regions overlap. The deletions in these regions of each of the sequences start and end at the same or similar positions (Table 3). The deletions are larger in C18 HIV.sub.StV and C18 HIV.sub.MBC sequences where totals of 397 and 456 nucleotides have been deleted (relative to NL4-3) compared to 291 nucleotides, from D36 and 158 nucleotides from C98 HIV. In the nef-alone region the two deletions in C18 HIV.sub.StV and the single deletion in C18 HIV.sub.MBC occupy the same region as the three deletions in D36 PBMC. Similarly, the nef/LTR region in the three deletions in the C18 HIV.sub.StV, the two deletions in the C18 HIV.sub.MBC and the D36 PBMC sequences occupy the same region. These findings indicate that mutant virus was transmitted from D36 to C18 after which further deletions and rearrangements occurred. Similarly, the sequence of C98 HIV in the nef/LTR region indicates two deletions occupying the same region as the nef/LTR deletions in D36 and the C18 sequences. However, the size (only 16 nucleotides) and the position of the deletion in the nef-alone region of C98 HIV are distinct from those of the D36 PBMC and C18 sequences.
The timing of transmission of virus by transfusion was that recipient C18 was transfused approximately 19 months after C98. Consistent with the relative timing of transmission and the sequence similarities and differences is the suggestion that at the time of transmission to C98, the D36 sequence had deletions in the nef/LTR region but not in nef-alone region, After transmission to C98, the C98 virus developed further deletions and rearrangements, including the deletion in the nef-alone region. The D36 virus evolved so that at the time of transmission to C18, further deletions and rearrangements had occurred including deletion of sequence from the nef-alone region distinct from the C98 HIV nef-alone region deletion. After transmission to C18, further deletions and rearrangements occurred in the C18 virus giving rise to at least two sequences (HIV.sub.StV and HIV.sub.MBC).
The nef-alone deletion region may be a mutation or recombination "hotspot" as it includes sequences that were found to be variably duplicated in 28 out of 54 Nef protein sequences derived from 8 of 12 patients analysed in a study (Shugars et al 1993). The sequence between the nef-alone and the nef/LTR region deletions is highly conserved and is important in provirus integration into the infected cell genome and interacts with a number of cellular proteins. It is interesting that the sequence equivalent to NL4-3 nucleotides 9209 to 9225 is retained in D36 and C98 HIV but lost in the C18 HIV sequences. This includes part of a sequence of dyad symmetry (9210 to 9231) and is a significant part of the binding site for NRT-1 (Yamamoto et al 1991) which has been shown to have a negative regulatory effect on HIV-1 expression. The presence of this sequence in D36 and C98 HIV and its absence from the C18 isolates may correlate with the inability to isolate virus from D36 PBMC and the poor replication of C98 HIV but the ability to isolate HIV-1 from C18 PBMC, The deletion of sequence equivalent to nucleotides 9281 to 9395 of NL4-3 causes the loss of some transcription factor binding sites including NFAT and USF from the D36, C18 HIV and C98 HIV sequences.
A further similarity between the D36, C18 HIV.sub.StV, C18 HIV.sub.MBC and C98 HIV sequences is a region of low homology to HIV-1 NL4-3 extending downstream of the nef/LTR deleted region to the NFKB enhancer/Sp1 promoter site region. This low homology region in fact consists of incomplete duplications of part of the NFKB/Sp1 region (FIG. 5) resulting in D36 and C98 HIV having 2 extra NFKB sites upstream of an altered 5' NFKB site while the C18 sequences have one extra NFKB site and altered spacing between the 5' and 3' wild type NFKB sites due to an insertion of 9 nucleotides.
For the C18 and C98 HIV-1 isolates virus replication was assessed in PHA-stimulated and non-stimulated PBMCs (FIGS. 6 and 7). In PHA-stimulated PBMCs we also studied cell surface CD4 and IL-2R expression (FIG. 8). In comparison with HIV-1 wild type SI and NSI isolates clearly both C18 HIV.sub.MBC and C98 viruses are replication competent, though C98 HIV replicates more poorly than C18 HIV.sub.MBC and are of the NSI phenotype when syncytium formation and CD4 and IL-2R surface expression are taken into account. Additionally, and more surprisingly, these two viruses replicated almost as efficiently in non-PHA stimulated PBMCs when compared to a typical local wild type SI isolate (HIV-1 228200, FIG. 7).
When protein expression was assessed for C18 HIV.sub.MBC and C98 HIV.sub.MBC although structural proteins were identified, no typical Nef protein was seen in infected cells. However, analysis of cell lysates prepared front PBMC infected with C18 HIV.sub.MBC or PBMC infected with C98 HIV.sub.MBC (which were subsequently stimulated by UV irradiation, see Valerie et al, 1988) by Western immunoblotting using two antibodies specific for the N-terminal region of Nef showed the presence of smaller proteins of 19 kDa and 21 kDa, respectively. These proteins were not observed in mock-injected control PBMC lysates and were not observed when the infected-cell lysates were probed were probed with antibodies reactive with the C-terminus of Nef.
Thus, although the C18 and C98 HIV isolates are replication competent in vitro they clearly replicate differently using different conditions for cell activation and from the known functions of HIV-1 Nef protein and the LTR show that the major deletion in the nef gene and/or the LTR is at least in part responsible for the outcome of infection implicating the importance of Nef and/or the LTR in the clinical outcome of infection in vivo.
EXAMPLE 9
Determination of Degree of Relatedness Between Viruses
To determine the degree of relatedness between viruses such as between mutants or between mutants and a wild-type virus and to ascertain putative infected patients, the method of Delwart et al was employed.
EXAMPLE 10
Immune Responsiveness of Subjects Infected by Non-pathogenic HIV-1 Isolate
In this example, the donor and recipients of the cohort were tissue typed and assessed for basic cellular immune responses. Proliferative responses and IL-2 production to the mitogens ConA and PHA, to allogeneic mononuclear cells (irradiated pooled mononuclear cells from 20 random donors) and to recall antigens (e.g. influenza and tetanus toxoid) were within normal ranges. While at the immunogenetic level, HLA typing failed to identify a consistently common allele or haplotype within the group.
The conservation of CD4+ counts observed in the cohort, the relative integrity of their immune system and the varied HLA types of the donor and recipients further supports the fact that the symptomless condition of the cohort members is due to a non-pathogenic strain of HIV-1 or a stain of low virulence.
Accordingly, this provides a screening procedure for subjects putatively infected by a non-pathogenic HIV-1 isolate where such subjects are seropositive for HIV-1 (e.g. have antibodies to an HIV-1 glycoprotein) yet have normal proliferative responses and cytokine production to mitogens, allogeneic mononuclear cells and to recall antigens.
EXAMPLE 11
Clinical Immunology of Cohort
To establish that the donor and the recipients belonging to the cohort exhibit normal immunological profiles, members of the cohort were assayed for CD3, CD4, CD8, lymphocyte count, CD4/CD8 ratio and .beta.-2-microglobulin over time since seroconversion.
Parameters considered normal in non-infected individuals range as follows:
______________________________________Parameter______________________________________CD3 55-82% 620-2200 (.times. 10.sup.6 /L)CD4 29-58% 420-1410 (.times. 10.sup.6 /L)CD8 12-43% 200-980 (.times. 10.sup.6 /L)Lymphocyte count 1000-3500 (.times. 10.sup.6 /L)CD4/CD8 0.7-3.7.beta.-2-microglobulin 0.00-2.20 mg/L______________________________________
The results are shown in FIGS. 10(a)-(g) and clearly show that the immunological profiles of cohort members are substantially normal further highlighting the non-pathogenicity of the HIV-1 isolates of the present invention. FIG. 10(g) shows a graph of the Kaplan-Meier (Ox and Oates, 1989) estimates of time to dime a progression (AIDS or CD4>250). The results demonstrate that the difference is large in spite of the conservative bias, with a median time to progression of 6.2 years in the main database. An exact logrank test (Cytel Software Corporation, 1989, StatXact: Statistical Software for Exact Nonparametric Inference. Cambridge, Mass.) was performed, demonstrating that the difference between the groups was highly statistically significant (logrank statistic 11.8, p<0.0001).
TABLE 3__________________________________________________________________________Deletions and their sizes in the nef-alone andthe nef/LTR regions of the Long-Term Asymptomatic HIV-1 Sequences Region Region Total Deletion Deletion DeletionSequence nef-alone Region (nt) nef/LTR Region (nt) (nt)__________________________________________________________________________D36 PBMC 8830-8862 (33) 107 9112-9204 (93) 184 291 8882-8928 (47) 9281-9371 (91) 9009-9035 (27)C18 HIV.sub.StV 8830-9006 (177) 188 9105-9224 (120) 202 390 9019-9029 (11) 9281-9362 (82)C18 HIV.sub.MBC 8792-9041 (250) 250 9105-9224 (120) 206 456 9281-9366 (86)C98 HIV 9033-9048 (16) 16 9148-9189 (42) 142 158 9271-9370 (100)C54 PBMC incomplete ? 9281-9375 (95) 95 95+__________________________________________________________________________ Sequence numbering relates to the equivalent position in HIV1 NL43. Numbers in brackets are the deletion sizes in nucleotides (nt). The nef ORF starts at nt 8787 and the 3LTR starts at nt 9074 in HIV1 NL43.
EXAMPLE 12
Sequencing of Isolate HIV-1 C18.sub.MBC
The genome of variant HIV-1 designated C18 HIV-1.sub.MBC was amplified by the polymerase chain reaction (PCR) as 7 overlapping fragments using the sets of inner and outer oligonucleotide primers, designed using the programme PCRPLAN (IntelliGenetics), listed in Table 5 and either UlTma (Applied Biosystems) or a mixture of KlenTaq and Pfu (KlenTaq LA, Ab Peptides Inc) polymerases (for faithful amplification of long fragments). The resulting fragments were cloned into the SmaI site of the plasmid vector pGEM7Zf+. Insert-containing clones representing each region of the full length variant HIV-1 were sequenced by a nested deletion strategy (Gou & Wu, 1982) and cycle sequencing with Taq polymerase and dye labelled primers complimentary to the T7 or SP6 sites within the cloning vector. Nucleotide sequences were entered and collated by ASSEMGEL and SEQIN (IntelliGenetics) and SEQED (Applied Biosystems) and translated to the encoded amino acid sequences using TRANSL (IntelliGenetics) programmes. Sequence alignments used NALIGN, CLUSTAL (IntelliGenetics) and SEQED programmes.
The full length sequence (FIG. 9; SEQ ID NO:800) of isolate HIV-1 C18.sub.MBC is 9207 nucleotides long which is 506 nucleotides shorter than the HIV NL4-3 sequence. This size difference is comprised of 126 nucleotides of insertions and 632 nucleotides of deletions, see Table 6. The most extensive differences between the HIV-1 C18.sub.MBC sequence and HIV-1 NL4-3 are in the U3 region of the LTR and in the nef gene, as hereinafter described.
The 5' LTR has deletions of 120 and 87 nucleotides and a region of low sequence homology, which is the result of an imperfect duplication of the downstream NF.kappa.B and Sp1 response sequences. These result in the loss of sequence from a number sites important in the regulation of transcription of HIV-1 genes, including the negative response element (NRE) and the response elements for a number of transcription factors including NF-AT, NRT-1, USF and TCF-1.alpha.. Furthermore, the low homology region contains an extra NF.kappa.B and Sp1 sites as well as an insertion of 9 nucleotides between the usual NF.kappa.B sites. Downstream of the NF.kappa.B sites the sequence of the LTR has a high level of homology (96.2%) with the same region of HIV NL4-3.
The gag gene contains 3 insertions, which represent direct repetitions of adjacent sequences. The first is a perfect repeat of 15 nucleotides after the equivalent of nucleotide 1134 of HIV- NL4-3 and adds 5 amino acids to the C-terminus region of p17.sup.gag. The remaining 2 insertions are imperfect and perfect repeats of 30 and 6 nucleotides, respectively, after the equivalent of HIV NL4-3 nucleotides 2163 and 2232, respectively. These encode an extra 12 amino acids in the C-terminus region of p15.sup.gag just downstream of the gag to pol frameshift sequences. The variation in sequence length of the gag gene at these two positions is unusual. The homology of the encoded amino acid sequence of HIV-1 C18.sub.MBC and HIV NL4-3 for the gag p17, p24, and p15 proteins is 87.1%, 93.5% and 94.3%, respectively.
In the pol ORF, the encoded proteins have high homology with the NL4-3 sequences being 95.5% overall comprising p10 protease 92.9%, p66 reverse transcriptase 95.4% and p34 integrase 95.8%. The amino acid sequence of the p61 RT lacks the mutations associated with resistance to the nucleoside (AZT, ddI, ddC) and non-nucleoside (Nevirapine) analogue drugs used in the treatment of HIV-1-infected persons.
The vif gene encodes a 192 amino acid protein with 88.0% homology with that of HIV-1 NL4-3. The vpr gene encodes a 96 amino acid protein with 89.6% homology with that of HIV-1 NL4-3.
There are 2 insertions and 1 deletion of sequences in the vpu gene. The insertions of 3 and 9 nucleotides are after the equivalent of nucleotide 6071 and 6234, respectively, of HIV-1 NL4-3. These add 1 amino acid after amino acid 3, and 3 amino acids after amino acid 59 of the encoded Vpu protein. The deletion of 12 nucleotides after the equivalent of HIV-1 NL4-3 nucleotide 6261 deletes 4 amino acids from the C-terminal region of Vpu as well as from the signal peptide of the env polyprotein, which is encoded by an overlapping reading frame. Amino acid sequence homology of HIV-1 C18.sub.MBC Vpu with NL4-3 is 85.2%.
The sequence encoding the env gp120 has 9 insertions totalling 45 nucleotides (encoding 15 amino acids) and the deletion of a total of 18 nucleotides (encoding 6 amino acids). These are listed in Table 6. All of these events (insertions and deletions) are at positions in the env gene. This is within the env V3 coding region, immediately upstream of the sequence encoding the so called V3 tip (or loop) amino acid sequence, Gly Pro Gly Arg. The V3 region sequence is that of a typical clade B subtype (North America, Europe and Australia) being identical to the clad B consensus sequence (based on 186 env sequences) at 29/35 positions. The type of amino acid at positions 11 and 28 of the V3 loop region (where position 1 is the Cys at amino acid 266 of the env gpl120) is predictive of the viral non-syncytium/syncytium forming phenotype (Fouchier et al. 1992). The HIV-1 C18.sub.MBC env gene encoded amino acid sequence has Ser at position 11 and Ile at position 28 of the V3 loop region. The lack of a positively charged amino acid at both positions is strongly indicative of a non-syncytium viral phenotype. The overall amino acid sequence homology with HIV-1 NL4-3 (ignoring deletions and insertions) is 86.1%, comprising 85.5% for the gp120 region and 87.6% for the gp41 region.
Both the tat and rev second exon open reading frames (ORF) are longer than in HIV-1 NL4-3. A change of the tat termination codon from TAG to TCG extends the tat ORF to a downstream in phase termination codon extending the encoded tat amino acid sequence by 15 residues, compared with the 86 amino acid long NL4-3 tat protein, to a total length of 101 amino acids. However, this is the usual length of the HIV-1 tat protein.
Similarly, the normal rev termination codon is changed from TAG to GAG. This extends the rev ORF to an in-phase termination codon 3 codons downstream so that the encoded Rev protein is 119 amino acids long instead of the usual 116.
As mentioned above the most extensive differences between the sequences of the isolate HIV-1 C18.sub.MBC and HIV-1 NL4-3 are in the nef gene and the LTR region. While the nef gene overlaps the 3' LTR, these differences are found in both the nef alone and the nef/LTR overlap regions. The HIV C18.sub.MBC -encoded nef protein is only 24 amino acids long compared with the normal length of 206 amino acids. This severe shortening of the nef protein is due to the deletion of 18 nucleotides (the 177 and 11 nucleotide deletions) from the nef-alone region which also brings into phase a termination codon, TAG, at the resulting 25th codon. Downstream there is further loss of potential nef gene sequences by the 120 and 87 nucleotide deletions situated in the nef/LTR overlap region. The resulting 24 amino acid nef protein is identical to the N-terminus of the HIV-1 NL4-3 nef at 9 of the first 10 positions. Thereafter, homology is lost completely.
Some sequences used in the generation of mature mRNAs are altered or lost in C18.sub.MBC. The dinucleotide immediately after the splice donor site 2 (SD2) at nts 4818-4819 NL4-3 equivalent nts 4963-4964)is changed from the conserved GT to GC. It is expected that this change would lead to loss of function of this site as a splice donor. Splice donor 2 is used in the processing of HIV-1 transcripts to some of the mRNAs that encode Tat, Rev and nef proteins. Similarly the splice acceptor site 7 (SA7) sequence at nts 6477-6478 (NL4-3 equivalent nts 6602-6603) is changed from the conserved AG dinucleotide to TC. This change is expected to lead to loss of function of this site as a splice acceptor. While this SA site is used in HIV-1 mRNA processing it is not a major site and is not used in the production of the regulatory proteins (Tat, Rev or nef) mRNAs. The splice donor 12 site is absent from the C18.sub.MBC sequence (NL43 equivalent nts 9161-9162) as it is within the first deletion region in the nef/LTR overlap region which occurs at nt 8797 and results in the loss of NL43 nucleotides 9105 to 9224. It is significant that the SA12 site is absent from the sequence of all of the cohort virus isolates so far obtained as well as from the sequence of D36 PBMC, however, the C.sub.54 PBMC sequence does contain the SA12 site. SA12 is not used in the processing of mRNAs that encode the viral regulatory proteins. Normally SA12 is used in splicing in conjunction with SD1, 2, 3 and 4 and the resulting spliced RNA is probably not a mRNA but may have a regulatory role involving binding to cellular proteins (Smith et al, 1992).
An interesting feature of the sequence of the HIV-1 C18.sub.MBC isolate is the deletion and rearrangement of sequence from the 5'-LTR U3 region and the deletion of sequence from the nef gene (both nef alone and nef/3' LTR regions). These being the only features of the sequence distinct from disease-causing HIV-1. The lack of AIDS or AIDS-like symptoms in the patient C18 is attributed to the effects of the loss of LTR sequence and/or the loss of nef coding sequences and their role in the pathogenesis of AIDS.
TABLE 4__________________________________________________________________________Primers used to Amplify Overlapping regions of HIV-1 C18.sub.MBC 5'- Direction PrimerPrimer Coordinate (+/-) Length Sequence (nt)__________________________________________________________________________CL 1A 1 + 30 TGGAAGGGCTAATTTACTCCCAAAAAAGACCL 14 896 - 25 AATCGTTCTAGCTCCCTGCTTGCCCCL 1B 1 + 30 AATCCCGGGTGGAAGGGCTAATTTACTCCCCL 13 796 - 31 CCTCTAGACCGCTTAATACTGACGCTCTCGCCL 11 682 + 23 TCTCTCGACGCAGGACTCGGCTTCL 18 3440 - 30 CTGTTTTCTGCCAGTTCTAGCTCTGCTTCTCL 12A 732 + 26 TTTCCCGGGCGGCGACTGGTGAGTACCL 17 3330 - 32 CCCTCTAGACTTGCCCAATTCAATTTTCCCACCL 26 3193 + 39 CCACACCAGACAAAAAGCATCAGAAAGAACCCCCATTCCCL 6B 9671 - 39 TGCTAGAGATTTTCCACACGGACTAAAATGGTCTGAGGGCL 27 3251 + 39 CCATCCTGATAAATGGACAGTACAACCCATAGTACTGCCCL 28 639 - 37 TGGCCCAAACATTATGTACCTCTGCATCATATGCCL 19 5449 + 30 AGCAGGACATAACAAGGTAGGATCTCTACACL 24 8422 - 28 GGATCTGTCTCTGTCTCTCTCTCCACCT__________________________________________________________________________ Underlined sequences depict added restriction enzyme site + and - orientations refer to sense and antisense strands of the double stranded DNA sequence
TABLE 5______________________________________Sequence Deletions and Insertions in HIV-1 C18.sub.MBC*Compared with HIV-1 NL43 Position (nt) Deletions InsertionsGene or Region C18.sub.MBC NL43 (nt) (nt)______________________________________5'-LTR U3 29 29 120 --5'-LTR U3 85 205 87 --5'-LTR U3 154 360 -- 9gag p17 939 1134 -- 15gag p15 1982 2163 -- 30gag p15 2081 2232 -- 6vpu 5927 6062 -- 3vpu/env 6092 6234 -- 9vpu/env 6128 6261 12 --env 6483 6628 -- 6env 6514 6653 2 --env 6524 6665 1 --env 6630 6772 -- 9env 6646 6778 -- 3env 7011 7141 6 --env 7140 7276 3 --env 7195 7334 -- 6env 7266 7399 3 --env 7278 7414 -- 6env 7290 7420 -- 2env 7300 7429 -- 1env 7314 7441 3 --env 7463 7593 -- 3env 7471 7598 -- 9nef 8711 8829 177 --nef 8723 9018 11 --nef/LTR 8798 9104 120 --nef/LTR 8854 9280 87 --LTR U3 8923 9435 -- 9 632 126______________________________________
EXAMPLE 13
Macrophage Isolates of HIV-1 C18 and HIV-1 C98
HIV-1 has been isolated from the macrophages of patients C18 and C98
Patient monocytes were prepared as follows. Whole blood was spun at 2000 rpm for 10 minutes. Plasma was removed into a separate tube and the remaining cells were diluted 1:2 in PBS.sup.- (magnesium and calcium free phosphate buffered saline). This was underlaid with 10 ml of Ficoll Isopaque and spun at 2000 rpm for 20 minutes. Cells were collected from the interphase and washed three times with PBS.sup.-. These cells were then seeded into a 6 well Costar tray at a concentration of 1.0.times.10.sup.7 /ml and allowed to adhere for 1 hour, Any non-adherent cells were removed by aspiration.
Donor HIV-1 negative macrophages for use in co-cultivation were prepared as follows. Peripheral blood mononuclear cells were purified from whole blood using Ficoll/sopaque density gradient. These cells were seeded at a concentration of 2.0.times.10.sup.6 /ml in teflon. PBMC wore cultured in the presence of 3 .mu.g/ml of PHA and 1000 U/ml of M-CSF 3 days prior to co-culture.
On day of co-culture, donor PBMC were CD8 depleted. Dyna beads coated with anti-CD8 were used for this purpose. Dyna beads were washed once in PBS.sup.- and then applied to a magnet for 3 minutes. Supernatant was removed and the beads were then resuspended in 250 .mu.l of RF-10. Aliquots of 2.0.times.10.sup.8 patient cells were then added to 250 .mu.l (3 beads: 1 CD8 T-cell) of Dyne beads and allowed to incubate for 30 minutes on ice with occasional mixing. After 30 minutes the cell suspension was placed onto a magnet for 3 minutes. The supernatant was then removed placed into a second tube containing 142 .mu.l (1 bead: 1 CD8 T-cell) of Dyna beads. This suspension was placed on ice for an additional 30 minutes with occasional mixing. After 30 minutes cell suspension was placed onto a magnet for 3 minutes. Supernatant was removed and washed once in RF-10.
For co-culture, CD8 depleted PBMC were then added to patient monocytes. Half media changes were done every 7 days for a period of 21 days. Aliquots of 2.5 ml of medium was removed from these cultures and replaced with CD9 depleted donor PBMC in Iscoves containing 10% HuS (Human serum), 5% v/v FCS and 5% w/v IL-2 and 1000 .mu./ml of M-CSF. Harvested supernatants were spun at 1400 rpm for 10 minutes and stored as 1 ml aliquots. Cell pellets were lysed in 200 .mu.l of lysis buffer for PCR analysis. Infection was quantitated using a p24 EIA Kit.
Cells were harvested from the co-cultures and used to prepare DNA as described above. The nef/3'-LTR region of both virus isolates was amplified by PCR using the above described primer sets and conditions (Example 12). The resulting amplimers were cloned into the plasmid vector pT7T3U19 and the nucleotide sequence determined by the Taq cycle sequencing method with dye-labelled primers.
The C18 macrophage sequence has 3 deletions starting and finishing at positions within 3 nucleotides of the same deletions in C18.sub.MBC. The encoded nef protein is 3 amino acids long compared with 7 amino acids for C18.sub.MBC. The low homology region of the LTR U 3 region of C18 macrophage is very similar in sequence to C18.sub.MBC and similarly it has one extra upstream NF.kappa.B site.
On the other hand, the sequence of C98 macrophage has a number of differences from the C98 isolate. While it has exactly the same first deletion of 16 nucleotides just upstream of the polypurine tract (PPT), in the nef-alone region, and exactly the same second deletion (position and size) it has an extra deletion of 18 nucleotides at NL4-3 equivalent nucleotides 9206 to 9223. The final deletion is in approximately the same position as in the C98 isolate but is 5 nucleotides longer. The encoded nef protein is 34 amino acids long compared with 86 amino acids for the C98 isolate. The low homology region is very similar to the C98 isolate, having the same 2 extra upstream NF-.kappa.B sites and completely lacking the normal 5'-NF.kappa.B site.
EXAMPLE 14
Construction and Use of an Infectious A Molecular Clone
Molecular biological techniques can be used to construct a molecular clone of, for example, HIV-1 C18.sub.MBC. Two schemes may be used. In the first scheme genomic DNA, extracted from either the CD4 positive PBMC of the patient C18 or donor PBMC that have been infected with the isolate HIV-1 C18.sub.MBC, is used as the template for polymerase chain reaction amplification, using thermostable polymerase of high transcriptional fidelity (eg UlTma polymerase or KlenTaq/Pfu polymerase mixture), of long (6 to 7 kb) overlapping fragments representing the 5'- and 3'-parts of the HIV-1 C18.sub.MBC proviral genome of total length 9207 nts. The amplified fragments may then be ligated together after digestion with a restriction enzyme that cleaves at a unique site common to the overlapping region of the amplified fragments, for example the unique Bgl I or Nco I sites. Ligation of this full length proviral DNA into a plasmid vector will allow its propagation in E coli and the subsequent preparation of large (mg) quantities of this molecularly cloned proviral DNA.
In the second scheme donor PBMC that have been infected with the isolate HIV-1 C18.sub.MBC are used as a source of non-integrated proviral DNA which can be extracted from the infected cells by the Hirt extraction method (Hirt, 1967). Circular proviral DNA molecules may be linearised by digestion with a restriction enzyme that cleaves at a unique position in the genome (eg the Bgl I or Nco I sites). The resilting linearised molecules can be ligated into a plasmid or, more usually, a bacteriophage lambda (.lambda.) based vector (eg Charon 4a, .lambda.WES) after modification of the end to provide blunt or cohesive ends compatible with the vector. Transformation or transduction of E coli with the recombinant plasmid or bacteriophage material, respectively allows the propagation of the proviral DNA. Clones of E coli containing proviral DNA may be selected and DNA prepared. Molecular clones of retroviral genomes prepared in this way are often permuted. Rearrangement to the functional arrangement of sequences is achieved by restriction enzyme cleavage and religation of fragments to reconstruct the correctly permuted proviral genome.
The molecularly cloned DNA products of both schemes can be used to prepare variant proviral genomes that may be used as the basis of a biologically attenuated HIV-1 vaccine strain. Similarly, they may be modified to contain extra DNA sequences in the nef-alone deletion region that may deliver sequences that may be of therapeutic advantage (eg antisense or ribozyme sequences).
Infectious virus particles of HIV-1 C18.sub.MBC, or modified virus, can be produced by transfection of human cells (eg HeLa cells) which will produce, and release to the culture medium, virus particles of HIV-1 C18.sub.MBC, or modified virus. These virus particles can be used to infect a variety of CD4 positive cells for further propagation or experimentation.
EXAMPLE 15
In vivo Primate Model
Following construction of infectious molecular clones of the mutant HIV-1 strains, studies are then undertaken in primates to establish attenuation, immunogenicity and vaccine prophylactic efficacy. All studies compare mutant clones of HIV-1 with isogenic wild-type (WT) virus. Initial studies are performed using the macaque (M. nemistrina) model of HIV-1 infection. Macaque infectious WT HIV-1 and mutant clones are compared with respect to duration of viremia, anatomic sites of replication, and cellular and humoral immune responses. Where the mutant HIV-1 clones induce an immune response in the macques infected, challenge studies with WT virus are also performed. Studies are performed in a limited number of chimpanzees, generally in parallel with the macaque studies. Relevant mutations are engineered into WT HIV-1 clones previously shown to produce chronic infection in chimps, and the course of chimp infection with mutant clones compared with historical controls. If infection is established, WT challenge studies is also performed.
Those skilled in the art will appreciate that the invention described herein is susceptible to variations and modifications other than those specifically described. It is to be understood that the invention includes all such variations and modifications. The invention also includes all of the steps, features, compositions and compounds referred to or indicated in this specification, individually or collectively, and any and all combinations of any two or more of said steps or features.
Bibliography
BACHMANN B, LUKE W AND HUNSMANN G (1990). Nucl Acids Res 18: 1309.
BARRE-SINOUSSI F, CHERMANN J C, REY F, et al (1983) Science 220: 868-871.
BUSCH M P, E L AMAD Z, SHEPPARD H W, ASCHER M S, LANG W (1991) N Engl J Med 325: 733-735.
CHENG-MAYER C, SHIODA T, LEVY J A (1991) J Virol 65: 6931-6941.
CLERICI M, STOCKS N I, ZAJAC R A, et al (1989) J Clin Invest 84: 1892-1899.
COX and OAKES (1989) Survival Analysis, Chapman & Hall.
DANIEL M D, KIRCHHOFF F, CZAJAK S C, SEHGAL P AND DESROSIERS R C (1992). Science 258: 1938-1941.
DELWART E L, et al (1993) Science 262: 1257-1261.
FOUCHER RAM, et al (1992) J. Virol. 66: 3183-3187.
GAYNOR R (1992). AIDS 6m 347-363.
GOU L-H and WU R. (1982) Nucleic Acids Research 10: 2065-2084.
GREENWAY et al (1994) Virology 198: 245-256.
GROENINK M, FOUCHIER RAM, BROERSEN S, et al (1993) Science 260: 1513-1515.
HAMMES S R, DIXON E P, MALIM M H, CULLEN B R and GREENE W C, (1989) Proc Natl Acad Sci USA 86: 9549-9553.
HIRT B. (1967) J Mol Biol 26: 365-369.
HWANG S S, BOYLE T J, LYERLY H K, CULLEN B R (1991) Science 253: 71-74.
KASLOW R A, DUQUESNOY R, VAN RADEN M, KINGSLEY L, MARRARI M. (1990) Lancet 335: 927-930.
KEMP B E, RYLATT D B, BUNDESEN P G, DOHERTY R R, MCPHEE D A, STAPLETON D, COTTIS L E, WILSON K, JOHN M A, KHAN J M, DINH D P, MILES S & HILLYARD C J (1988). Science 241: 1352-1354.
KESTLER H W, RINGLER D J, MORI K, PANICALI D L, SEHGAL P K, DANIEL M D & DESROSIERS R C (1991). Cell 65: 651-662.
KIERNAN R. et al (1990) AIDS Res. Hum. Retroviruses 6: 743-752.
KIM S, IKEUCHI K, BYRN R, GROOPMAN J and BALTIMORE D (1989) Proc Natl Acad Sci USA 86: 9544-9548.
LANG W. PERKINS H, ANDERSON R E, ROYCE R. JEWELL N. WILKELSTEIN W. (1989) J Acquir Immune Defic Syndr 2: 63-69.
LEARMONT J, TINDALL B, EVANS L, CUNNINGHAM A, CUNNINGHAM P, WELLS J, PENNY R, KALDOR J AND COOPER D A. (1992). Lancet 340: 863-867.
LEGUERN M, SHIODA T, LEVY J A, CHENG-MAYER C. (1993) Virology 195: 441-447.
LEVY J A, (1993) AIDS 7: 1401-1410.
LIFSON A R, BUCHBINDER S P, SHEPPARD H W, et al (1991) J infect Dis 163: 959-965.
LUCIW P A, CHENG-MAYER C and LEVY J A (1987) Proc Natl Acad Sci USA 84: 1434-1438.
MANIATIS T et al (1982). Molecular cloning. A Laboratory Manual, 1st edition Pub. Cold Spring Harbor Laboratory Press.
MOSIER D E, GULIZIA R J, MACISAAC P D, TORBETT B E, LEVY J A (1993) Science 260: 689-692.
MYERS A, KORBAR B, BERZOFSKY J A, SMITH R F & PAVLAKIS S A eds (1992; 1993). Human retroviruses and AIDS. A compilation and analysis of nucleic acid and amino acid sequences. Pub Theoretical Biology and Biophysics Group. Los Alamos National Laboratory, Los Alamos, N. Mex. USA.
NEATE E V, HEALY D S, PRINGLE R C, GUST I D, AND JOWLETT J M B (1987). Aus NZ J Med 17: 461-466.
NIEDERMAN T M J, THIELAN B J, and RATNER L. (1989) Proc Natl Acad Sci USA 86: 1128-1132.
PEPER R J, TINA W Z, & MICHELSON M M (1968). J Lab Clin Med 72: 842-846.
SANGER F, NICKLEN S AND COULSON A R (1977). Proc Natl Acad Sci USA 4: 5463-67.
SHEPPARD H W, LANG W, ASCHER M S, VITTINGHOF E and WINKELSTEIN W. (1993) AIDS 7: 1159-1166.
SHIODA T, LEVY J A, CHENG-MAYER C (1992) Proc Natl Acad Sci USA 89: 9434-9438.
SHUGARS D C, SMITH M S, GLUECK D H, NANTERMET P V, SEILLIER-MOISEIWITSCH F AND SWANSTROM R (1993). J Virol 67: 4639-4650.
SMITH J, AZAD A A, and DEACON N J (1992) J Gen Virol 73: 1825-1828.
SULLIVAN N, THALI M, FURMAN C, HO D D, SODROSKI J (1993) J Virol 67: 3674-3679.
TEEUWSEN V J P, SIEBELINK K H J, DE WOLF F, GOUDSMIT J, UYTDEHAAG F G C M, OSTERHAUS A D M E (1990) AIDS 4: 77-81.
TERSMETTE M, DE GOEDE R E Y, BERT J M, et al (1988) J Virol 62: 2026-2032.
TERWILLIGER E, SODROSKI J G, ROSEN C A, and HASELTINE W A, (1986) J Virol 60: 754-760.
YAMANOTO K MORI S, OKAMOTO T, SHINOTOHNO K, AND KYOGOKU Y (1991). Nucl, Acids Res 22: 6107-6112.
YANISCH-PERRON C, VIEIRA J, and MESSING J Gene 13: 103-119.
__________________________________________________________________________# SEQUENCE LISTING- (1) GENERAL INFORMATION:- (iii) NUMBER OF SEQUENCES: 800- (2) INFORMATION FOR SEQ ID NO:1:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 9709 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:1:- TGGAAGGGCT AATTTGGTCC CAAAAAAGAC AAGAGATCCT TGATCTGTGG AT - #CTACCACA 60- CACAAGGCTA CTTCCCTGAT TGGCAGAACT ACACACCAGG GCCAGGGATC AG - #ATATCCAC 120- TGACCTTTGG ATGGTGCTTC AAGTTAGTAC CAGTTGAACC AGAGCAAGTA GA - #AGAGGCCA 180- AATAAGGAGA GAAGAACAGC TTGTTACACC CTATGAGCCA GCATGGGATG GA - #GGACCCGG 240- AGGGAGAAGT ATTAGTGTGG AAGTTTGACA GCCTCCTAGC ATTTCGTCAC AT - #GGCCCGAG 300- AGCTGCATCC GGAGTACTAC AAAGACTGCT GACATCGAGC TTTCTACAAG GG - #ACTTTCCG 360- CTGGGGACTT TCCAGGGAGG TGTGGCCTGG GCGGGACTGG GGAGTGGCGA GC - #CCTCAGAT 420- GCTACATATA AGCAGCTGCT TTTTGCCTGT ACTGGGTCTC TCTGGTTAGA CC - #AGATCTGA 480- GCCTGGGAGC TCTCTGGCTA ACTAGGGAAC CCACTGCTTA AGCCTCAATA AA - #GCTTGCCT 540- TGAGTGCTCA AAGTAGTGTG TGCCCGTCTG TTGTGTGACT CTGGTAACTA GA - #GATCCCTC 600- AGACCCTTTT AGTCAGTGTG GAAAATCTCT AGCAGTGGCG CCCGAACAGG GA - #CTTGAAAG 660- CGAAAGTAAA GCCAGAGGAG ATCTCTCGAC GCAGGACTCG GCTTGCTGAA GC - #GCGCACGG 720- CAAGAGGCGA GGGGCGGCGA CTGGTGAGTA CGCCAAAAAT TTTGACTAGC GG - #AGGCTAGA 780- AGGAGAGAGA TGGGTGCGAG AGCGTCGGTA TTAAGCGGGG GAGAATTAGA TA - #AATGGGAA 840- AAAATTCGGT TAAGGCCAGG GGGAAAGAAA CAATATAAAC TAAAACATAT AG - #TATGGGCA 900- AGCAGGGAGC TAGAACGATT CGCAGTTAAT CCTGGCCTTT TAGAGACATC AG - #AAGGCTGT 960- AGACAAATAC TGGGACAGCT ACAACCATCC CTTCAGACAG GATCAGAAGA AC - #TTAGATCA1020- TTATATAATA CAATAGCAGT CCTCTATTGT GTGCATCAAA GGATAGATGT AA - #AAGACACC1080- AAGGAAGCCT TAGATAAGAT AGAGGAAGAG CAAAACAAAA GTAAGAAAAA GG - #CACAGCAA1140- GCAGCAGCTG ACACAGGAAA CAACAGCCAG GTCAGCCAAA ATTACCCTAT AG - #TGCAGAAC1200- CTCCAGGGGC AAATGGTACA TCAGGCCATA TCACCTAGAA CTTTAAATGC AT - #GGGTAAAA1260- GTAGTAGAAG AGAAGGCTTT CAGCCCAGAA GTAATACCCA TGTTTTCAGC AT - #TATCAGAA1320- GGAGCCACCC CACAAGATTT AAATACCATG CTAAACACAG TGGGGGGACA TC - #AAGCAGCC1380- ATGCAAATGT TAAAAGAGAC CATCAATGAG GAAGCTGCAG AATGGGATAG AT - #TGCATCCA1440- GTGCATGCAG GGCCTATTGC ACCAGGCCAG ATGAGAGAAC CAAGGGGAAG TG - #ACATAGCA1500- GGAACTACTA GTACCCTTCA GGAACAAATA GGATGGATGA CACATAATCC AC - #CTATCCCA1560- GTAGGAGAAA TCTATAAAAG ATGGATAATC CTGGGATTAA ATAAAATAGT AA - #GAATGTAT1620- AGCCCTACCA GCATTCTGGA CATAAGACAA GGACCAAAGG AACCCTTTAG AG - #ACTATGTA1680- GACCGATTCT ATAAAACTCT AAGAGCCGAG CAAGCTTCAC AAGAGGTAAA AA - #ATTGGATG1740- ACAGAAACCT TGTTGGTCCA AAATGCGAAC CCAGATTGTA AGACTATTTT AA - #AAGCATTG1800- GGACCAGGAG CGACACTAGA AGAAATGATG ACAGCATGTC AGGGAGTGGG GG - #GACCCGGC1860- CATAAAGCAA GAGTTTTGGC TGAAGCAATG AGCCAAGTAA CAAATCCAGC TA - #CCATAATG1920- ATACAGAAAG GCAATTTTAG GAACCAAAGA AAGACTGTTA AGTGTTTCAA TT - #GTGGCAAA1980- GAAGGGCACA TAGCCAAAAA TTGCAGGGCC CCTAGGAAAA AGGGCTGTTG GA - #AATGTGGA2040- AAGGAAGGAC ACCAAATGAA AGATTGTACT GAGAGACAGG CTAATTTTTT AG - #GGAAGATC2100- TGGCCTTCCC ACAAGGGAAG GCCAGGGAAT TTTCTTCAGA GCAGACCAGA GC - #CAACAGCC2160- CCACCAGAAG AGAGCTTCAG GTTTGGGGAA GAGACAACAA CTCCCTCTCA GA - #AGCAGGAG2220- CCGATAGACA AGGAACTGTA TCCTTTAGCT TCCCTCAGAT CACTCTTTGG CA - #GCGACCCC2280- TCGTCACAAT AAAGATAGGG GGGCAATTAA AGGAAGCTCT ATTAGATACA GG - #AGCAGATG2340- ATACAGTATT AGAAGAAATG AATTTGCCAG GAAGATGGAA ACCAAAAATG AT - #AGGGGGAA2400- TTGGAGGTTT TATCAAAGTA GGACAGTATG ATCAGATACT CATAGAAATC TG - #CGGACATA2460- AAGCTATAGG TACAGTATTA GTAGGACCTA CACCTGTCAA CATAATTGGA AG - #AAATCTGT2520- TGACTCAGAT TGGCTGCACT TTAAATTTTC CCATTAGTCC TATTGAGACT GT - #ACCAGTAA2580- AATTAAAGCC AGGAATGGAT GGCCCAAAAG TTAAACAATG GCCATTGACA GA - #AGAAAAAA2640- TAAAAGCATT AGTAGAAATT TGTACAGAAA TGGAAAAGGA AGGAAAAATT TC - #AAAAATTG2700- GGCCTGAAAA TCCATACAAT ACTCCAGTAT TTGCCATAAA GAAAAAAGAC AG - #TACTAAAT2760- GGAGAAAATT AGTAGATTTC AGAGAACTTA ATAAGAGAAC TCAAGATTTC TG - #GGAAGTTC2820- AATTAGGAAT ACCACATCCT GCAGGGTTAA AACAGAAAAA ATCAGTAACA GT - #ACTGGATG2880- TGGGCGATGC ATATTTTTCA GTTCCCTTAG ATAAAGACTT CAGGAAGTAT AC - #TGCATTTA2940- CCATACCTAG TATAAACAAT GAGACACCAG GGATTAGATA TCAGTACAAT GT - #GCTTCCAC3000- AGGGATGGAA AGGATCACCA GCAATATTCC AGTGTAGCAT GACAAAAATC TT - #AGAGCCTT3060- TTAGAAAACA AAATCCAGAC ATAGTCATCT ATCAATACAT GGATGATTTG TA - #TGTAGGAT3120- CTGACTTAGA AATAGGGCAG CATAGAACAA AAATAGAGGA ACTGAGACAA CA - #TCTGTTGA3180- GGTGGGGATT TACCACACCA GACAAAAAAC ATCAGAAAGA ACCTCCATTC CT - #TTGGATGG3240- GTTATGAACT CCATCCTGAT AAATGGACAG TACAGCCTAT AGTGCTGCCA GA - #AAAGGACA3300- GCTGGACTGT CAATGACATA CAGAAATTAG TGGGAAAATT GAATTGGGCA AG - #TCAGATTT3360- ATGCAGGGAT TAAAGTAAGG CAATTATGTA AACTTCTTAG GGGAACCAAA GC - #ACTAACAG3420- AAGTAGTACC ACTAACAGAA GAAGCAGAGC TAGAACTGGC AGAAAACAGG GA - #GATTCTAA3480- AAGAACCGGT ACATGGAGTG TATTATGACC CATCAAAAGA CTTAATAGCA GA - #AATACAGA3540- AGCAGGGGCA AGGCCAATGG ACATATCAAA TTTATCAAGA GCCATTTAAA AA - #TCTGAAAA3600- CAGGAAAATA TGCAAGAATG AAGGGTGCCC ACACTAATGA TGTGAAACAA TT - #AACAGAGG3660- CAGTACAAAA AATAGCCACA GAAAGCATAG TAATATGGGG AAAGACTCCT AA - #ATTTAAAT3720- TACCCATACA AAAGGAAACA TGGGAAGCAT GGTGGACAGA GTATTGGCAA GC - #CACCTGGA3780- TTCCTGAGTG GGAGTTTGTC AATACCCCTC CCTTAGTGAA GTTATGGTAC CA - #GTTAGAGA3840- AAGAACCCAT AATAGGAGCA GAAACTTTCT ATGTAGATGG GGCAGCCAAT AG - #GGAAACTA3900- AATTAGGAAA AGCAGGATAT GTAACTGACA GAGGAAGACA AAAAGTTGTC CC - #CCTAACGG3960- ACACAACAAA TCAGAAGACT GAGTTACAAG CAATTCATCT AGCTTTGCAG GA - #TTCGGGAT4020- TAGAAGTAAA CATAGTGACA GACTCACAAT ATGCATTGGG AATCATTCAA GC - #ACAACCAG4080- ATAAGAGTGA ATCAGAGTTA GTCAGTCAAA TAATAGAGCA GTTAATAAAA AA - #GGAAAAAG4140- TCTACCTGGC ATGGGTACCA GCACACAAAG GAATTGGAGG AAATGAACAA GT - #AGATGGGT4200- TGGTCAGTGC TGGAATCAGG AAAGTACTAT TTTTAGATGG AATAGATAAG GC - #CCAAGAAG4260- AACATGAGAA ATATCACAGT AATTGGAGAG CAATGGCTAG TGATTTTAAC CT - #ACCACCTG4320- TAGTAGCAAA AGAAATAGTA GCCAGCTGTG ATAAATGTCA GCTAAAAGGG GA - #AGCCATGC4380- ATGGACAAGT AGACTGTAGC CCAGGAATAT GGCAGCTAGA TTGTACACAT TT - #AGAAGGAA4440- AAGTTATCTT GGTAGCAGTT CATGTAGCCA GTGGATATAT AGAAGCAGAA GT - #AATTCCAG4500- CAGAGACAGG GCAAGAAACA GCATACTTCC TCTTAAAATT AGCAGGAAGA TG - #GCCAGTAA4560- AAACAGTACA TACAGACAAT GGCAGCAATT TCACCAGTAC TACAGTTAAG GC - #CGCCTGTT4620- GGTGGGCGGG GATCAAGCAG GAATTTGGCA TTCCCTACAA TCCCCAAAGT CA - #AGGAGTAA4680- TAGAATCTAT GAATAAAGAA TTAAAGAAAA TTATAGGACA GGTAAGAGAT CA - #GGCTGAAC4740- ATCTTAAGAC AGCAGTACAA ATGGCAGTAT TCATCCACAA TTTTAAAAGA AA - #AGGGGGGA4800- TTGGGGGGTA CAGTGCAGGG GAAAGAATAG TAGACATAAT AGCAACAGAC AT - #ACAAACTA4860- AAGAATTACA AAAACAAATT ACAAAAATTC AAAATTTTCG GGTTTATTAC AG - #GGACAGCA4920- GAGATCCAGT TTGGAAAGGA CCAGCAAAGC TCCTCTGGAA AGGTGAAGGG GC - #AGTAGTAA4980- TACAAGATAA TAGTGACATA AAAGTAGTGC CAAGAAGAAA AGCAAAGATC AT - #CAGGGATT5040- ATGGAAAACA GATGGCAGGT GATGATTGTG TGGCAAGTAG ACAGGATGAG GA - #TTAACACA5100- TGGAAAAGAT TAGTAAAACA CCATATGTAT ATTTCAAGGA AAGCTAAGGA CT - #GGTTTTAT5160- AGACATCACT ATGAAAGTAC TAATCCAAAA ATAAGTTCAG AAGTACACAT CC - #CACTAGGG5220- GATGCTAAAT TAGTAATAAC AACATATTGG GGTCTGCATA CAGGAGAAAG AG - #ACTGGCAT5280- TTGGGTCAGG GAGTCTCCAT AGAATGGAGG AAAAAGAGAT ATAGCACACA AG - #TAGACCCT5340- GACCTAGCAG ACCAACTAAT TCATCTGCAC TATTTTGATT GTTTTTCAGA AT - #CTGCTATA5400- AGAAATACCA TATTAGGACG TATAGTTAGT CCTAGGTGTG AATATCAAGC AG - #GACATAAC5460- AAGGTAGGAT CTCTACAGTA CTTGGCACTA GCAGCATTAA TAAAACCAAA AC - #AGATAAAG5520- CCACCTTTGC CTAGTGTTAG GAAACTGACA GAGGACAGAT GGAACAAGCC CC - #AGAAGACC5580- AAGGGCCACA GAGGGAGCCA TACAATGAAT GGACACTAGA GCTTTTAGAG GA - #ACTTAAGA5640- GTGAAGCTGT TAGACATTTT CCTAGGATAT GGCTCCATAA CTTAGGACAA CA - #TATCTATG5700- AAACTTACGG GGATACTTGG GCAGGAGTGG AAGCCATAAT AAGAATTCTG CA - #ACAACTGC5760- TGTTTATCCA TTTCAGAATT GGGTGTCGAC ATAGCAGAAT AGGCGTTACT CG - #ACAGAGGA5820- GAGCAAGAAA TGGAGCCAGT AGATCCTAGA CTAGAGCCCT GGAAGCATCC AG - #GAAGTCAG5880- CCTAAAACTG CTTGTACCAA TTGCTATTGT AAAAAGTGTT GCTTTCATTG CC - #AAGTTTGT5940- TTCATGACAA AAGCCTTAGG CATCTCCTAT GGCAGGAAGA AGCGGAGACA GC - #GACGAAGA6000- GCTCATCAGA ACAGTCAGAC TCATCAAGCT TCTCTATCAA AGCAGTAAGT AG - #TACATGTA6060- ATGCAACCTA TAATAGTAGC AATAGTAGCA TTAGTAGTAG CAATAATAAT AG - #CAATAGTT6120- GTGTGGTCCA TAGTAATCAT AGAATATAGG AAAATATTAA GACAAAGAAA AA - #TAGACAGG6180- TTAATTGATA GACTAATAGA AAGAGCAGAA GACAGTGGCA ATGAGAGTGA AG - #GAGAAGTA6240- TCAGCACTTG TGGAGATGGG GGTGGAAATG GGGCACCATG CTCCTTGGGA TA - #TTGATGAT6300- CTGTAGTGCT ACAGAAAAAT TGTGGGTCAC AGTCTATTAT GGGGTACCTG TG - #TGGAAGGA6360- AGCAACCACC ACTCTATTTT GTGCATCAGA TGCTAAAGCA TATGATACAG AG - #GTACATAA6420- TGTTTGGGCC ACACATGCCT GTGTACCCAC AGACCCCAAC CCACAAGAAG TA - #GTATTGGT6480- AAATGTGACA GAAAATTTTA ACATGTGGAA AAATGACATG GTAGAACAGA TG - #CATGAGGA6540- TATAATCAGT TTATGGGATC AAAGCCTAAA GCCATGTGTA AAATTAACCC CA - #CTCTGTGT6600- TAGTTTAAAG TGCACTGATT TGAAGAATGA TACTAATACC AATAGTAGTA GC - #GGGAGAAT6660- GATAATGGAG AAAGGAGAGA TAAAAAACTG CTCTTTCAAT ATCAGCACAA GC - #ATAAGAGA6720- TAAGGTGCAG AAAGAATATG CATTCTTTTA TAAACTTGAT ATAGTACCAA TA - #GATAATAC6780- CAGCTATAGG TTGATAAGTT GTAACACCTC AGTCATTACA CAGGCCTGTC CA - #AAGGTATC6840- CTTTGAGCCA ATTCCCATAC ATTATTGTGC CCCGGCTGGT TTTGCGATTC TA - #AAATGTAA6900- TAATAAGACG TTCAATGGAA CAGGACCATG TACAAATGTC AGCACAGTAC AA - #TGTACACA6960- TGGAATCAGG CCAGTAGTAT CAACTCAACT GCTGTTAAAT GGCAGTCTAG CA - #GAAGAAGA7020- TGTAGTAATT AGATCTGCCA ATTTCACAGA CAATGCTAAA ACCATAATAG TA - #CAGCTGAA7080- CACATCTGTA GAAATTAATT GTACAAGACC CAACAACAAT ACAAGAAAAA GT - #ATCCGTAT7140- CCAGAGGGGA CCAGGGAGAG CATTTGTTAC AATAGGAAAA ATAGGAAATA TG - #AGACAAGC7200- ACATTGTAAC ATTAGTAGAG CAAAATGGAA TGCCACTTTA AAACAGATAG CT - #AGCAAATT7260- AAGAGAACAA TTTGGAAATA ATAAAACAAT AATCTTTAAG CAATCCTCAG GA - #GGGGACCC7320- AGAAATTGTA ACGCACAGTT TTAATTGTGG AGGGGAATTT TTCTACTGTA AT - #TCAACACA7380- ACTGTTTAAT AGTACTTGGT TTAATAGTAC TTGGAGTACT GAAGGGTCAA AT - #AACACTGA7440- AGGAAGTGAC ACAATCACAC TCCCATGCAG AATAAAACAA TTTATAAACA TG - #TGGCAGGA7500- AGTAGGAAAA GCAATGTATG CCCCTCCCAT CAGTGGACAA ATTAGATGTT CA - #TCAAATAT7560- TACTGGGCTG CTATTAACAA GAGATGGTGG TAATAACAAC AATGGGTCCG AG - #ATCTTCAG7620- ACCTGGAGGA GGCGATATGA GGGACAATTG GAGAAGTGAA TTATATAAAT AT - #AAAGTAGT7680- AAAAATTGAA CCATTAGGAG TAGCACCCAC CAAGGCAAAG AGAAGAGTGG TG - #CAGAGAGA7740- AAAAAGAGCA GTGGGAATAG GAGCTTTGTT CCTTGGGTTC TTGGGAGCAG CA - #GGAAGCAC7800- TATGGGCTGC ACGTCAATGA CGCTGACGGT ACAGGCCAGA CAATTATTGT CT - #GATATAGT7860- GCAGCAGCAG AACAATTTGC TGAGGGCTAT TGAGGCGCAA CAGCATCTGT TG - #CAACTCAC7920- AGTCTGGGGC ATCAAACAGC TCCAGGCAAG AATCCTGGCT GTGGAAAGAT AC - #CTAAAGGA7980- TCAACAGCTC CTGGGGATTT GGGGTTGCTC TGGAAAACTC ATTTGCACCA CT - #GCTGTGCC8040- TTGGAATGCT AGTTGGAGTA ATAAATCTCT GGAACAGATT TGGAATAACA TG - #ACCTGGAT8100- GGAGTGGGAC AGAGAAATTA ACAATTACAC AAGCTTAATA CACTCCTTAA TT - #GAAGAATC8160- GCAAAACCAG CAAGAAAAGA ATGAACAAGA ATTATTGGAA TTAGATAAAT GG - #GCAAGTTT8220- GTGGAATTGG TTTAACATAA CAAATTGGCT GTGGTATATA AAATTATTCA TA - #ATGATAGT8280- AGGAGGCTTG GTAGGTTTAA GAATAGTTTT TGCTGTACTT TCTATAGTGA AT - #AGAGTTAG8340- GCAGGGATAT TCACCATTAT CGTTTCAGAC CCACCTCCCA ATCCCGAGGG GA - #CCCGACAG8400- GCCCGAAGGA ATAGAAGAAG AAGGTGGAGA GAGAGACAGA GACAGATCCA TT - #CGATTAGT8460- GAACGGATCC TTAGCACTTA TCTGGGACGA TCTGCGGAGC CTGTGCCTCT TC - #AGCTACCA8520- CCGCTTGAGA GACTTACTCT TGATTGTAAC GAGGATTGTG GAACTTCTGG GA - #CGCAGGGG8580- GTGGGAAGCC CTCAAATATT GGTGGAATCT CCTACAGTAT TGGAGTCAGG AA - #CTAAAGAA8640- TAGTGCTGTT AACTTGCTCA ATGCCACAGC CATAGCAGTA GCTGAGGGGA CA - #GATAGGGT8700- TATAGAAGTA TTACAAGCAG CTTATAGAGC TATTCGCCAC ATACCTAGAA GA - #ATAAGACA8760- GGGCTTGGAA AGGATTTTGC TATAAGATGG GTGGCAAGTG GTCAAAAAGT AG - #TGTGATTG8820- GATGGCCTGC TGTAAGGGAA AGAATGAGAC GAGCTGAGCC AGCAGCAGAT GG - #GGTGGGAG8880- CAGTATCTCG AGACCTAGAA AAACATGGAG CAATCACAAG TAGCAATACA GC - #AGCTAACA8940- ATGCTGCTTG TGCCTGGCTA GAAGCACAAG AGGAGGAAGA GGTGGGTTTT CC - #AGTCACAC9000- CTCAGGTACC TTTAAGACCA ATGACTTACA AGGCAGCTGT AGATCTTAGC CA - #CTTTTTAA9060- AAGAAAAGGG GGGACTGGAA GGGCTAATTC ACTCCCAAAG AAGACAAGAT AT - #CCTTGATC9120- TGTGGATCTA CCACACACAA GGCTACTTCC CTGATTGGCA GAACTACACA CC - #AGGGCCAG9180- GGGTCAGATA TCCACTGACC TTTGGATGGT GCTACAAGCT AGTACCAGTT GA - #GCCAGATA9240- AGGTAGAAGA GGCCAATAAA GGAGAGAACA CCAGCTTGTT ACACCCTGTG AG - #CCTGCATG9300- GAATGGATGA CCCTGAGAGA GAAGTGTTAG AGTGGAGGTT TGACAGCCGC CT - #AGCATTTC9360- ATCACGTGGC CCGAGAGCTG CATCCGGAGT ACTTCAAGAA CTGCTGACAT CG - #AGCTTGCT9420- ACAAGGGACT TTCCGCTGGG GACTTTCCAG GGAGGCGTGG CCTGGGCGGG AC - #TGGGGAGT9480- GGCGAGCCCT CAGATGCTGC ATATAAGCAG CTGCTTTTTG CCTGTACTGG GT - #CTCTCTGG9540- TTAGACCAGA TCTGAGCCTG GGAGCTCTCT GGCTAACTAG GGAACCCACT GC - #TTAAGCCT9600- CAATAAAGCT TGCCTTGAGT GCTTCAAGTA GTGTGTGCCC GTCTGTTGTG TG - #ACTCTGGT9660# 9709AGACC CTTTTAGTCA GTGTGGAAAA TCTCTAGCA- (2) INFORMATION FOR SEQ ID NO:2:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:2:# 10- (2) INFORMATION FOR SEQ ID NO:3:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:3:# 10- (2) INFORMATION FOR SEQ ID NO:4:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:4:# 10- (2) INFORMATION FOR SEQ ID NO:5:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:5:# 10- (2) INFORMATION FOR SEQ ID NO:6:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:6:# 10- (2) INFORMATION FOR SEQ ID NO:7:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:7:# 10- (2) INFORMATION FOR SEQ ID NO:8:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:8:# 10- (2) INFORMATION FOR SEQ ID NO:9:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:9:# 10- (2) INFORMATION FOR SEQ ID NO:10:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:10:# 10- (2) INFORMATION FOR SEQ ID NO:11:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:11:# 10- (2) INFORMATION FOR SEQ ID NO:12:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:12:# 10- (2) INFORMATION FOR SEQ ID NO:13:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:13:# 10- (2) INFORMATION FOR SEQ ID NO:14:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:14:# 10- (2) INFORMATION FOR SEQ ID NO:15:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:15:# 10- (2) INFORMATION FOR SEQ ID NO:16:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:16:# 10- (2) INFORMATION FOR SEQ ID NO:17:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:17:# 10- (2) INFORMATION FOR SEQ ID NO:18:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:18:# 10- (2) INFORMATION FOR SEQ ID NO:19:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:19:# 10- (2) INFORMATION FOR SEQ ID NO:20:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:20:# 10- (2) INFORMATION FOR SEQ ID NO:21:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:21:# 10- (2) INFORMATION FOR SEQ ID NO:22:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:22:# 10- (2) INFORMATION FOR SEQ ID NO:23:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:23:# 10- (2) INFORMATION FOR SEQ ID NO:24:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:24:# 10- (2) INFORMATION FOR SEQ ID NO:25:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:25:# 10- (2) INFORMATION FOR SEQ ID NO:26:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:26:# 10- (2) INFORMATION FOR SEQ ID NO:27:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:27:# 10- (2) INFORMATION FOR SEQ ID NO:28:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:28:# 10- (2) INFORMATION FOR SEQ ID NO:29:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:29:# 10- (2) INFORMATION FOR SEQ ID NO:30:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:30:# 10- (2) INFORMATION FOR SEQ ID NO:31:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:31:# 10- (2) INFORMATION FOR SEQ ID NO:32:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:32:# 10- (2) INFORMATION FOR SEQ ID NO:33:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:33:# 10- (2) INFORMATION FOR SEQ ID NO:34:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:34:# 10- (2) INFORMATION FOR SEQ ID NO:35:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:35:# 10- (2) INFORMATION FOR SEQ ID NO:36:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:36:# 10- (2) INFORMATION FOR SEQ ID NO:37:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:37:# 10- (2) INFORMATION FOR SEQ ID NO:38:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:38:# 10- (2) INFORMATION FOR SEQ ID NO:39:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:39:# 10- (2) INFORMATION FOR SEQ ID NO:40:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:40:# 10- (2) INFORMATION FOR SEQ ID NO:41:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:41:# 10- (2) INFORMATION FOR SEQ ID NO:42:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:42:# 10- (2) INFORMATION FOR SEQ ID NO:43:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:43:# 10- (2) INFORMATION FOR SEQ ID NO:44:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:44:# 10- (2) INFORMATION FOR SEQ ID NO:45:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:45:# 10- (2) INFORMATION FOR SEQ ID NO:46:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:46:# 10- (2) INFORMATION FOR SEQ ID NO:47:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:47:# 10- (2) INFORMATION FOR SEQ ID NO:48:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:48:# 10- (2) INFORMATION FOR SEQ ID NO:49:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:49:# 10- (2) INFORMATION FOR SEQ ID NO:50:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:50:# 10- (2) INFORMATION FOR SEQ ID NO:51:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:51:# 10- (2) INFORMATION FOR SEQ ID NO:52:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:52:# 10- (2) INFORMATION FOR SEQ ID NO:53:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:53:# 10- (2) INFORMATION FOR SEQ ID NO:54:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:54:# 10- (2) INFORMATION FOR SEQ ID NO:55:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:55:# 10- (2) INFORMATION FOR SEQ ID NO:56:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:56:# 10- (2) INFORMATION FOR SEQ ID NO:57:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:57:# 10- (2) INFORMATION FOR SEQ ID NO:58:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:58:# 10- (2) INFORMATION FOR SEQ ID NO:59:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:59:# 10- (2) INFORMATION FOR SEQ ID NO:60:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:60:# 10- (2) INFORMATION FOR SEQ ID NO:61:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:61:# 10- (2) INFORMATION FOR SEQ ID NO:62:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:62:# 10- (2) INFORMATION FOR SEQ ID NO:63:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:63:# 10- (2) INFORMATION FOR SEQ ID NO:64:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:64:# 10- (2) INFORMATION FOR SEQ ID NO:65:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:65:# 10- (2) INFORMATION FOR SEQ ID NO:66:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:66:# 10- (2) INFORMATION FOR SEQ ID NO:67:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:67:# 10- (2) INFORMATION FOR SEQ ID NO:68:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:68:# 10- (2) INFORMATION FOR SEQ ID NO:69:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:69:# 10- (2) INFORMATION FOR SEQ ID NO:70:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:70:# 10- (2) INFORMATION FOR SEQ ID NO:71:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:71:# 10- (2) INFORMATION FOR SEQ ID NO:72:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:72:# 10- (2) INFORMATION FOR SEQ ID NO:73:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:73:# 10- (2) INFORMATION FOR SEQ ID NO:74:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:74:# 10- (2) INFORMATION FOR SEQ ID NO:75:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:75:# 10- (2) INFORMATION FOR SEQ ID NO:76:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:76:# 10- (2) INFORMATION FOR SEQ ID NO:77:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:77:# 10- (2) INFORMATION FOR SEQ ID NO:78:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:78:# 10- (2) INFORMATION FOR SEQ ID NO:79:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:79:# 10- (2) INFORMATION FOR SEQ ID NO:80:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:80:# 10- (2) INFORMATION FOR SEQ ID NO:81:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:81:# 10- (2) INFORMATION FOR SEQ ID NO:82:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:82:# 10- (2) INFORMATION FOR SEQ ID NO:83:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:83:# 10- (2) INFORMATION FOR SEQ ID NO:84:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:84:# 10- (2) INFORMATION FOR SEQ ID NO:85:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:85:# 10- (2) INFORMATION FOR SEQ ID NO:86:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:86:# 10- (2) INFORMATION FOR SEQ ID NO:87:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:87:# 10- (2) INFORMATION FOR SEQ ID NO:88:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:88:# 10- (2) INFORMATION FOR SEQ ID NO:89:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:89:# 10- (2) INFORMATION FOR SEQ ID NO:90:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:90:# 10- (2) INFORMATION FOR SEQ ID NO:91:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:91:# 10- (2) INFORMATION FOR SEQ ID NO:92:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:92:# 10- (2) INFORMATION FOR SEQ ID NO:93:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:93:# 10- (2) INFORMATION FOR SEQ ID NO:94:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:94:# 10- (2) INFORMATION FOR SEQ ID NO:95:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:95:# 10- (2) INFORMATION FOR SEQ ID NO:96:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:96:# 10- (2) INFORMATION FOR SEQ ID NO:97:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:97:# 10- (2) INFORMATION FOR SEQ ID NO:98:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:98:# 10- (2) INFORMATION FOR SEQ ID NO:99:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:99:# 10- (2) INFORMATION FOR SEQ ID NO:100:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:100:# 10- (2) INFORMATION FOR SEQ ID NO:101:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:101:# 10- (2) INFORMATION FOR SEQ ID NO:102:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:102:# 10- (2) INFORMATION FOR SEQ ID NO:103:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:103:# 10- (2) INFORMATION FOR SEQ ID NO:104:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:104:# 10- (2) INFORMATION FOR SEQ ID NO:105:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:105:# 10- (2) INFORMATION FOR SEQ ID NO:106:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:106:# 10- (2) INFORMATION FOR SEQ ID NO:107:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:107:# 10- (2) INFORMATION FOR SEQ ID NO:108:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:108:# 10- (2) INFORMATION FOR SEQ ID NO:109:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:109:# 10- (2) INFORMATION FOR SEQ ID NO:110:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:110:# 10- (2) INFORMATION FOR SEQ ID NO:111:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:111:# 10- (2) INFORMATION FOR SEQ ID NO:112:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:112:# 10- (2) INFORMATION FOR SEQ ID NO:113:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:113:# 10- (2) INFORMATION FOR SEQ ID NO:114:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:114:# 10- (2) INFORMATION FOR SEQ ID NO:115:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:115:# 10- (2) INFORMATION FOR SEQ ID NO:116:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:116:# 10- (2) INFORMATION FOR SEQ ID NO:117:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:117:# 10- (2) INFORMATION FOR SEQ ID NO:118:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:118:# 10- (2) INFORMATION FOR SEQ ID NO:119:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:119:# 10- (2) INFORMATION FOR SEQ ID NO:120:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:120:# 10- (2) INFORMATION FOR SEQ ID NO:121:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:121:# 10- (2) INFORMATION FOR SEQ ID NO:122:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:122:# 10- (2) INFORMATION FOR SEQ ID NO:123:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:123:# 10- (2) INFORMATION FOR SEQ ID NO:124:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:124:# 10- (2) INFORMATION FOR SEQ ID NO:125:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:125:# 10- (2) INFORMATION FOR SEQ ID NO:126:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:126:# 10- (2) INFORMATION FOR SEQ ID NO:127:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:127:# 10- (2) INFORMATION FOR SEQ ID NO:128:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:128:# 10- (2) INFORMATION FOR SEQ ID NO:129:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:129:# 10- (2) INFORMATION FOR SEQ ID NO:130:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:130:# 10- (2) INFORMATION FOR SEQ ID NO:131:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:131:# 10- (2) INFORMATION FOR SEQ ID NO:132:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:132:# 10- (2) INFORMATION FOR SEQ ID NO:133:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:133:# 10- (2) INFORMATION FOR SEQ ID NO:134:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:134:# 10- (2) INFORMATION FOR SEQ ID NO:135:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:135:# 10- (2) INFORMATION FOR SEQ ID NO:136:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:136:# 10- (2) INFORMATION FOR SEQ ID NO:137:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:137:# 10- (2) INFORMATION FOR SEQ ID NO:138:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:138:# 10- (2) INFORMATION FOR SEQ ID NO:139:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:139:# 10- (2) INFORMATION FOR SEQ ID NO:140:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:140:# 10- (2) INFORMATION FOR SEQ ID NO:141:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:141:# 10- (2) INFORMATION FOR SEQ ID NO:142:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:142:# 10- (2) INFORMATION FOR SEQ ID NO:143:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:143:# 10- (2) INFORMATION FOR SEQ ID NO:144:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:144:# 10- (2) INFORMATION FOR SEQ ID NO:145:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:145:# 10- (2) INFORMATION FOR SEQ ID NO:146:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:146:# 10- (2) INFORMATION FOR SEQ ID NO:147:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:147:# 10- (2) INFORMATION FOR SEQ ID NO:148:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:148:# 10- (2) INFORMATION FOR SEQ ID NO:149:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:149:# 10- (2) INFORMATION FOR SEQ ID NO:150:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:150:# 10- (2) INFORMATION FOR SEQ ID NO:151:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:151:# 10- (2) INFORMATION FOR SEQ ID NO:152:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:152:# 10- (2) INFORMATION FOR SEQ ID NO:153:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:153:# 10- (2) INFORMATION FOR SEQ ID NO:154:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:154:# 10- (2) INFORMATION FOR SEQ ID NO:155:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:155:# 10- (2) INFORMATION FOR SEQ ID NO:156:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:156:# 10- (2) INFORMATION FOR SEQ ID NO:157:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:157:# 10- (2) INFORMATION FOR SEQ ID NO:158:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:158:# 10- (2) INFORMATION FOR SEQ ID NO:159:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:159:# 10- (2) INFORMATION FOR SEQ ID NO:160:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:160:# 10- (2) INFORMATION FOR SEQ ID NO:161:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:161:# 10- (2) INFORMATION FOR SEQ ID NO:162:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:162:# 10- (2) INFORMATION FOR SEQ ID NO:163:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:163:# 10- (2) INFORMATION FOR SEQ ID NO:164:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:164:# 10- (2) INFORMATION FOR SEQ ID NO:165:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:165:# 10- (2) INFORMATION FOR SEQ ID NO:166:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:166:# 10- (2) INFORMATION FOR SEQ ID NO:167:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:167:# 10- (2) INFORMATION FOR SEQ ID NO:168:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:168:# 10- (2) INFORMATION FOR SEQ ID NO:169:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:169:# 10- (2) INFORMATION FOR SEQ ID NO:170:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:170:# 10- (2) INFORMATION FOR SEQ ID NO:171:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:171:# 10- (2) INFORMATION FOR SEQ ID NO:172:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:172:# 10- (2) INFORMATION FOR SEQ ID NO:173:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:173:# 10- (2) INFORMATION FOR SEQ ID NO:174:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:174:# 10- (2) INFORMATION FOR SEQ ID NO:175:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:175:# 10- (2) INFORMATION FOR SEQ ID NO:176:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:176:# 10- (2) INFORMATION FOR SEQ ID NO:177:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:177:# 10- (2) INFORMATION FOR SEQ ID NO:178:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:178:# 10- (2) INFORMATION FOR SEQ ID NO:179:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:179:# 10- (2) INFORMATION FOR SEQ ID NO:180:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:180:# 10- (2) INFORMATION FOR SEQ ID NO:181:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:181:# 10- (2) INFORMATION FOR SEQ ID NO:182:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:182:# 10- (2) INFORMATION FOR SEQ ID NO:183:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:183:# 10- (2) INFORMATION FOR SEQ ID NO:184:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:184:# 10- (2) INFORMATION FOR SEQ ID NO:185:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:185:# 10- (2) INFORMATION FOR SEQ ID NO:186:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:186:# 10- (2) INFORMATION FOR SEQ ID NO:187:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:187:# 10- (2) INFORMATION FOR SEQ ID NO:188:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:188:# 10- (2) INFORMATION FOR SEQ ID NO:189:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:189:# 10- (2) INFORMATION FOR SEQ ID NO:190:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:190:# 10- (2) INFORMATION FOR SEQ ID NO:191:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:191:# 10- (2) INFORMATION FOR SEQ ID NO:192:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:192:# 10- (2) INFORMATION FOR SEQ ID NO:193:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:193:# 10- (2) INFORMATION FOR SEQ ID NO:194:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:194:# 10- (2) INFORMATION FOR SEQ ID NO:195:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:195:# 10- (2) INFORMATION FOR SEQ ID NO:196:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:196:# 10- (2) INFORMATION FOR SEQ ID NO:197:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:197:# 10- (2) INFORMATION FOR SEQ ID NO:198:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:198:# 10- (2) INFORMATION FOR SEQ ID NO:199:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:199:# 10- (2) INFORMATION FOR SEQ ID NO:200:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:200:# 10- (2) INFORMATION FOR SEQ ID NO:201:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:201:# 10- (2) INFORMATION FOR SEQ ID NO:202:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:202:# 10- (2) INFORMATION FOR SEQ ID NO:203:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:203:# 10- (2) INFORMATION FOR SEQ ID NO:204:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:204:# 10- (2) INFORMATION FOR SEQ ID NO:205:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:205:# 10- (2) INFORMATION FOR SEQ ID NO:206:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:206:# 10- (2) INFORMATION FOR SEQ ID NO:207:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:207:# 10- (2) INFORMATION FOR SEQ ID NO:208:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:208:# 10- (2) INFORMATION FOR SEQ ID NO:209:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:209:# 10- (2) INFORMATION FOR SEQ ID NO:210:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:210:# 10- (2) INFORMATION FOR SEQ ID NO:211:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:211:# 10- (2) INFORMATION FOR SEQ ID NO:212:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:212:# 10- (2) INFORMATION FOR SEQ ID NO:213:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:213:# 10- (2) INFORMATION FOR SEQ ID NO:214:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:214:# 10- (2) INFORMATION FOR SEQ ID NO:215:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:215:# 10- (2) INFORMATION FOR SEQ ID NO:216:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:216:# 10- (2) INFORMATION FOR SEQ ID NO:217:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:217:# 10- (2) INFORMATION FOR SEQ ID NO:218:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:218:# 10- (2) INFORMATION FOR SEQ ID NO:219:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:219:# 10- (2) INFORMATION FOR SEQ ID NO:220:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:220:# 10- (2) INFORMATION FOR SEQ ID NO:221:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:221:# 10- (2) INFORMATION FOR SEQ ID NO:222:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:222:# 10- (2) INFORMATION FOR SEQ ID NO:223:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:223:# 10- (2) INFORMATION FOR SEQ ID NO:224:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:224:# 10- (2) INFORMATION FOR SEQ ID NO:225:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:225:# 10- (2) INFORMATION FOR SEQ ID NO:226:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:226:# 10- (2) INFORMATION FOR SEQ ID NO:227:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:227:# 10- (2) INFORMATION FOR SEQ ID NO:228:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:228:# 10- (2) INFORMATION FOR SEQ ID NO:229:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:229:# 10- (2) INFORMATION FOR SEQ ID NO:230:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:230:# 10- (2) INFORMATION FOR SEQ ID NO:231:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:231:# 10- (2) INFORMATION FOR SEQ ID NO:232:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:232:# 10- (2) INFORMATION FOR SEQ ID NO:233:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:233:# 10- (2) INFORMATION FOR SEQ ID NO:234:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:234:# 10- (2) INFORMATION FOR SEQ ID NO:235:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:235:# 10- (2) INFORMATION FOR SEQ ID NO:236:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:236:# 10- (2) INFORMATION FOR SEQ ID NO:237:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:237:# 10- (2) INFORMATION FOR SEQ ID NO:238:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:238:# 10- (2) INFORMATION FOR SEQ ID NO:239:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:239:# 10- (2) INFORMATION FOR SEQ ID NO:240:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:240:# 10- (2) INFORMATION FOR SEQ ID NO:241:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:241:# 10- (2) INFORMATION FOR SEQ ID NO:242:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:242:# 10- (2) INFORMATION FOR SEQ ID NO:243:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:243:# 10- (2) INFORMATION FOR SEQ ID NO:244:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:244:# 10- (2) INFORMATION FOR SEQ ID NO:245:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:245:# 10- (2) INFORMATION FOR SEQ ID NO:246:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:246:# 10- (2) INFORMATION FOR SEQ ID NO:247:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:247:# 10- (2) INFORMATION FOR SEQ ID NO:248:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:248:# 10- (2) INFORMATION FOR SEQ ID NO:249:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:249:# 10- (2) INFORMATION FOR SEQ ID NO:250:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:250:# 10- (2) INFORMATION FOR SEQ ID NO:251:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:251:# 10- (2) INFORMATION FOR SEQ ID NO:252:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:252:# 10- (2) INFORMATION FOR SEQ ID NO:253:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:253:# 10- (2) INFORMATION FOR SEQ ID NO:254:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:254:# 10- (2) INFORMATION FOR SEQ ID NO:255:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:255:# 10- (2) INFORMATION FOR SEQ ID NO:256:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:256:# 10- (2) INFORMATION FOR SEQ ID NO:257:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:257:# 10- (2) INFORMATION FOR SEQ ID NO:258:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:258:# 10- (2) INFORMATION FOR SEQ ID NO:259:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:259:# 10- (2) INFORMATION FOR SEQ ID NO:260:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:260:# 10- (2) INFORMATION FOR SEQ ID NO:261:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:261:# 10- (2) INFORMATION FOR SEQ ID NO:262:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:262:# 10- (2) INFORMATION FOR SEQ ID NO:263:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:263:# 10- (2) INFORMATION FOR SEQ ID NO:264:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:264:# 10- (2) INFORMATION FOR SEQ ID NO:265:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:265:# 10- (2) INFORMATION FOR SEQ ID NO:266:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:266:# 10- (2) INFORMATION FOR SEQ ID NO:267:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:267:# 10- (2) INFORMATION FOR SEQ ID NO:268:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:268:# 10- (2) INFORMATION FOR SEQ ID NO:269:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:269:# 10- (2) INFORMATION FOR SEQ ID NO:270:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:270:# 10- (2) INFORMATION FOR SEQ ID NO:271:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:271:# 10- (2) INFORMATION FOR SEQ ID NO:272:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:272:# 10- (2) INFORMATION FOR SEQ ID NO:273:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:273:# 10- (2) INFORMATION FOR SEQ ID NO:274:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:274:# 10- (2) INFORMATION FOR SEQ ID NO:275:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:275:# 10- (2) INFORMATION FOR SEQ ID NO:276:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:276:# 10- (2) INFORMATION FOR SEQ ID NO:277:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:277:# 10- (2) INFORMATION FOR SEQ ID NO:278:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:278:# 10- (2) INFORMATION FOR SEQ ID NO:279:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:279:# 10- (2) INFORMATION FOR SEQ ID NO:280:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:280:# 10- (2) INFORMATION FOR SEQ ID NO:281:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:281:# 10- (2) INFORMATION FOR SEQ ID NO:282:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:282:# 10- (2) INFORMATION FOR SEQ ID NO:283:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:283:# 10- (2) INFORMATION FOR SEQ ID NO:284:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:284:# 10- (2) INFORMATION FOR SEQ ID NO:285:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:285:# 10- (2) INFORMATION FOR SEQ ID NO:286:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:286:# 10- (2) INFORMATION FOR SEQ ID NO:287:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:287:# 10- (2) INFORMATION FOR SEQ ID NO:288:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:288:# 10- (2) INFORMATION FOR SEQ ID NO:289:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:289:# 10- (2) INFORMATION FOR SEQ ID NO:290:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:290:# 10- (2) INFORMATION FOR SEQ ID NO:291:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:291:# 10- (2) INFORMATION FOR SEQ ID NO:292:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:292:# 10- (2) INFORMATION FOR SEQ ID NO:293:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:293:# 10- (2) INFORMATION FOR SEQ ID NO:294:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:294:# 10- (2) INFORMATION FOR SEQ ID NO:295:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:295:# 10- (2) INFORMATION FOR SEQ ID NO:296:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:296:# 10- (2) INFORMATION FOR SEQ ID NO:297:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:297:# 10- (2) INFORMATION FOR SEQ ID NO:298:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:298:# 10- (2) INFORMATION FOR SEQ ID NO:299:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:299:# 10- (2) INFORMATION FOR SEQ ID NO:300:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:300:# 10- (2) INFORMATION FOR SEQ ID NO:301:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:301:# 10- (2) INFORMATION FOR SEQ ID NO:302:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:302:# 10- (2) INFORMATION FOR SEQ ID NO:303:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:303:# 10- (2) INFORMATION FOR SEQ ID NO:304:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:304:# 10- (2) INFORMATION FOR SEQ ID NO:305:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:305:# 10- (2) INFORMATION FOR SEQ ID NO:306:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:306:# 10- (2) INFORMATION FOR SEQ ID NO:307:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:307:# 10- (2) INFORMATION FOR SEQ ID NO:308:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:308:# 10- (2) INFORMATION FOR SEQ ID NO:309:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:309:# 10- (2) INFORMATION FOR SEQ ID NO:310:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:310:# 10- (2) INFORMATION FOR SEQ ID NO:311:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:311:# 10- (2) INFORMATION FOR SEQ ID NO:312:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:312:# 10- (2) INFORMATION FOR SEQ ID NO:313:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:313:# 10- (2) INFORMATION FOR SEQ ID NO:314:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:314:# 10- (2) INFORMATION FOR SEQ ID NO:315:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:315:# 10- (2) INFORMATION FOR SEQ ID NO:316:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:316:# 10- (2) INFORMATION FOR SEQ ID NO:317:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:317:# 10- (2) INFORMATION FOR SEQ ID NO:318:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:318:# 10- (2) INFORMATION FOR SEQ ID NO:319:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:319:# 10- (2) INFORMATION FOR SEQ ID NO:320:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:320:# 10- (2) INFORMATION FOR SEQ ID NO:321:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:321:# 10- (2) INFORMATION FOR SEQ ID NO:322:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:322:# 10- (2) INFORMATION FOR SEQ ID NO:323:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:323:# 10- (2) INFORMATION FOR SEQ ID NO:324:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:324:# 10- (2) INFORMATION FOR SEQ ID NO:325:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:325:# 10- (2) INFORMATION FOR SEQ ID NO:326:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:326:# 10- (2) INFORMATION FOR SEQ ID NO:327:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:327:# 10- (2) INFORMATION FOR SEQ ID NO:328:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:328:# 10- (2) INFORMATION FOR SEQ ID NO:329:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:329:# 10- (2) INFORMATION FOR SEQ ID NO:330:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:330:# 10- (2) INFORMATION FOR SEQ ID NO:331:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:331:# 10- (2) INFORMATION FOR SEQ ID NO:332:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:332:# 10- (2) INFORMATION FOR SEQ ID NO:333:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:333:# 10- (2) INFORMATION FOR SEQ ID NO:334:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:334:# 10- (2) INFORMATION FOR SEQ ID NO:335:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:335:# 10- (2) INFORMATION FOR SEQ ID NO:336:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:336:# 10- (2) INFORMATION FOR SEQ ID NO:337:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:337:# 10- (2) INFORMATION FOR SEQ ID NO:338:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:338:# 10- (2) INFORMATION FOR SEQ ID NO:339:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:339:# 10- (2) INFORMATION FOR SEQ ID NO:340:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:340:# 10- (2) INFORMATION FOR SEQ ID NO:341:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:341:# 10- (2) INFORMATION FOR SEQ ID NO:342:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:342:# 10- (2) INFORMATION FOR SEQ ID NO:343:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:343:# 10- (2) INFORMATION FOR SEQ ID NO:344:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:344:# 10- (2) INFORMATION FOR SEQ ID NO:345:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:345:# 10- (2) INFORMATION FOR SEQ ID NO:346:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:346:# 10- (2) INFORMATION FOR SEQ ID NO:347:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:347:# 10- (2) INFORMATION FOR SEQ ID NO:348:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:348:# 10- (2) INFORMATION FOR SEQ ID NO:349:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:349:# 10- (2) INFORMATION FOR SEQ ID NO:350:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:350:# 10- (2) INFORMATION FOR SEQ ID NO:351:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:351:# 10- (2) INFORMATION FOR SEQ ID NO:352:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:352:# 10- (2) INFORMATION FOR SEQ ID NO:353:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:353:# 10- (2) INFORMATION FOR SEQ ID NO:354:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:354:# 10- (2) INFORMATION FOR SEQ ID NO:355:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:355:# 10- (2) INFORMATION FOR SEQ ID NO:356:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:356:# 10- (2) INFORMATION FOR SEQ ID NO:357:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:357:# 10- (2) INFORMATION FOR SEQ ID NO:358:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:358:# 10- (2) INFORMATION FOR SEQ ID NO:359:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:359:# 10- (2) INFORMATION FOR SEQ ID NO:360:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:360:# 10- (2) INFORMATION FOR SEQ ID NO:361:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:361:# 10- (2) INFORMATION FOR SEQ ID NO:362:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:362:# 10- (2) INFORMATION FOR SEQ ID NO:363:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:363:# 10- (2) INFORMATION FOR SEQ ID NO:364:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:364:# 10- (2) INFORMATION FOR SEQ ID NO:365:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:365:# 10- (2) INFORMATION FOR SEQ ID NO:366:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:366:# 10- (2) INFORMATION FOR SEQ ID NO:367:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:367:# 10- (2) INFORMATION FOR SEQ ID NO:368:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:368:# 10- (2) INFORMATION FOR SEQ ID NO:369:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:369:# 10- (2) INFORMATION FOR SEQ ID NO:370:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:370:# 10- (2) INFORMATION FOR SEQ ID NO:371:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:371:# 10- (2) INFORMATION FOR SEQ ID NO:372:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:372:# 10- (2) INFORMATION FOR SEQ ID NO:373:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:373:# 10- (2) INFORMATION FOR SEQ ID NO:374:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:374:# 10- (2) INFORMATION FOR SEQ ID NO:375:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:375:# 10- (2) INFORMATION FOR SEQ ID NO:376:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:376:# 10- (2) INFORMATION FOR SEQ ID NO:377:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:377:# 10- (2) INFORMATION FOR SEQ ID NO:378:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:378:# 10- (2) INFORMATION FOR SEQ ID NO:379:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:379:# 10- (2) INFORMATION FOR SEQ ID NO:380:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:380:# 10- (2) INFORMATION FOR SEQ ID NO:381:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:381:# 10- (2) INFORMATION FOR SEQ ID NO:382:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:382:# 10- (2) INFORMATION FOR SEQ ID NO:383:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:383:# 10- (2) INFORMATION FOR SEQ ID NO:384:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:384:# 10- (2) INFORMATION FOR SEQ ID NO:385:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:385:# 10- (2) INFORMATION FOR SEQ ID NO:386:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:386:# 10- (2) INFORMATION FOR SEQ ID NO:387:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:387:# 10- (2) INFORMATION FOR SEQ ID NO:388:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:388:# 10- (2) INFORMATION FOR SEQ ID NO:389:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:389:# 10- (2) INFORMATION FOR SEQ ID NO:390:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:390:# 10- (2) INFORMATION FOR SEQ ID NO:391:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:391:# 10- (2) INFORMATION FOR SEQ ID NO:392:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:392:# 10- (2) INFORMATION FOR SEQ ID NO:393:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:393:# 10- (2) INFORMATION FOR SEQ ID NO:394:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:394:# 10- (2) INFORMATION FOR SEQ ID NO:395:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:395:# 10- (2) INFORMATION FOR SEQ ID NO:396:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:396:# 10- (2) INFORMATION FOR SEQ ID NO:397:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:397:# 10- (2) INFORMATION FOR SEQ ID NO:398:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:398:# 10- (2) INFORMATION FOR SEQ ID NO:399:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:399:# 10- (2) INFORMATION FOR SEQ ID NO:400:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:400:# 10- (2) INFORMATION FOR SEQ ID NO:401:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:401:# 10- (2) INFORMATION FOR SEQ ID NO:402:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:402:# 10- (2) INFORMATION FOR SEQ ID NO:403:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:403:# 10- (2) INFORMATION FOR SEQ ID NO:404:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:404:# 10- (2) INFORMATION FOR SEQ ID NO:405:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:405:# 10- (2) INFORMATION FOR SEQ ID NO:406:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:406:# 10- (2) INFORMATION FOR SEQ ID NO:407:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:407:# 10- (2) INFORMATION FOR SEQ ID NO:408:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:408:# 10- (2) INFORMATION FOR SEQ ID NO:409:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:409:# 10- (2) INFORMATION FOR SEQ ID NO:410:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:410:# 10- (2) INFORMATION FOR SEQ ID NO:411:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:411:# 10- (2) INFORMATION FOR SEQ ID NO:412:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:412:# 10- (2) INFORMATION FOR SEQ ID NO:413:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:413:# 10- (2) INFORMATION FOR SEQ ID NO:414:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:414:# 10- (2) INFORMATION FOR SEQ ID NO:415:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:415:# 10- (2) INFORMATION FOR SEQ ID NO:416:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:416:# 10- (2) INFORMATION FOR SEQ ID NO:417:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:417:# 10- (2) INFORMATION FOR SEQ ID NO:418:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:418:# 10- (2) INFORMATION FOR SEQ ID NO:419:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:419:# 10- (2) INFORMATION FOR SEQ ID NO:420:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:420:# 10- (2) INFORMATION FOR SEQ ID NO:421:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:421:# 10- (2) INFORMATION FOR SEQ ID NO:422:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:422:# 10- (2) INFORMATION FOR SEQ ID NO:423:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:423:# 10- (2) INFORMATION FOR SEQ ID NO:424:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:424:# 10- (2) INFORMATION FOR SEQ ID NO:425:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:425:# 10- (2) INFORMATION FOR SEQ ID NO:426:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:426:# 10- (2) INFORMATION FOR SEQ ID NO:427:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:427:# 10- (2) INFORMATION FOR SEQ ID NO:428:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:428:# 10- (2) INFORMATION FOR SEQ ID NO:429:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:429:# 10- (2) INFORMATION FOR SEQ ID NO:430:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:430:# 10- (2) INFORMATION FOR SEQ ID NO:431:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:431:# 10- (2) INFORMATION FOR SEQ ID NO:432:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:432:# 10- (2) INFORMATION FOR SEQ ID NO:433:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:433:# 10- (2) INFORMATION FOR SEQ ID NO:434:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:434:# 10- (2) INFORMATION FOR SEQ ID NO:435:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:435:# 10- (2) INFORMATION FOR SEQ ID NO:436:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:436:# 10- (2) INFORMATION FOR SEQ ID NO:437:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:437:# 10- (2) INFORMATION FOR SEQ ID NO:438:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:438:# 10- (2) INFORMATION FOR SEQ ID NO:439:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:439:# 10- (2) INFORMATION FOR SEQ ID NO:440:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:440:# 10- (2) INFORMATION FOR SEQ ID NO:441:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:441:# 10- (2) INFORMATION FOR SEQ ID NO:442:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:442:# 10- (2) INFORMATION FOR SEQ ID NO:443:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:443:# 10- (2) INFORMATION FOR SEQ ID NO:444:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:444:# 10- (2) INFORMATION FOR SEQ ID NO:445:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:445:# 10- (2) INFORMATION FOR SEQ ID NO:446:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:446:# 10- (2) INFORMATION FOR SEQ ID NO:447:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:447:# 10- (2) INFORMATION FOR SEQ ID NO:448:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:448:# 10- (2) INFORMATION FOR SEQ ID NO:449:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:449:# 10- (2) INFORMATION FOR SEQ ID NO:450:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:450:# 10- (2) INFORMATION FOR SEQ ID NO:451:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:451:# 10- (2) INFORMATION FOR SEQ ID NO:452:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:452:# 10- (2) INFORMATION FOR SEQ ID NO:453:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:453:# 10- (2) INFORMATION FOR SEQ ID NO:454:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:454:# 10- (2) INFORMATION FOR SEQ ID NO:455:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:455:# 10- (2) INFORMATION FOR SEQ ID NO:456:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:456:# 10- (2) INFORMATION FOR SEQ ID NO:457:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:457:# 10- (2) INFORMATION FOR SEQ ID NO:458:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:458:# 10- (2) INFORMATION FOR SEQ ID NO:459:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:459:# 10- (2) INFORMATION FOR SEQ ID NO:460:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:460:# 10- (2) INFORMATION FOR SEQ ID NO:461:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:461:# 10- (2) INFORMATION FOR SEQ ID NO:462:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:462:# 10- (2) INFORMATION FOR SEQ ID NO:463:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:463:# 10- (2) INFORMATION FOR SEQ ID NO:464:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:464:# 10- (2) INFORMATION FOR SEQ ID NO:465:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:465:# 10- (2) INFORMATION FOR SEQ ID NO:466:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:466:# 10- (2) INFORMATION FOR SEQ ID NO:467:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:467:# 10- (2) INFORMATION FOR SEQ ID NO:468:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:468:# 10- (2) INFORMATION FOR SEQ ID NO:469:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:469:# 10- (2) INFORMATION FOR SEQ ID NO:470:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:470:# 10- (2) INFORMATION FOR SEQ ID NO:471:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:471:# 10- (2) INFORMATION FOR SEQ ID NO:472:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:472:# 10- (2) INFORMATION FOR SEQ ID NO:473:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:473:# 10- (2) INFORMATION FOR SEQ ID NO:474:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:474:# 10- (2) INFORMATION FOR SEQ ID NO:475:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:475:# 10- (2) INFORMATION FOR SEQ ID NO:476:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:476:# 10- (2) INFORMATION FOR SEQ ID NO:477:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:477:# 10- (2) INFORMATION FOR SEQ ID NO:478:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:478:# 10- (2) INFORMATION FOR SEQ ID NO:479:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:479:# 10- (2) INFORMATION FOR SEQ ID NO:480:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:480:# 10- (2) INFORMATION FOR SEQ ID NO:481:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:481:# 10- (2) INFORMATION FOR SEQ ID NO:482:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:482:# 10- (2) INFORMATION FOR SEQ ID NO:483:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:483:# 10- (2) INFORMATION FOR SEQ ID NO:484:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:484:# 10- (2) INFORMATION FOR SEQ ID NO:485:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:485:# 10- (2) INFORMATION FOR SEQ ID NO:486:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:486:# 10- (2) INFORMATION FOR SEQ ID NO:487:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:487:# 10- (2) INFORMATION FOR SEQ ID NO:488:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:488:# 10- (2) INFORMATION FOR SEQ ID NO:489:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:489:# 10- (2) INFORMATION FOR SEQ ID NO:490:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:490:# 10- (2) INFORMATION FOR SEQ ID NO:491:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:491:# 10- (2) INFORMATION FOR SEQ ID NO:492:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:492:# 10- (2) INFORMATION FOR SEQ ID NO:493:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:493:# 10- (2) INFORMATION FOR SEQ ID NO:494:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:494:# 10- (2) INFORMATION FOR SEQ ID NO:495:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:495:# 10- (2) INFORMATION FOR SEQ ID NO:496:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:496:# 10- (2) INFORMATION FOR SEQ ID NO:497:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:497:# 10- (2) INFORMATION FOR SEQ ID NO:498:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:498:# 10- (2) INFORMATION FOR SEQ ID NO:499:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:499:# 10- (2) INFORMATION FOR SEQ ID NO:500:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:500:# 10- (2) INFORMATION FOR SEQ ID NO:501:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:501:# 10- (2) INFORMATION FOR SEQ ID NO:502:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:502:# 10- (2) INFORMATION FOR SEQ ID NO:503:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:503:# 10- (2) INFORMATION FOR SEQ ID NO:504:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:504:# 10- (2) INFORMATION FOR SEQ ID NO:505:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:505:# 10- (2) INFORMATION FOR SEQ ID NO:506:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:506:# 10- (2) INFORMATION FOR SEQ ID NO:507:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:507:# 10- (2) INFORMATION FOR SEQ ID NO:508:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:508:# 10- (2) INFORMATION FOR SEQ ID NO:509:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:509:# 10- (2) INFORMATION FOR SEQ ID NO:510:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:510:# 10- (2) INFORMATION FOR SEQ ID NO:511:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:511:# 10- (2) INFORMATION FOR SEQ ID NO:512:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:512:# 10- (2) INFORMATION FOR SEQ ID NO:513:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:513:# 10- (2) INFORMATION FOR SEQ ID NO:514:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:514:# 10- (2) INFORMATION FOR SEQ ID NO:515:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:515:# 10- (2) INFORMATION FOR SEQ ID NO:516:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:516:# 10- (2) INFORMATION FOR SEQ ID NO:517:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:517:# 10- (2) INFORMATION FOR SEQ ID NO:518:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:518:# 10- (2) INFORMATION FOR SEQ ID NO:519:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:519:# 10- (2) INFORMATION FOR SEQ ID NO:520:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:520:# 10- (2) INFORMATION FOR SEQ ID NO:521:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:521:# 10- (2) INFORMATION FOR SEQ ID NO:522:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:522:# 10- (2) INFORMATION FOR SEQ ID NO:523:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:523:# 10- (2) INFORMATION FOR SEQ ID NO:524:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:524:# 10- (2) INFORMATION FOR SEQ ID NO:525:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:525:# 10- (2) INFORMATION FOR SEQ ID NO:526:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:526:# 10- (2) INFORMATION FOR SEQ ID NO:527:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:527:# 10- (2) INFORMATION FOR SEQ ID NO:528:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:528:# 10- (2) INFORMATION FOR SEQ ID NO:529:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:529:# 10- (2) INFORMATION FOR SEQ ID NO:530:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:530:# 10- (2) INFORMATION FOR SEQ ID NO:531:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:531:# 10- (2) INFORMATION FOR SEQ ID NO:532:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:532:# 10- (2) INFORMATION FOR SEQ ID NO:533:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:533:# 10- (2) INFORMATION FOR SEQ ID NO:534:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:534:# 10- (2) INFORMATION FOR SEQ ID NO:535:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:535:# 10- (2) INFORMATION FOR SEQ ID NO:536:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:536:# 10- (2) INFORMATION FOR SEQ ID NO:537:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:537:# 10- (2) INFORMATION FOR SEQ ID NO:538:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:538:# 10- (2) INFORMATION FOR SEQ ID NO:539:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:539:# 10- (2) INFORMATION FOR SEQ ID NO:540:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:540:# 10- (2) INFORMATION FOR SEQ ID NO:541:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:541:# 10- (2) INFORMATION FOR SEQ ID NO:542:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:542:# 10- (2) INFORMATION FOR SEQ ID NO:543:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:543:# 10- (2) INFORMATION FOR SEQ ID NO:544:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:544:# 10- (2) INFORMATION FOR SEQ ID NO:545:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:545:# 10- (2) INFORMATION FOR SEQ ID NO:546:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:546:# 10- (2) INFORMATION FOR SEQ ID NO:547:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:547:# 10- (2) INFORMATION FOR SEQ ID NO:548:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:548:# 10- (2) INFORMATION FOR SEQ ID NO:549:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:549:# 10- (2) INFORMATION FOR SEQ ID NO:550:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:550:# 10- (2) INFORMATION FOR SEQ ID NO:551:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:551:# 10- (2) INFORMATION FOR SEQ ID NO:552:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:552:# 10- (2) INFORMATION FOR SEQ ID NO:553:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:553:# 10- (2) INFORMATION FOR SEQ ID NO:554:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:554:# 10- (2) INFORMATION FOR SEQ ID NO:555:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:555:# 10- (2) INFORMATION FOR SEQ ID NO:556:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:556:# 10- (2) INFORMATION FOR SEQ ID NO:557:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:557:# 10- (2) INFORMATION FOR SEQ ID NO:558:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:558:# 10- (2) INFORMATION FOR SEQ ID NO:559:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:559:# 10- (2) INFORMATION FOR SEQ ID NO:560:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:560:# 10- (2) INFORMATION FOR SEQ ID NO:561:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:561:# 10- (2) INFORMATION FOR SEQ ID NO:562:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:562:# 10- (2) INFORMATION FOR SEQ ID NO:563:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:563:# 10- (2) INFORMATION FOR SEQ ID NO:564:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:564:# 10- (2) INFORMATION FOR SEQ ID NO:565:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:565:# 10- (2) INFORMATION FOR SEQ ID NO:566:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:566:# 10- (2) INFORMATION FOR SEQ ID NO:567:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:567:# 10- (2) INFORMATION FOR SEQ ID NO:568:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:568:# 10- (2) INFORMATION FOR SEQ ID NO:569:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:569:# 10- (2) INFORMATION FOR SEQ ID NO:570:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:570:# 10- (2) INFORMATION FOR SEQ ID NO:571:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:571:# 10- (2) INFORMATION FOR SEQ ID NO:572:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:572:# 10- (2) INFORMATION FOR SEQ ID NO:573:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:573:# 10- (2) INFORMATION FOR SEQ ID NO:574:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:574:# 10- (2) INFORMATION FOR SEQ ID NO:575:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:575:# 10- (2) INFORMATION FOR SEQ ID NO:576:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:576:# 10- (2) INFORMATION FOR SEQ ID NO:577:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:577:# 10- (2) INFORMATION FOR SEQ ID NO:578:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:578:# 10- (2) INFORMATION FOR SEQ ID NO:579:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:579:# 10- (2) INFORMATION FOR SEQ ID NO:580:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:580:# 10- (2) INFORMATION FOR SEQ ID NO:581:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:581:# 10- (2) INFORMATION FOR SEQ ID NO:582:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:582:# 10- (2) INFORMATION FOR SEQ ID NO:583:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:583:# 10- (2) INFORMATION FOR SEQ ID NO:584:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:584:# 10- (2) INFORMATION FOR SEQ ID NO:585:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:585:# 10- (2) INFORMATION FOR SEQ ID NO:586:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:586:# 10- (2) INFORMATION FOR SEQ ID NO:587:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:587:# 10- (2) INFORMATION FOR SEQ ID NO:588:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:588:# 10- (2) INFORMATION FOR SEQ ID NO:589:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:589:# 10- (2) INFORMATION FOR SEQ ID NO:590:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:590:# 10- (2) INFORMATION FOR SEQ ID NO:591:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:591:# 10- (2) INFORMATION FOR SEQ ID NO:592:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:592:# 10- (2) INFORMATION FOR SEQ ID NO:593:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:593:# 10- (2) INFORMATION FOR SEQ ID NO:594:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:594:# 10- (2) INFORMATION FOR SEQ ID NO:595:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:595:# 10- (2) INFORMATION FOR SEQ ID NO:596:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:596:# 10- (2) INFORMATION FOR SEQ ID NO:597:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:597:# 10- (2) INFORMATION FOR SEQ ID NO:598:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:598:# 10- (2) INFORMATION FOR SEQ ID NO:599:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:599:# 10- (2) INFORMATION FOR SEQ ID NO:600:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:600:# 10- (2) INFORMATION FOR SEQ ID NO:601:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:601:# 10- (2) INFORMATION FOR SEQ ID NO:602:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:602:# 10- (2) INFORMATION FOR SEQ ID NO:603:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:603:# 10- (2) INFORMATION FOR SEQ ID NO:604:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:604:# 10- (2) INFORMATION FOR SEQ ID NO:605:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:605:# 10- (2) INFORMATION FOR SEQ ID NO:606:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:606:# 10- (2) INFORMATION FOR SEQ ID NO:607:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:607:# 10- (2) INFORMATION FOR SEQ ID NO:608:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:608:# 10- (2) INFORMATION FOR SEQ ID NO:609:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:609:# 10- (2) INFORMATION FOR SEQ ID NO:610:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:610:# 10- (2) INFORMATION FOR SEQ ID NO:611:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:611:# 10- (2) INFORMATION FOR SEQ ID NO:612:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:612:# 10- (2) INFORMATION FOR SEQ ID NO:613:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:613:# 10- (2) INFORMATION FOR SEQ ID NO:614:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 1305 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:614:- GAAGAGATTT GGGAGAACAT GACCTGGATG CAGTGGGAAA AAGAAATTCA CA - #ATCACACA 60- AAATACATAT ACTCCTTACT TGAAAAATCG CAGAACCAAC AAGAAAAGAA TG - #AACAAGAA 120- CTATTGGAAT TGGATCAATG GGCAAGTTTG TGGAATTGGT TTGACATAAC AA - #AATGGCTG 180- TGGTATATAA AAATATTCAT AATGGTAGTA GGAGGCTTGA TAGGTTTAAG AA - #TAGTTTTT 240- GCTGTACTTT CTATAGTGAA TAGAGTTAGG CAGGGATACT CACCATTGTC GT - #TTCAGACC 300- CTCCTCCCAA CCCCGAGGGG ACCCGACAGG CCCGAAGGAA TCGAAGAAGA AG - #GTGGAGAG 360- AGAGACAGAG ACAGATCCAC TCGATTAGTA CACGGATTCT TAGCACTTTT CT - #GGGACGAC 420- CTGAGGAGCC TGTGCCTCTT CCTCTACCAC CACTTGAGAG ACTTACTCTT GA - #TTGTAACA 480- AGGATTGTGG AACTTCTGGG ACGCAGGGGA TGGGAAGCCC TCAAATATTG GT - #GGAACCTC 540- CTAAAGTATT GGAGCCAGGA ACTGCAGAAG AGTGCTGTTA TCTTGCTCAA TG - #CCACCGCC 600- ATAGCAGTAG CTGAGGGGAC AGATAGAGTT TTAGAAGTAT TACAAAGAGC TT - #ATAGAGCT 660- ATCCTCCACA TACCTAGAAG AATAAGACAG GGCCTCGAAA TGGCTTTGCT AT - #AAAATGGG 720- TGGCAAGTGA GCAAAAAGTA GTGTAGTCAG ATAGCATGCA TCATAAGGGG TG - #GGGGCCAA 780- CAACTAACAA TGCTGATCGT GCCTGGCTAG AAGCACAAGA GAAGGAAGAA GC - #GGGTTTTC 840- CAGTCAAACC TCAGGTAGCT GTAGATCTTA GCCACTTTTT AAAAGAAAAG GG - #GGGACTGG 900- AAGGGCTAAT TCACTCCCAA AGAAGACAAG ATACACAGTG CTGCAAACTA TT - #ACCAGTGG 960- AGTCAGCGAA GATAGAAGAG GCCAATGGAG GAGAAAACCA CAGATTGTTC TG - #TTGGGGAC1020- TTTCCATCCG TTGGGGACTT TCCAAGGCGG CGTGGCCTGG GTGACTAGTT CC - #GGTGGGGA1080- CTTTCCAAGA AGGCGCGGCC TGGGCGGGAC TGGGGAGTGG CGAGCCCTCA GA - #TGCTGCAT1140- ATAAGCAGCT GCTTTCTGCT GTTACTGGGT CTCTCGGGTT AGACCAGATC TG - #AGCCTGGG1200- AGCTCTCTGG CTAACTAGGG AACCCACTGC TTAAGCCTCA ATAAAGCTTG CC - #TTGAGTGC1260# 1305GT CTGTTGTGTG ACTCTGGTAT CTAGA- (2) INFORMATION FOR SEQ ID NO:615:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 1208 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:615:- GAAACAATTT GGGATAACAT GACCTGGATG CAGTGGGAAA GAGAAATTGA CA - #ATTACACA 60- AACATAATAT ACACCTTAAT TGAAGAATCG CAGAACCAAC AAGAAAAAAA TG - #AACTAGAA 120- TTATTGGAAT TGGATAAATG GGCAAATTTG TGGAATTGGT TTAGTATATC AA - #ACTGGCTA 180- TGGTATATAA AATTATTCAT AATGGTAGTA GGAGGCTTGG TAGGTTTAAG AA - #TAGTTTTT 240- ACTGTACTTT CTATAGTGAA TAGAGTTAGG CAGGGATACT CACCATTGTC GT - #TTCAGACC 300- CACCTCCCAA CCCCGAAGGG ACCCGACAGG CCAGAAGGAA TCGAAGAAGA AG - #GTGGAGAG 360- AGAGACAGAG GCAGCTCCAC TCGATTAGTG CACGGATTCT TAGCACTTTT CT - #GGGACGAC 420- CTGAGGAGTC TGTGCCTCTT CAGCTACCAC CACTTGAGAG ACTTACTCTT GA - #TTGTAACG 480- AGGATTGTGG AACTTCTGGG ACGCAGGGGA TGGGAAGCCC TCAAATACTG GT - #GGAATCTC 540- CTGCAGTATT GGAGGCAGGA ACTACAGAAG AGTGCTGTTA GCTTGTTCAA TG - #GCACGGCC 600- ATAGCAGTAG CTGAGGGGAC AGATAGAGTT ATAGAAGCTT TACGAAGGGC TT - #ATAGAGCT 660- ATTCTCCACA TACCTAGAAG AATAAGACAG GGCTTAGAAA GGGCTTTGCT AT - #AAAATGGG 720- TGGCAAGTGG TCAGAAAGTA GTGTGGTTAG AAGGCATGTA CCTTTAAGAC AA - #GGCAGCTA 780- TAGATCTTAG CCGCTTTTTA AAAGAAAAGG GGGGACTGGA AGGGCTAATT CA - #CTCACAGA 840- GAAGATCAGT TGAACCAGAA GAAGATAGAA GAGGCCATGA AGAAGAAAAC AA - #CAGATTGT 900- TCCGTTTGTT CCGTTGGGGA CTTTCCAGGA GACGTGGCCT GAGTGATAAG CC - #GCTGGGGA 960- CTTTCCGAAG AGGCGTGACG GGACTTTCCA AGGCGACGTG GCCTGGGCGG GA - #CTGGGGAG1020- TGGCGAGCCC TCAGATGCTG CATATAAGCA GCTGCTTTCT GCCTGTACTG GG - #TCTCTCTG1080- GTTAGACCAG ATCTGAGCCT GGGAGCTCTC TGGCTAACTA GGGAACCCAC TG - #CTTAAGCC1140- TCAATAAAGC TTGCCTTGAG TGCTTCAAGT AGTGTGTGCC CGTCTGTTGT GT - #GACTCTGG1200# 1208- (2) INFORMATION FOR SEQ ID NO:616:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 18 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:616:# 18 GT- (2) INFORMATION FOR SEQ ID NO:617:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 25 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:617:# 25 TAGC CTGTC- (2) INFORMATION FOR SEQ ID NO:618:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 20 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:618:# 20 TAAC- (2) INFORMATION FOR SEQ ID NO:619:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 20 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:619:# 20 ATGG- (2) INFORMATION FOR SEQ ID NO:620:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 19 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:620:# 19 CAC- (2) INFORMATION FOR SEQ ID NO:621:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 20 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:621:# 20 CAGG- (2) INFORMATION FOR SEQ ID NO:622:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 21 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:622:#21 AGAT A- (2) INFORMATION FOR SEQ ID NO:623:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 21 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:623:#21 ATTC C- (2) INFORMATION FOR SEQ ID NO:624:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 26 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:624:# 26 TCAA CATAAT- (2) INFORMATION FOR SEQ ID NO:625:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 22 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:625:# 22GCT TG- (2) INFORMATION FOR SEQ ID NO:626:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 18 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:626:# 18 CC- (2) INFORMATION FOR SEQ ID NO:627:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 19 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:627:# 19 GAG- (2) INFORMATION FOR SEQ ID NO:628:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 19 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:628:# 19 CAG- (2) INFORMATION FOR SEQ ID NO:629:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 19 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:629:# 19 CAC- (2) INFORMATION FOR SEQ ID NO:630:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 17 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:630:# 17 T- (2) INFORMATION FOR SEQ ID NO:631:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 19 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:631:# 19 GAG- (2) INFORMATION FOR SEQ ID NO:632:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 17 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:632:# 17 T- (2) INFORMATION FOR SEQ ID NO:633:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 17 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:633:# 17 C- (2) INFORMATION FOR SEQ ID NO:634:- (i) SEQUENCE CHARACTERISTICS:#acids (A) LENGTH: 13 amino (B) TYPE: amino acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: peptide- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:634:- Ala Val Arg Glu Arg Met Arg Arg Ala Glu Pr - #o Ala Ala# 10- (2) INFORMATION FOR SEQ ID NO:635:- (i) SEQUENCE CHARACTERISTICS:#acids (A) LENGTH: 32 amino (B) TYPE: amino acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: protein- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:635:- Pro Thr Ser Gln Ser Arg Gly Asp Pro Thr Gl - #y Pro Lys Glu Lys# 15- Lys Lys Val Glu Arg Glu Thr Glu Thr Asp Pr - #o Phe Asp Thr Asp# 30- Pro His 32- (2) INFORMATION FOR SEQ ID NO:636:- (i) SEQUENCE CHARACTERISTICS:#acids (A) LENGTH: 34 amino (B) TYPE: amino acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: protein- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:636:- Pro Ser Ser Gln Pro Arg Gly Asp Pro Thr Gl - #y Pro Lys Glu Ser# 15- Lys Lys Lys Val Glu Arg Glu Thr Glu Thr As - #p Pro Leu Asp Tyr# 30- Thr Asp Ser His- (2) INFORMATION FOR SEQ ID NO:637:- (i) SEQUENCE CHARACTERISTICS:#acids (A) LENGTH: 34 amino (B) TYPE: amino acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: protein- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:637:- Pro Thr Ser Gln Pro Arg Arg Asp Pro Thr Gl - #y Gln Lys Glu Ser# 15- Thr Lys Lys Lys Val Glu Arg Glu Thr Glu Al - #a Ala Pro Leu Asp# 30- Cys Asp Ser His- (2) INFORMATION FOR SEQ ID NO:638:- (i) SEQUENCE CHARACTERISTICS:#acids (A) LENGTH: 106 amino (B) TYPE: amino acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: protein- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:638:- Asp Pro Pro Pro Asn Pro Glu Gly Thr Arg Gl - #n Ala Arg Arg Asn Arg# 15- Arg Arg Arg Trp Arg Glu Arg Gln Arg Gln Il - #e His Ser Ile Ser Glu# 30- Arg Ile Leu Ser Thr Tyr Leu Gly Arg Ser Al - #a Glu Pro Val Pro Leu# 45- Gln Leu Pro Pro Leu Glu Arg Leu Thr Leu As - #p Cys Asn Glu Asp Cys# 60- Gly Thr Ser Gly Thr Gln Gly Val Gly Ser Pr - #o Gln Ile Leu Val Glu#80- Ser Pro Thr Val Leu Glu Ser Gly Thr Lys Gl - #u Cys Cys Leu Ala Gln# 95- Cys His Ser His Ser Ser Ser Gly Asp Arg# 105- (2) INFORMATION FOR SEQ ID NO:639:- (i) SEQUENCE CHARACTERISTICS:#acids (A) LENGTH: 108 amino (B) TYPE: amino acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: protein- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:639:- Asp Pro Pro Pro Asn Pro Glu Gly Thr Arg Gl - #n Ala Arg Arg Asn Arg# 15- Arg Arg Arg Trp Arg Glu Arg Gln Arg Gln Il - #e His Ser Ile Ser Thr# 30- Arg Ile Leu Ser Thr Phe Leu Gly Arg Pro Gl - #u Glu Pro Val Pro Leu# 45- Pro Leu Pro Pro Leu Glu Arg Leu Thr Leu As - #p Cys Asn Lys Asp Cys# 60- Gly Thr Ser Gly Thr Gln Gly Met Gly Ser Pr - #o Gln Ile Leu Val Glu#80- Pro Pro Lys Val Leu Glu Pro Gly Thr Ala Gl - #u Glu Cys Cys Tyr Leu# 95- Ala Gln Cys His Arg His Ser Ser Ser Gly As - #p Arg# 105- (2) INFORMATION FOR SEQ ID NO:640:- (i) SEQUENCE CHARACTERISTICS:#acids (A) LENGTH: 107 amino (B) TYPE: amino acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: protein- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:640:- Asp Pro Pro Pro Asn Pro Glu Gly Thr Arg Gl - #n Ala Arg Arg Asn Arg# 15- Arg Arg Arg Trp Arg Glu Arg Gln Arg Gln Le - #u His Ser Ile Ser Ala# 30- Arg Ile Leu Ser Thr Phe Leu Gly Arg Pro Gl - #u Glu Ser Val Pro Leu# 45- Gln Leu Pro Pro Leu Glu Arg Leu Thr Leu As - #p Cys Asn Glu Asp Cys# 60- Gly Thr Ser Gly Thr Gln Gly Met Gly Ser Pr - #o Gln Ile Leu Val Glu#80- Ser Pro Ala Val Leu Glu Ala Gly Thr Thr Gl - #u Glu Cys Cys Leu Val# 95- Gln Trp His Gly His Ser Ser Ser Gly Asp Ar - #g# 105- (2) INFORMATION FOR SEQ ID NO:641:- (i) SEQUENCE CHARACTERISTICS:#acids (A) LENGTH: 237 amino (B) TYPE: amino acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: protein- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:641:- Glu Gln Ile Trp Asn Asn Met Thr Trp Met Gl - #u Trp Asp Arg Glu Ile# 15- Asn Asn Tyr Thr Ser Leu Ile His Ser Leu Il - #e Glu Glu Ser Gln Asn# 30- Gln Gln Glu Lys Asn Glu Gln Glu Leu Leu Gl - #u Leu Asp Lys Trp Ala# 45- Ser Leu Trp Asn Trp Phe Asn Ile Thr Asn Tr - #p Leu Trp Tyr Ile Lys# 60- Leu Phe Ile Met Ile Val Gly Gly Leu Val Gl - #y Leu Arg Ile Val Phe#80- Ala Val Leu Ser Ile Val Asn Arg Val Arg Gl - #n Gly Tyr Ser Pro Leu# 95- Ser Phe Gln Thr His Leu Pro Ile Pro Arg Gl - #y Pro Asp Arg Pro Glu# 110- Gly Ile Glu Glu Glu Gly Gly Glu Arg Asp Ar - #g Asp Arg Ser Ile Arg# 125- Leu Val Asn Gly Ser Leu Ala Leu Ile Trp As - #p Asp Leu Arg Ser Leu# 140- Cys Leu Phe Ser Tyr His Arg Leu Arg Asp Le - #u Leu Leu Ile Val Thr145 1 - #50 1 - #55 1 -#60- Arg Ile Val Glu Leu Leu Gly Arg Arg Gly Tr - #p Glu Ala Leu Lys Tyr# 175- Trp Trp Asn Leu Leu Gln Tyr Trp Ser Gln Gl - #u Leu Lys Asn Ser Ala# 190- Val Asn Leu Leu Asn Ala Thr Ala Ile Ala Va - #l Ala Glu Gly Thr Asp# 205- Arg Val Ile Glu Val Leu Gln Ala Ala Tyr Ar - #g Ala Ile Arg His Ile# 220- Pro Arg Arg Ile Arg Gln Gly Leu Glu Arg Il - #e Leu Leu225 2 - #30 2 - #35- (2) INFORMATION FOR SEQ ID NO:642:- (i) SEQUENCE CHARACTERISTICS:#acids (A) LENGTH: 237 amino (B) TYPE: amino acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: protein- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:642:- Glu Glu Ile Trp Glu Asn Met Thr Trp Met Gl - #n Trp Glu Lys Glu Ile# 15- His Asn His Thr Lys Tyr Ile Tyr Ser Leu Le - #u Glu Lys Ser Gln Asn# 30- Gln Gln Glu Lys Asn Glu Gln Glu Leu Leu Gl - #u Leu Asp Gln Trp Ala# 45- Ser Leu Trp Asn Trp Phe Asp Ile Thr Lys Tr - #p Leu Trp Tyr Ile Lys# 60- Ile Phe Ile Met Val Val Gly Gly Leu Ile Gl - #y Leu Arg Ile Val Phe#80- Ala Val Leu Ser Ile Val Asn Arg Val Arg Gl - #n Gly Tyr Ser Pro Leu# 95- Ser Phe Gln Thr Leu Leu Pro Thr Pro Arg Gl - #y Pro Asp Arg Pro Glu# 110- Gly Ile Glu Glu Met Gly Gly Glu Arg Asp Ar - #g Asp Arg Ser Thr Arg# 125- Leu Val His Gly Phe Leu Ala Leu Phe Trp As - #p Asp Leu Arg Ser Leu# 140- Cys Leu Phe Leu Tyr His His Leu Arg Asp Le - #u Leu Leu Ile Val Thr145 1 - #50 1 - #55 1 -#60- Arg Ile Val Glu Leu Leu Gly Arg Arg Gly Tr - #p Glu Ala Leu Lys Tyr# 175- Trp Trp Asn Leu Leu Lys Tyr Trp Ser Gln Gl - #u Leu Gln Lys Ser Ala# 190- Val Ile Leu Leu Asn Ala Thr Ala Ile Ala Va - #l Ala Glu Gly Thr Asp# 205- Arg Val Leu Glu Val Leu Gln Arg Ala Tyr Ar - #g Ala Ile Leu His Ile# 220- Pro Arg Arg Ile Arg Gln Gly Leu Glu Met Al - #a Leu Leu225 2 - #30 2 - #35- (2) INFORMATION FOR SEQ ID NO:643:- (i) SEQUENCE CHARACTERISTICS:#acids (A) LENGTH: 237 amino (B) TYPE: amino acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: protein- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:643:- Glu Thr Ile Trp Asp Asn Met Thr Trp Met Gl - #n Trp Glu Arg Glu Ile# 15- Asp Asn Tyr Thr Asn Ile Ile Tyr Thr Leu Il - #e Glu Glu Ser Gln Asn# 30- Gln Gln Glu Lys Asn Glu Leu Glu Leu Leu Gl - #u Leu Asp Lys Trp Ala# 45- Asn Leu Trp Asn Trp Phe Ser Ile Ser Asn Tr - #p Leu Trp Tyr Ile Lys# 60- Leu Phe Ile Met Val Val Gly Gly Leu Val Gl - #y Leu Arg Ile Val Phe#80- Thr Val Leu Ser Ile Val Asn Arg Val Arg Gl - #n Gly Tyr Ser Pro Leu# 95- Ser Phe Gln Thr His Leu Pro Thr Pro Lys Gl - #y Pro Asp Arg Pro Glu# 110- Gly Ile Glu Glu Glu Gly Gly Glu Arg Asp Ar - #g Gly Ser Ser Thr Arg# 125- Leu Val His Gly Phe Leu Ala Leu Phe Trp As - #p Asp Leu Arg Ser Leu# 140- Cys Leu Phe Ser Tyr His His Leu Arg Asp Le - #u Leu Leu Ile Val Thr145 1 - #50 1 - #55 1 -#60- Arg Ile Val Glu Leu Leu Gly Arg Arg Gly Tr - #p Glu Ala Leu Lys Tyr# 175- Trp Trp Asn Leu Leu Gln Tyr Trp Arg Gln Gl - #u Leu Gln Lys Ser Ala# 190- Val Ser Leu Phe Asn Gly Thr Ala Ile Ala Va - #l Ala Glu Gly Thr Asp# 205- Arg Val Ile Glu Ala Leu Arg Arg Ala Tyr Ar - #g Ala Ile Leu His Ile# 220- Pro Arg Arg Ile Arg Gln Gly Leu Glu Arg Al - #a Leu Leu225 2 - #30 2 - #35- (2) INFORMATION FOR SEQ ID NO:644:- (i) SEQUENCE CHARACTERISTICS:#acids (A) LENGTH: 206 amino (B) TYPE: amino acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: protein- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:644:- Met Gly Gly Lys Trp Ser Lys Ser Ser Val Il - #e Gly Trp Pro Ala Val# 15- Arg Glu Arg Met Arg Arg Ala Glu Pro Ala Al - #a Asp Gly Val Gly Ala# 30- Val Ser Arg Asp Leu Glu Lys His Gly Ala Il - #e Thr Ser Ser Asn Thr# 45- Ala Ala Asn Asn Ala Ala Cys Ala Trp Leu Gl - #u Ala Gln Glu Glu Glu# 60- Glu Val Gly Phe Pro Val Thr Pro Gln Val Pr - #o Leu Arg Pro Met Thr#80- Tyr Lys Ala Ala Val Asp Leu Ser His Phe Le - #u Lys Glu Lys Gly Gly# 95- Leu Glu Gly Leu Ile His Ser Gln Arg Arg Gl - #n Asp Ile Leu Asp Leu# 110- Trp Ile Tyr His Thr Gln Gly Tyr Phe Pro As - #p Trp Gln Asn Tyr Thr# 125- Pro Gly Pro Gly Val Arg Tyr Pro Leu Thr Ph - #e Gly Trp Cys Tyr Lys# 140- Leu Val Pro Val Glu Pro Asp Lys Val Glu Gl - #u Ala Asn Lys Gly Glu145 1 - #50 1 - #55 1 -#60- Asn Thr Ser Leu Leu His Pro Val Ser Leu Hi - #s Gly Met Asp Asp Pro# 175- Glu Arg Glu Val Leu Glu Trp Arg Phe Asp Se - #r Arg Leu Ala Phe His# 190- His Val Ala Arg Glu Leu His Pro Glu Tyr Ph - #e Lys Asn Cys# 205- (2) INFORMATION FOR SEQ ID NO:645:- (i) SEQUENCE CHARACTERISTICS:#acids (A) LENGTH: 22 amino (B) TYPE: amino acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: protein- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:645:- Met Gly Gly Lys Ala Lys Ser Ser Val Val Ar - #g His Ala Ser Gly# 15- Val Gly Ala Asn Asn Gln Cys 20- (2) INFORMATION FOR SEQ ID NO:646:- (i) SEQUENCE CHARACTERISTICS:#acids (A) LENGTH: 26 amino (B) TYPE: amino acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: protein- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:646:- Met Gly Gly Lys Trp Ser Glu Ser Ser Val Va - #l Arg Arg His Val# 15- Pro Leu Arg Gln Gly Ser Tyr Arg Ser Pro Le - #u# 25- (2) INFORMATION FOR SEQ ID NO:647:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 74 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:647:- CTACAAGGGA CTTTCCGCTG GGGACTTTCC AGGGAGGCGT GGCCTGGGCG GG - #ACTGGGGA 60# 74- (2) INFORMATION FOR SEQ ID NO:648:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 78 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:648:- CTGTTGGGGA CTTTCCATCC GTTGGGGACT TTCCAAGGCG GCGTGGCCTG GG - #TGACTAGT 60# 78 CA- (2) INFORMATION FOR SEQ ID NO:649:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 67 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:649:- CCGTTTGTTC CGTTGGGGAC TTTCCAGGAG ACGTGGCCTG AGTGACTAAG CC - #GCTGGGGA 60# 67- (2) INFORMATION FOR SEQ ID NO:650:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 621 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:650:- ATGGGTGGCA AGTGGTCAAA AAGTAGTGTG ATTGGATGGC CTGCTGTAAG GG - #AAAGAATG 60- AGACGAGCTG AGCCAGCAGC AGATGGGGTG GGAGCAGTAT CTCGAGACCT AG - #AAAAACAT 120- GGAGCAATCA CAAGTAGCAA TACAGCAGCT AACAATGCTG CTTGTGCCTG GC - #TAGAAGCA 180- CAAGAGGAGG AAGAGGTGGG TTTTCCAGTC ACACCTCAGG TACCTTTAAG AC - #CAATGACT 240- TACAAGGCAG CTGTAGATCT TAGCCACTTT TTAAAAGAAA AGGGGGGACT GG - #AAGGGCTA 300- ATTCACTCCC AAAGAAGACA AGATATCCTT GATCTGTGGA TCTACCACAC AC - #AAGGCTAC 360- TTCCCTGATT GGCAGAACTA CACACCAGGG CCAGGGGTCA GATATCCACT GA - #CCTTTGGA 420- TGGTGCTACA AGCTAGTACC AGTTGAGCCA GATAAGGTAG AAGAGGCCAA TA - #AAGGAGAG 480- AACACCAGCT TGTTACACCC TGTGAGCCTG CATGGAATGG ATGACCCTGA GA - #GAGAAGTG 540- TTAGAGTGGA GGTTTGACAG CCGCCTAGCA TTTCATCACG TGGCCCGAGA GC - #TGCATCCG 600# 621TG A- (2) INFORMATION FOR SEQ ID NO:651:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 1596 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:651:- GAACAGATTT GGAATAACAT GACCTGGATG GAGTGGGACA GAGAAATTAA CA - #ATTACACA 60- AGCTTAATAC ACTCCTTAAT TGAAGAATCG CAAAACCAGC AAGAAAAGAA TG - #AACAAGAA 120- TTATTGGAAT TAGATAAATG GGCAAGTTTG TGGAATTGGT TTAACATAAC AA - #ATTGGCTG 180- TGGTATATAA AATTATTCAT AATGATAGTA GGAGGCTTGG TAGGTTTAAG AA - #TAGTTTTT 240- GCTGTACTTT CTATAGTGAA TAGAGTTAGG CAGGGATATT CACCATTATC GT - #TTCAGACC 300- CACCTCCCAA TCCCGAGGGG ACCCGACAGG CCCGAAGGAA TAGAAGAAGA AG - #GTGGAGAG 360- AGAGACAGAG ACAGATCCAT TCGATTAGTG AACGGATCCT TAGCACTTAT CT - #GGGACGAT 420- CTGCGGAGCC TGTGCCTCTT CAGCTACCAC CGCTTGAGAG ACTTACTCTT GA - #TTGTAACG 480- AGGATTGTGG AACTTCTGGG ACGCAGGGGG TGGGAAGCCC TCAAATATTG GT - #GGAATCTC 540- CTACAGTATT GGAGTCAGGA ACTAAAGAAT AGTGCTGTTA ACTTGCTCAA TG - #CCACAGCC 600- ATAGCAGTAG CTGAGGGGAC AGATAGGGTT ATAGAAGTAT TACAAGCAGC TT - #ATAGAGCT 660- ATTCGCCACA TACCTAGAAG AATAAGACAG GGCTTGGAAA GGATTTTGCT AT - #AAGATGGG 720- TGGCAAGTGG TCAAAAAGTA GTGTGATTGG ATGGCCTGCT GTAAGGGAAA GA - #ATGAGACG 780- AGCTGAGCCA GCAGCAGATG GGGTGGGAGC AGTATCTCGA GACCTAGAAA AA - #CATGGAGC 840- AATCACAAGT AGCAATACAG CAGCTAACAA TGCTGCTTGT GCCTGGCTAG AA - #GCACAAGA 900- GGAGGAAGAG GTGGGTTTTC CAGTCACACC TCAGGTACCT TTAAGACCAA TG - #ACTTACAA 960- GGCAGCTGTA GATCTTAGCC ACTTTTTAAA AGAAAAGGGG GGACTGGAAG GG - #CTAATTCA1020- CTCCCAAAGA AGACAAGATA TCCTTGATCT GTGGATCTAC CACACACAAG GC - #TACTTCCC1080- TGATTGGCAG AACTACACAC CAGGGCCAGG GGTCAGATAT CCACTGACCT TT - #GGATGGTG1140- CTACAAGCTA GTACCAGTTG AGCCAGATAA GGTAGAAGAG GCCAATAAAG GA - #GAGAACAC1200- CAGCTTGTTA CACCCTGTGA GCCTGCATGG AATGGATGAC CCTGAGAGAG AA - #GTGTTAGA1260- GTGGAGGTTT GACAGCCGCC TAGCATTTCA TCACGTGGCC CGAGAGCTGC AT - #CCGGAGTA1320- CTTCAAGAAC TGCTGACATC GAGCTTGCTA CAAGGGACTT TCCGCTGGGG AC - #TTTCCAGG1380- GAGGCGTGGC CTGGGCGGGA CTGGGGAGTG GCGAGCCCTC AGATGCTGCA TA - #TAAGCAGC1440- TGCTTTTTGC CTGTACTGGG TCTCTCTGGT TAGACCAGAT CTGAGCCTGG GA - #GCTCTCTG1500- GCTAACTAGG GAACCCACTG CTTAAGCCTC AATAAAGCTT GCCTTGAGTG CT - #TCAAGTAG1560# 1596 GTGT GACTCTGGTA ACTAGA- (2) INFORMATION FOR SEQ ID NO:652:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:652:# 10- (2) INFORMATION FOR SEQ ID NO:653:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:653:# 10- (2) INFORMATION FOR SEQ ID NO:654:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:654:# 10- (2) INFORMATION FOR SEQ ID NO:655:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:655:# 10- (2) INFORMATION FOR SEQ ID NO:656:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:656:# 10- (2) INFORMATION FOR SEQ ID NO:657:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:657:# 10- (2) INFORMATION FOR SEQ ID NO:658:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:658:# 10- (2) INFORMATION FOR SEQ ID NO:659:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:659:# 10- (2) INFORMATION FOR SEQ ID NO:660:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:660:# 10- (2) INFORMATION FOR SEQ ID NO:661:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:661:# 10- (2) INFORMATION FOR SEQ ID NO:662:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:662:# 10- (2) INFORMATION FOR SEQ ID NO:663:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:663:# 10- (2) INFORMATION FOR SEQ ID NO:664:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:664:# 10- (2) INFORMATION FOR SEQ ID NO:665:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:665:# 10- (2) INFORMATION FOR SEQ ID NO:666:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:666:# 10- (2) INFORMATION FOR SEQ ID NO:667:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:667:# 10- (2) INFORMATION FOR SEQ ID NO:668:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:668:# 10- (2) INFORMATION FOR SEQ ID NO:669:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:669:# 10- (2) INFORMATION FOR SEQ ID NO:670:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:670:# 10- (2) INFORMATION FOR SEQ ID NO:671:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:671:# 10- (2) INFORMATION FOR SEQ ID NO:672:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:672:# 10- (2) INFORMATION FOR SEQ ID NO:673:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:673:# 10- (2) INFORMATION FOR SEQ ID NO:674:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:674:# 10- (2) INFORMATION FOR SEQ ID NO:675:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:675:# 10- (2) INFORMATION FOR SEQ ID NO:676:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:676:# 10- (2) INFORMATION FOR SEQ ID NO:677:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:677:# 10- (2) INFORMATION FOR SEQ ID NO:678:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:678:# 10- (2) INFORMATION FOR SEQ ID NO:679:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:679:# 10- (2) INFORMATION FOR SEQ ID NO:680:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:680:# 10- (2) INFORMATION FOR SEQ ID NO:681:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:681:# 10- (2) INFORMATION FOR SEQ ID NO:682:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:682:# 10- (2) INFORMATION FOR SEQ ID NO:683:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:683:# 10- (2) INFORMATION FOR SEQ ID NO:684:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:684:# 10- (2) INFORMATION FOR SEQ ID NO:685:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:685:# 10- (2) INFORMATION FOR SEQ ID NO:686:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:686:# 10- (2) INFORMATION FOR SEQ ID NO:687:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:687:# 10- (2) INFORMATION FOR SEQ ID NO:688:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:688:# 10- (2) INFORMATION FOR SEQ ID NO:689:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:689:# 10- (2) INFORMATION FOR SEQ ID NO:690:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:690:# 10- (2) INFORMATION FOR SEQ ID NO:691:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:691:# 10- (2) INFORMATION FOR SEQ ID NO:692:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:692:# 10- (2) INFORMATION FOR SEQ ID NO:693:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:693:# 10- (2) INFORMATION FOR SEQ ID NO:694:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:694:# 10- (2) INFORMATION FOR SEQ ID NO:695:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:695:# 10- (2) INFORMATION FOR SEQ ID NO:696:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:696:# 10- (2) INFORMATION FOR SEQ ID NO:697:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:697:# 10- (2) INFORMATION FOR SEQ ID NO:698:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:698:# 10- (2) INFORMATION FOR SEQ ID NO:699:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:699:# 10- (2) INFORMATION FOR SEQ ID NO:700:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:700:# 10- (2) INFORMATION FOR SEQ ID NO:701:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:701:# 10- (2) INFORMATION FOR SEQ ID NO:702:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:702:# 10- (2) INFORMATION FOR SEQ ID NO:703:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:703:# 10- (2) INFORMATION FOR SEQ ID NO:704:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:704:# 10- (2) INFORMATION FOR SEQ ID NO:705:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:705:# 10- (2) INFORMATION FOR SEQ ID NO:706:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:706:# 10- (2) INFORMATION FOR SEQ ID NO:707:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:707:# 10- (2) INFORMATION FOR SEQ ID NO:708:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:708:# 10- (2) INFORMATION FOR SEQ ID NO:709:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:709:# 10- (2) INFORMATION FOR SEQ ID NO:710:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:710:# 10- (2) INFORMATION FOR SEQ ID NO:711:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:711:# 10- (2) INFORMATION FOR SEQ ID NO:712:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:712:# 10- (2) INFORMATION FOR SEQ ID NO:713:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:713:# 10- (2) INFORMATION FOR SEQ ID NO:714:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:714:# 10- (2) INFORMATION FOR SEQ ID NO:715:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:715:# 10- (2) INFORMATION FOR SEQ ID NO:716:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:716:# 10- (2) INFORMATION FOR SEQ ID NO:717:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:717:# 10- (2) INFORMATION FOR SEQ ID NO:718:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:718:# 10- (2) INFORMATION FOR SEQ ID NO:719:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:719:# 10- (2) INFORMATION FOR SEQ ID NO:720:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:720:# 10- (2) INFORMATION FOR SEQ ID NO:721:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:721:# 10- (2) INFORMATION FOR SEQ ID NO:722:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:722:# 10- (2) INFORMATION FOR SEQ ID NO:723:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:723:# 10- (2) INFORMATION FOR SEQ ID NO:724:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:724:# 10- (2) INFORMATION FOR SEQ ID NO:725:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:725:# 10- (2) INFORMATION FOR SEQ ID NO:726:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:726:# 10- (2) INFORMATION FOR SEQ ID NO:727:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:727:# 10- (2) INFORMATION FOR SEQ ID NO:728:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:728:# 10- (2) INFORMATION FOR SEQ ID NO:729:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:729:# 10- (2) INFORMATION FOR SEQ ID NO:730:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:730:# 10- (2) INFORMATION FOR SEQ ID NO:731:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:731:# 10- (2) INFORMATION FOR SEQ ID NO:732:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:732:# 10- (2) INFORMATION FOR SEQ ID NO:733:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:733:# 10- (2) INFORMATION FOR SEQ ID NO:734:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:734:# 10- (2) INFORMATION FOR SEQ ID NO:735:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:735:# 10- (2) INFORMATION FOR SEQ ID NO:736:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:736:# 10- (2) INFORMATION FOR SEQ ID NO:737:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:737:# 10- (2) INFORMATION FOR SEQ ID NO:738:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:738:# 10- (2) INFORMATION FOR SEQ ID NO:739:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:739:# 10- (2) INFORMATION FOR SEQ ID NO:740:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:740:# 10- (2) INFORMATION FOR SEQ ID NO:741:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:741:# 10- (2) INFORMATION FOR SEQ ID NO:742:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:742:# 10- (2) INFORMATION FOR SEQ ID NO:743:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:743:# 10- (2) INFORMATION FOR SEQ ID NO:744:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:744:# 10- (2) INFORMATION FOR SEQ ID NO:745:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:745:# 10- (2) INFORMATION FOR SEQ ID NO:746:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:746:# 10- (2) INFORMATION FOR SEQ ID NO:747:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:747:# 10- (2) INFORMATION FOR SEQ ID NO:748:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:748:# 10- (2) INFORMATION FOR SEQ ID NO:749:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:749:# 10- (2) INFORMATION FOR SEQ ID NO:750:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:750:# 10- (2) INFORMATION FOR SEQ ID NO:751:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:751:# 10- (2) INFORMATION FOR SEQ ID NO:752:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:752:# 10- (2) INFORMATION FOR SEQ ID NO:753:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:753:# 10- (2) INFORMATION FOR SEQ ID NO:754:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:754:# 10- (2) INFORMATION FOR SEQ ID NO:755:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:755:# 10- (2) INFORMATION FOR SEQ ID NO:756:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:756:# 10- (2) INFORMATION FOR SEQ ID NO:757:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:757:# 10- (2) INFORMATION FOR SEQ ID NO:758:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:758:# 10- (2) INFORMATION FOR SEQ ID NO:759:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:759:# 10- (2) INFORMATION FOR SEQ ID NO:760:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:760:# 10- (2) INFORMATION FOR SEQ ID NO:761:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:761:# 10- (2) INFORMATION FOR SEQ ID NO:762:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:762:# 10- (2) INFORMATION FOR SEQ ID NO:763:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:763:# 10- (2) INFORMATION FOR SEQ ID NO:764:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:764:# 10- (2) INFORMATION FOR SEQ ID NO:765:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:765:# 10- (2) INFORMATION FOR SEQ ID NO:766:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:766:# 10- (2) INFORMATION FOR SEQ ID NO:767:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:767:# 10- (2) INFORMATION FOR SEQ ID NO:768:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:768:# 10- (2) INFORMATION FOR SEQ ID NO:769:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:769:# 10- (2) INFORMATION FOR SEQ ID NO:770:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:770:# 10- (2) INFORMATION FOR SEQ ID NO:771:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:771:# 10- (2) INFORMATION FOR SEQ ID NO:772:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:772:# 10- (2) INFORMATION FOR SEQ ID NO:773:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:773:# 10- (2) INFORMATION FOR SEQ ID NO:774:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:774:# 10- (2) INFORMATION FOR SEQ ID NO:775:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:775:# 10- (2) INFORMATION FOR SEQ ID NO:776:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:776:# 10- (2) INFORMATION FOR SEQ ID NO:777:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:777:# 10- (2) INFORMATION FOR SEQ ID NO:778:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:778:# 10- (2) INFORMATION FOR SEQ ID NO:779:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:779:# 10- (2) INFORMATION FOR SEQ ID NO:780:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:780:# 10- (2) INFORMATION FOR SEQ ID NO:781:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:781:# 10- (2) INFORMATION FOR SEQ ID NO:782:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:782:# 10- (2) INFORMATION FOR SEQ ID NO:783:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:783:# 10- (2) INFORMATION FOR SEQ ID NO:784:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:784:# 10- (2) INFORMATION FOR SEQ ID NO:785:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:785:# 10- (2) INFORMATION FOR SEQ ID NO:786:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:786:# 10- (2) INFORMATION FOR SEQ ID NO:787:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:787:# 10- (2) INFORMATION FOR SEQ ID NO:788:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:788:# 10- (2) INFORMATION FOR SEQ ID NO:789:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:789:# 10- (2) INFORMATION FOR SEQ ID NO:790:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:790:# 10- (2) INFORMATION FOR SEQ ID NO:791:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:791:# 10- (2) INFORMATION FOR SEQ ID NO:792:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:792:# 10- (2) INFORMATION FOR SEQ ID NO:793:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:793:# 10- (2) INFORMATION FOR SEQ ID NO:794:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:794:# 10- (2) INFORMATION FOR SEQ ID NO:795:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:795:# 10- (2) INFORMATION FOR SEQ ID NO:796:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:796:# 10- (2) INFORMATION FOR SEQ ID NO:797:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:797:# 10- (2) INFORMATION FOR SEQ ID NO:798:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:798:# 10- (2) INFORMATION FOR SEQ ID NO:799:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 10 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:799:# 10- (2) INFORMATION FOR SEQ ID NO:800:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 9207 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: DNA (genomic)- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:800:- TGGAAGGGCT AATTCACTCA CGGAAAAGAC CAGTTGAACC AGAAGAAGAT AG - #AAGAGGCC 60- ATGAAGAAGA AAACAACAGA TTGTTCTGCT TGCTCAGCTG GGGACTTTCC AG - #AAGGCGCG 120- GCCTGAGTGA CTAAGCCCCG TTGGGGACTT TCCGAAGAGG CATGAAGGGA CT - #TTCCAAGG 180- CAGGCGTGGC CTGGGCGGGA CTGGGGAGTG GCGAGCCCTC AGATGCTGCA TA - #TAAGCAGC 240- TGCTTTCTGC CTGTACTGGG TCTCTCTGGT TAGACCAGAT CTGAGCCTGG GA - #GCTCTCTG 300- GCTAGCTAGG GAACCCACTG CTTAAGCCTC AATAAAGCTT GCCTTGAGTG CT - #TCAAGTAG 360- TGTGTGCCCG TCTGTTGTGT GACTCTGGTA TCTAGAGATC CCTCAGACCA TT - #TTAGTCCG 420- TGTGGAAAAT CTCTAGCAGT GGCGCCCGAA CAGGGACTTG AAAGCGAAAG GA - #AAACCAGA 480- GGAGCTCTCT CGACGCAGGA CTCGGCTTGC TGAAGCGCGC ACGGCAAGAG GC - #GAGGGGCG 540- GCGACTGGTG AGTACGCCGA AAATTTTGAC TAGCGGAGGC TAGAAGGAGA GA - #GATGGGTG 600- CGAGAGCGTC AATATTAAGC GGGGGAAAAT TAGATAGATG GGAGAAAATT CG - #GTTAAGGC 660- CAGGAGGAAA GAAAAAGTAT AAATTAAAAC ATATAGTATG GGCAAGCAGG GA - #GCTAGAAC 720- GATTCGCAGT CAATCCTGGC CTGTTGGAAA CATCAGAAGG CTGTAGACAA AT - #ACTGGGAC 780- AGTTACACCC GTCCCTTCAG ACAGGATCAG AAGAACTTAA ATCAGTATAT AA - #TGCAGTAG 840- CAGTCCTCTA TTGTGTGCAT CAAAACATAG ACATAAAGGA CACCAAGGAA GC - #TTTAGAAA 900- AGATAGAGGA AGAGCAAAAC AAATGTAAGA AAAAAGCACA GCAAGCAGCA GC - #ACAGCAAG 960- CAGCAGCTGG CACAGGAAAC AGCAACCCGG TCAGCCAAAA TTACCCTATA GT - #ACAGAACA1020- TGCAGGGGCA AATGGTACAT CAGGCCATAT CACCTAGAAC TTTAAATGCA TG - #GGTAAAAG1080- TAATAGAAGA GAAGGCTTTC AGCCCAGAGG TAATACCCAT GTTTTCAGCA TT - #ATCAGAAG1140- GAGCCACCCC ACAAGATTTA AACACCATGC TAAACACAGT GGGGGGACAT CA - #AGCAGCTA1200- TGCAAATGTT AAAAGAGACC ATCAATGAGG AAGCTGCAGA ATGGGATAGA TT - #ACATCCAG1260- CGCAGGCAGG GCCTGTTGCA CCAGGCCAGA TGAGAGACCC AAGGGGAAGT GA - #CATAGCAG1320- GAACTACTAG TACCCTTCAG GAACAAATAG GATGGATGAC AGGTAATCCA GC - #TATCCCAG1380- TAGGAGAAAT CTATAAAAGA TGGATAATCC TGGGATTAAA TAAAATAGTA AG - #GATGTATA1440- GCCCTATCAG CATTCTGGAC ATAAAACAAG GACCAAAGGA ACCCTTTAGA GA - #CTATGTAG1500- ACCGGTTCTA TAAAACTCTA AGAGCCGAGC AAGCTACACA GGAGGTAAAA AA - #TTGGATGA1560- CAGAAACCTT GTTGGTCCAA AATGCAAACC CAGATTGTAA GACTATTTTA AA - #AGCATTGG1620- GACCAGCAGC TACACTAGAA GAAATGATGA CAGCATGTCA GGGAGTGGGA GG - #ACCCAGCC1680- ATAAAGCAAG AGTTTTGGCA GAAGCAATGA GCCAAGCAAC AAATGCAGCT AC - #TGTAATGA1740- TGCAGAGAAG CAATTTTAGA AACCAAAGAA AGAATGTTAA GTGTTTCAAT TG - #TGGCAAAG1800- AAGGGCACAT AGCCAGAAAT TGCAGGGCTC CTAGGAAAAG GGGCTGTTGG AA - #ATGTGGAA1860- AGGAAGGACA CCAAATGAAA GATTGTACTG AGAGACAGGC TAATTTTTTA GG - #GAAAATCT1920- GGCCTTCCCA CAAGGGGAGG CCAGGGAACT TTCTTCAGAG CAGGCCAGAA CC - #AACAGCCC1980- CTCTCCAGGG CAGGCCGGAG CCATCAGCCC CGCCAGAAGA GAGCTTCAGG TT - #TGGGGAGG2040- AGACAACAAC TCCCTCTCAG AAGCAGGAGC CGATAGACAG GGACAGGGAT CT - #GTATCCTT2100- TAGCTTCCCT CAGATCACTC TTTGGCAACG ACCCCTCGTC ACAATAAAGA TA - #GGGGGGCA2160- GCTGAAGGAA GCTCTATTAG ATACAGGAGC AGATGATACA GTATTAGAAG AC - #ATGCATTT2220- GCCAGGAAAA TGGAAACCAA AAATGATAGG GGGAATTGGA GGTTTTATCA AA - #GTAAAACA2280- ATATGATGAA ATTCTTGTAG AAATCTGTGG ACATAAAGCT ATAGGTACAG TA - #TTAGTAGG2340- ACCTACACCT GTCAACATAA TTGGAAGAAA TCTGTTGACT CAGATTGGTT GC - #ACTTTAAA2400- TTTTCCCATT AGTCCTATTG AAACTGTACC AGTACAATTA AAGCCAGGAA TG - #GATGGCCC2460- AAAGGTTAAA CAATGGCCAT TGACAGAAGA GAAAATAAAA GCATTAGTAG AA - #ATTTGTAC2520- AGAAATGGAA AAGGAAGGAA AGATTTCAAA AATTGGGCCT GAAAATCCAT AC - #AATACTCC2580- AGTATTTGCC ATAAAGAAAA AAGATGGTAC TAAATGGAGA AAATTAGTAG AT - #TTCAGAGA2640- CCTTAATAAG AGAACTCAAG ACTTCTGGGA AGTTCAATTA GGAATACCAC AT - #CCCTCAGG2700- ATTAAAAAAG AAAAAATCAG TAACAGTACT GGATGTGGGT GATGCATACT TT - #TCAGTTCC2760- CTTAGATGAA AACTTCAGGA AGTATACTGC ATTTACCATA CCTAGTATAA AT - #AATGAGAC2820- ACCAGGGATT AGATATCAGT ACAATGTGCT TCCACAGGGA TGGAAAGGAT CA - #CCAGCAAT2880- ATTCCAAAGT AGCATGACAA GAATCTTAGA GCCTTTTAGA AGACAAAATC CA - #GACATAGT2940- TATCTATCAA TACATGGATG ACTTGTATGT AGGATCTGAT TTAGAAATAG GA - #CAGCATAG3000- AATAAAAATA GAGGAACTGA GACAACATCT GTTGAAGTGG GGATTTACCA CA - #CCAGACAA3060- AAAGCATCAG AAAGAACCCC CATTCCTTTG GATGGGTTAT GAACTCCATC CT - #GATAAATG3120- GACAGTGCAA CCTATAGTAC TGCCAGAAAA AGACAGCTGG ACTGTCAATG AC - #ATACAGAA3180- GTTAGTGGGT AAATTAAATT GGGCAAGTCA GATTTACCCA GGAATTAAAG TA - #AGGCAATT3240- ATGTAAACTC CTTAGGGGAA CCAAAGCACT AACAGAAGTA ATACCACTAA CA - #GAAGAAGC3300- AGAGCTAGAA CTGGCAGAAA ACAGGGAAAT TCTAAGAGAA CCAGTACATG GA - #GTGTATTA3360- TGACCCATCA AAAGACTTAA TAGCAGAAAT ACAGAAGCAG GAGCAAGGCC AA - #TGGACATA3420- TCAAATTTAT CAAGATCAAT TTAAAAATCT AAAAACAGGA AAGTATGCAA GA - #TTGAGGGG3480- TGCCCACACT AATGATGTAA AACAATTTCC AGAGGCAGTG CAAAAAATAG CC - #ACAGAAAG3540- CATAGTAATA TGGGGAAAGA CTCCTAAATT TAGACTACCC ATACAAAAAG AA - #ACATGGGA3600- CGCATGGTGG ACAGAGTATT GGCAAGCCAC CTGGATTCCT GAGTGGGAGT TT - #GTCAATAC3660- CCCTCCCCTA GTAAAATTAT GGTACCAGTT AGAAAAAGAA CCCATAATAG GA - #GCAGAAAC3720- TTTCTATGTA GATGGGGCAG CTAACAGAGA GACTAAATTA GGAAAAGCAG GA - #TATGTTAC3780- TGACAGAGGA AGACAAAAAG TTGTCTCCCT AACTGACACA ACAAATCAGA AG - #ACTGAGTT3840- ACAAGCAATT CATCTAGCTT TGCAGGATTC AGGATTAGAA GTAAACATAG TA - #ACAGACTC3900- ACAGTATGCA TTAGGAATCA TTCAAGCACA ACCAGATAAA AGTGAATCAG AA - #ATAGTCAA3960- TCAAATAATA GAGCAATTAA TAAAAAAGGA AAAGGTCTAC CTGGCATGGG TA - #CCAGCACA4020- CAAAGGAATT GGAGGGAATG AACAAGTAGA TAAATTAGTC AGTGCTGGAA TC - #AGGAAAAT4080- ACTATTTTTA GATGGAATAG ATAAGGCACA AGAAGGCCAT GAGAAATATC AC - #AGTAATTG4140- GAGAGCAATG GCTAGTGGTT TTAACCTGCC ACCTATAGTA GCAAAAGAAA TA - #GTAGCCAG4200- CTGTGATAAA TGTCAGCTAA AAGGAGAAGC CATGCATGGA CAAGTAGACT GT - #AGTCCAGG4260- AATATGGCAA CTAGATTGTA CACATCTAGA AGGAAAAATT ATCCTGGTAG CA - #GTTCATGT4320- AGCCAGTGGA TATATAGAAG CAGAAGTTAT TCCAGCAGAG ACAGGGCAGG AA - #ACAGCATA4380- CTTTATCTTA AAATTAGCAG GAAGGTGGCC AGTAAACACA ATACATACAG AC - #AATGGCGG4440- CAATTTCATC AGTACCACGG TTAAGGCCGC CTGTTGGTGG GCAGGGATCA AG - #CAGGAATT4500- TGGCATTCCC TACAATCCCC AAAGCCAAGG AGTAGTGGAA TCTATGAATA GA - #GAATTAAA4560- GAAAATTATA GGACAGGTAA GAGATCAGGC TGAACATCTT AAGACAGCAG TA - #CAAATGGC4620- AGTATTCATC CACAATTTTA AAAGAAAAGG GGGGATTGGG GGATACAGTG CA - #GGGGAAAG4680- AATAGTAGAC ATAATAGCAA CAGACATACA AACTAAAGAA TTACAAAAGC AA - #ATTACAAA4740- AATTCAAAAT TTTCGGGTTT ATTACAGGGA CAGCAGAGAT CCACTTTGGA AA - #GGACCAGC4800- AAAACTTCTC TGGAAAGGCG AAGGGGCAGT AGTAATACAA GATAATAGTG AC - #ATAAAAGT4860- AGTGCCAAGA AGAAAAGTAA AGATCATTAG GGATTATGGA AAACAGATGG CA - #GGTGATGA4920- TTGTGTGGCA AGTAGACAGG ATGAGGATTA GAACATGGAA CAGTTTAGTG AA - #ACACCATA4980- TGTATGTTTC AAAGAAAGCT AAGGGATGGA TTTATAGACA TCACTATGAA AA - #CACTCATC5040- CAAAAATAAG CTCAGAAGTA CACATCCCAC TAGGGGAAGC TAGATTGGTA AT - #AACAACAT5100- ATTGGGGTCT ACATACAGGA GAAAGAGACT GGCATTTGGG TCAGGGAGTC TC - #CATAGAAT5160- GGAGGGAAAG GACATATAGA ACACAAGTAG ACCCCGAACT AGCAGACCAA CT - #AATTCATA5220- TACATTACTT TGATTGTTTT TCAGAATCTG CCATAAGAAG TGCCATATTA GG - #ATATAGAG5280- TTAGGCATAG GTGTGAATAT CAAGCAGGAC ATAACAAGGT AGGATCTCTA CA - #GTACTTGG5340- CACTAACAGC ATTAATAACA CCAAAGAAGA TAAAGCCACC TTTGCCTAGT GT - #TGCGAAAC5400- TGACAGAGGA TAGATGGAAC AAGCCCCAGA AGACCAAGGG CCACAGAGGC AG - #CCATACAA5460- TGAATGGACA CTAGAACTTT TAGAGGAGCT TAAGAATGAA GCTGTTAGGC AT - #TTTCCTAG5520- GGTATGGCTC CATGGCTTAG GGCAACATAT CTATGAAACT TATGGGGATA CT - #TGGGAAGG5580- AGTGGAGGCC ATAACAAGAA CTCTGCAACA ACTGCTGTTT ATTCATTTCA GA - #ATTGGGTG5640- TCAACATAGC AGAATAGGCA TTATTCGACA GAGGAGAGCA AGAAATGGAG CC - #AGTAGATC5700- CTAGACTAGA GCCCTGGAAG CATCCAGGAA GTCAGCCTAA GACTGCGTGT AC - #CACTTGCT5760- ATTGTAAAAA GTGCTGCTTT CATTGCCAAG TTTGTTTTAT GACAAAAGGC TT - #AGGCATCT5820- CCTATGGCAG GAAGAAGCGG AGACAGCGAC GAAGAGCTCC TCAAGACAGT CA - #GACTCATC5880- AAGCTTATCT ATCAAAGCAG TAAGTAATAT ATGTAATGCA ACCTTTACAA AT - #AGTAGCAA5940- TAGTAGCATT AGTAGTAGCA GGAATAATAG CAATAGTTGT GTGGACCATA GT - #ATTCATAG6000- AATATAAGAA AATATTAAGA CAAAGAAAAA TAGACAGGTT GATTGATAGA AT - #AAGAGAAA6060- GAGCAGAAGA CAGTGGCAAT GACAGTGAAG GGGATCAGGA AGAATTATCG GC - #ACTTGTGG6120- ACATGGGGCA CCATGATCCT TGGGATATTA ATGATCTGTA GAGCTGCAAA CA - #ATTTGTGG6180- GTCACAGTCT ATTATGGGGT ACCTGTGTGG AGAGAAGCAA CCACCACTCT AT - #TTTGTGCA6240- TCAGATGCCA AGGCATATGA TGCAGAGGTA CATAATGTTT GGGCCACACA TG - #CCTGTGTA6300- CCCACAGACC CTAACCCACA AGAAGTAGAA TTGAAAAATG TGACAGAAAA TT - #TTAACATG6360- TGGAAAAATA ACATGGTAGA ACAGATGCAT GAGGATATAA TCAGTTTATG GG - #ATCAAAGC6420- CTGAAGCCAT GTGTAAAATT AACCCCACTC TGTGTTTCTT TAAATTGCAC TG - #ATGCTACT6480- AATACCACTA ATAGTAATAC CACTAGCAGC AGCGAGAAAC CGAAGGGGAC AG - #GGGAAATA6540- AAAAACTGCT CTTTCAATAT CACCACAAGC ATAAGAGATA AGGTGCAGAA AC - #AATATGCA6600- CTTTTTTATA GCCTTGATGT AGTACCAATG GATGATAATG ATAATAGTAC AA - #GCTATAGG6660- TTAATAAGTT GTAACACCTC AATCATTACA CAGGCCTGTC CAAAGATATC CT - #TTGAGCCA6720- ATTCCCATAC ATTATTGTGC CCCGGCTGGT TTTGCGATTC TAAAGTGTAA AG - #ATAAAAGG6780- TTCAATGGAA AAGGACCATG TACAAGTGTC AGCACAGTAC AGTGTACACA TG - #GAATTAGG6840- CCAGTAGTAT CAACTCAACT GTTGTTAAAT GGCAGTCTAG CAGAAGAAGA GG - #TAGTAATT6900- AGATCTGACA ATTTTACGAA CAATGCTAAA ACCATAATAG TACAGCTGAG CA - #AATCTGTA6960- GAAATTACTT GTGTAAGACC CAACAACAAT ACAAGAAAAA GTATAAGTAT GG - #GACCAGGG7020- AGAGCATTTT ATACAACAGA AATAATAGGA GATATAAGAC AAGCATATTG TA - #ACATTAGT7080- AAAGCAAACT GGACTGACAC TTTAGAACAG ATAGCTAGAA AATTAAGAGA AC - #AATTTGAG7140- AATAAAACAA TAGTCTTTAA GCCATCCTCA GGAGGGGACC CAGAAATTGT AA - #CACAGTTT7200- TACAGTTTTA ATTGTGGAGG GGAATTTTTC TACTGTAATT CAACACAACT GT - #TTAATGGT7260- ACTTGGAATG GTACTTGGGT TAATGGTACT TGGAGTAGTA ATAATACGAC TG - #ATACTGCA7320- AATATCACAC TCCCATGCAG AATAAAACAA TTTATAAACA TGTGGCAGGA AG - #TAGGAAAA7380- GCAATGTATG CCCCTCCCAT CAAAGGACAA ATTAAATGTA CATCAAATAT TA - #CAGGGCTG7440- ATATTAACAA GAGATGGTGG TAACAATAAC ACCACGAACG ACAACGAGAC CG - #AGACCTTC7500- AGACCTGGAG GAGGAGATAT GAGGGACAAT TGGAGAAGTG AATTATATAA AT - #ATAAAGTA7560- GTACAAGTTG AACCATTAGG AGTAGCACCC ACCAAGGCAA AGAGAAGAGT GG - #TGCAAAGA7620- GAAAAAAGAG CAGTGGGAAT AGGAGCTATG TTCCTTGGGT TCTTAGGAGC AG - #CAGGAAGC7680- ACTATGGGCG CAGCGTCAGT GACGCTGACG GTACAAGCCA GACAATTATT GT - #CTGGTATA7740- GTGCAGCAGC AGAACAATCT GCTGAGGGCT ATTGAGGCGC AACAGCATCT GT - #TGCAACTC7800- ACAGTCTGGG GCATCAAACA GCTCCAGGCA AGAGTCCTGG CTGTGGAAAG AT - #ACCTAAGG7860- GATCAACAGC TCCTGGGACT TTGGGGTTGC TCTGGAAAAC TCATTTGCAC CA - #CTACTGTG7920- CCTTGGAACA ATAGCTGGAG TAATAAATCT CTGGAAACAA TTTGGGATAA CA - #TGACCTGG7980- ATGCAGTGGG AAAGAGAAAT TGACAATTAC ACAAACATAA TATACACCTT AA - #TTGAAGAA8040- TCGCAGAACC AACAAGAAAA AAATGAACTA GAATTATTGG AATTGGATAA AT - #GGGCAAAT8100- TTGTGGAATT GGTTTAGTAT ATCAAACTGG CTATGGTATA TAAAATTATT CA - #TAATGGTA8160- GTAGGAGGCT TGGTAGGTTT AAGAATAGTT TTTACTGTAC TTTCTATAGT TA - #ATAGAGTT8220- AGGCAGGGAT ACTCACCATT ATCGTTTCAG ACCCACCTCC CAACCCCGAA GG - #GACCCGAC8280- AGGCCAGAAG GAATCGAAGA AGAAGGTGGA GAGAGAGACA GAGGCAGCTC CA - #CTCGATTA8340- GTGCACGGAT TCTTAGCACT TTTCTGGGAC GACCTGAGGA GTCTGTGCCT CT - #TCAGCTAC8400- CACCACTTGA GAGACTTACT CTTGATTGTA ACGAGGATTG TGGAACTTCT GG - #GACGCAGG8460- GGATGGGAAG CCCTCAAATA CTGGTGGAAT CTCCTGCAGT ATTGGAGGCA GG - #AACTACAG8520- AAGAGTGCTG TTAGCTTGTT CAATGGCACG GCCATAGCAG TAGCTGAGGG GA - #CAGATAGA8580- GTTATAGAAG CTTTACGAAG GGCTTATAGA GCTATTCTCC ACATACCTAG AA - #GAATAAGA8640- CAGGGCTTAG AAAGGGCTTT GCTATAAAAT GGGTGGCAAG TGGTCAGAAA GT - #AGTGTGGT8700- TAGAAGGCAT GTACCTTTAA GACAAGGCAG CTATAGATCT TAGCCGCTTT TT - #AAAAGAAA8760- AGGGGGGACT GGAAGGGCTA ATTCACTCAC GGAAAAGACC AGTTGAACCA GA - #AGAAGATA8820- GAAGAGGCCA TGAAGAAGAA AACAACAGAT TGTTCTGCTT GCTCAGCTGG GG - #ACTTTCCA8880- GAAGGCGCGG CCTGAGTGAC TAAGCCCCGT TGGGGACTTT CCGAAGAGGC AT - #GAAGGGAC8940- TTTCCAAGGC AGGCGTGGCC TGGGCGGGAC TGGGGAGTGG CGAGCCCTCA GA - #TGCTGCAT9000- ATAAGCAGCT GCTTTCTGCC TGTACTGGGT CTCTCTGGTT AGACCAGATC TG - #AGCCTGGG9060- AGCTCTCTGG CTAGCTAGGG AACCCACTGC TTAAGCCTCA ATAAAGCTTG CC - #TTGAGTGC9120- TTCAAGTAGT GTGTGCCCGT CTGTTGTGTG ACTCTGGTAT CTAGAGATCC CT - #CAGACCAT9180# 9207 AATC TCTAGCA__________________________________________________________________________

Non-pathogenic strains of HIV-1 containing mutations in the NEF gene or the U3 region of the long terminal repeat

Information

Patent Number

Date Filed

Date Issued

Inventors

Original Assignees

Examiners

Agents

CPC

US Classifications

Field of Search

US

International Classifications

Abstract

Description

Claims

Non-Patent Literature Citations (13)

Entry
Kirchoff et al., 1995, New Engl. J. Med. 332:228-232.
Huang et al., 1995, J. Virol. 69:93-100.
Terwilliger et al., 1991, Proc. Natl. Acad. Sci. USA 88:10971-10975.
Michael et al., 1995, J. Virol. 69:6758-6769.
Haynes, B., 1993, Science 260:1279-1286.
Graham et al., 1995, New Engl. J. Med. 333:1331-1339.
Ruprecht et al., 1995, The Lancet 346:177-178.
Baba et al., 1995, Science 267:1820-1825.
Miller et al., 1994, J. Exp. Med. 179:101-113.
Zagury et al., 1990, AIDS Res. Human Retro. 6:1079-1085.
Kestler et al., 1991, Cell 65:651-662.
Binninger et al., 1991, J. Virol. 65:5237-5243.
Desrosiers,R., 1992, AIDS Res. Human Retro. 8:411-421.